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1.1 Spinal Cord Injury  
Injuries to the spinal column often cause a disruption or 
compression of the medulla which results in loss of sensory, 
motor and autonomic function below the level of injury. Injuries 
to the cervical spinal cord can cause deficits in all four extremities 
(tetraplegia), while injuries to the thoracic or lumbar spinal cord 
affect the legs and, depending on the lesion level, also the 
muscles of the trunk (paraplegia). Persons with tetraplegia are 
injured between the first and the eighth cervical spinal vertebra 
(C1-C8) and individuals with paraplegia between the first 
thoracic spinal vertebra and the fifth lumbar spinal vertebra (T1-
L5) (Figure 1). Neurological level and completeness of an injury 
largely determine functional independence after a spinal cord 
injury (SCI). The classification of a SCI is based on the lowest 
intact spinal segment for motor and sensory function respectively. 
In order to better classify impairments related to the different 
lesion levels, including information about completeness of motor 
and sensory functioning, the American Spinal Injury 
Association (ASIA) defined a so called ‘ASIA impairment 
scale’ (12) that consists of 5 categories (Table 1).  
 
Table 1: ASIA impairment scale         
 Descriptions of categories 
ASIA A Complete injury where no sensory or motor function is preserved in sacral 
segments S4-S5. 
ASIA B Incomplete injury where sensory, but not motor function is preserved below the 
neurologic level and extends through sacral segments S4-S5. 
ASIA C 
Incomplete injury where motor function is preserved below the neurologic level 
and most key muscle below the neurologic level have muscle grade less than 3 
(active full range movements against gravity). 
ASIA D 
Incomplete injury where motor function is preserved below the neurologic level 
and most key muscles below the neurologic level have muscle grade greater 
than or equal to 3. 
ASIA E Normal sensory and motor functions. 
 
Figure 1: The spinal cord with 
indication of segments  
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Both in the U.S. and the Netherlands incomplete tetraplegia represents the most frequent 
category of patients, followed by complete paraplegia, complete tetraplegia and incomplete 
paraplegia (4, 136).  As a result of the loss in sensory, motor and autonomic function below 
the lesion level, persons with a SCI experience lesion level dependent changes in bladder and 
bowel function, sexual function, gastrointestinal function, blood pressure, thermoregulation 
and breathing ability (142). Secondary complications such as deep vein thrombosis and 
autonomic dysreflexia, hypotension, osteoporosis, heterotopic ossification, contractures, 
pressure ulcers, pain, spasticity, atelectasis and pneumonia are further problems that often 
occur during the course of a SCI (33, 34, 63, 117, 135, 142, 161). 
 
Epidemiology of SCI 
The incidence of SCI is estimated to be approximately 40 cases per million population per 
year in the U.S. (4) and 30 cases per million persons per year in Switzerland (60). 
Interestingly, in the Netherlands and Ireland the incidence of SCI seems to be much lower 
with only 12 and 13 cases per million persons per year (152, 119). More consistent 
epidemiologic data regarding the difference between countries include the variables gender 
and age at injury. Generally, it is men (70-80%) rather than women (20-30%) that get affected 
by SCI (4, 28, 35, 136, 152). The mean age at injury for traumatic lesions lies between 20 and 
30 years in the majority of cases (4, 35, 136).  Non-traumatic lesions normally occur much 
later with a peak in the age group of 60 to 70 years (136). Injuries to the spinal cord may 
either be traumatic (motor vehicle accidents, falls, various sports accidents or gun shots) or 
non-traumatic (tumors, spinal stenosis, vascular or birth defects). Epidemiologic data of 
traumatic and non-traumatic SCI cases reported in literature varies widely (28, 35, 77, 136, 
152). Schönherr et al. (136) reported a figure of 52% for non-traumatic causes for SCI in the 
Netherlands, while we know that in Switzerland the percentage of non-traumatic cases 
continuously rose over the last few years (50). A main difference in the rehabilitation of 
traumatic and non-traumatic SCI involves in the length of stay in the rehabilitation unit. 
Usually the rehabilitation of persons with non-traumatic SCI lasts much shorter than the 
rehabilitation of individuals with traumatic SCI (133, 136). Data from the Netherlands and 
Israel report an average of 85 and 106 days of inpatient rehabilitation for non-traumatic SCI, 
while their traumatic counterparts had a mean duration of 205 and 239 days of inpatient 
rehabilitation, respectively (133, 136). Length of stay for persons with traumatic SCI shows 
major differences between Europe and the U.S. (35). In contrast to the fairly long duration of 
inpatient rehabilitation in most European countries (200-400 days on average) (35, 133, 136), 
length of stay in the rehabilitation unit in the U.S. decreased from a mean of 115 days in 1974 
to 39 days in 2004 (3). This big difference between European and U.S. countries in length of 
stay during inpatient rehabilitation may arise from differences in rehabilitation goals. 
Rehabilitation of SCI in European countries not only contains the restoration of physical 
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functioning, but also factors such as emotional adaptation to the new situation, regaining 
social independence and reintegration into the community which often includes adaptations in 
housing and the working place. Reintegration into the community and resumption of work are 
not only important contributing factors to the quality of life of each individual living with SCI 
on the one hand, but it also helps reducing health care costs that encumber the whole 
community. Another factor that continuously entails an increase in health care costs are 
rehospitalizations (113). The main causes of rehospitalisations after discharge from inpatient 
rehabilitation of individuals with SCI are diseases of the genitourinary and the respiratory 
system (25). Individuals with tetraplegia tend to be more frequently rehospitalized due to 
respiratory complications, while individuals with paraplegia commonly encounter diseases of 
the genitourinary system (25). Even though life expectancy in SCI increased drastically 
during the last decades due to various advances in medical and critical care, it still remains 
somewhat below the average of the able bodied population (48). Life expectancy decreases 
the lower the age at injury and the higher the lesion level (3). Ventilator dependency further 
reduces life expectancy regardless of lesion level (3). Mortality rates are significantly higher 
during the first year after injury than during the subsequent years (3.) The primary causes of 
death in the SCI population are pneumonia, pulmonary emboli and septicaemia (3, 47). 
Therefore, cardio-pulmonary tasks seem to be an important issue during and after SCI 
rehabilitation. 
 
1.2 Respiratory mechanics and physiology in able bodied persons 
Respiration is an essentially vital process and 
therefore respiratory muscles have to work 
continuously throughout the whole day. The 
coordinated action of respiratory muscle activity 
rhythmically moves the rib cage and the diaphragm 
to pump air in and out of the lungs. The chest wall 
mainly consists of the rib cage and the abdomen 
separated by the diaphragm and can be considered 
as one interacting system (37). During inspiration, 
the diaphragm moves caudally and the chest wall 
and anterior abdominal wall move outward. The 
diaphragm is the main respiratory muscle, that has to 
work continuously and consists of a dome and the 
zone of apposition (Figure 2) (37). During 
inspiration, the zone of apposition applies an 
expanding pressure on the lower rib cage which supports the action of the external intercostal 
muscles (37). The expansion of the rib cage essentially happens through an outward-upward 
Figure 2: Dome and zone of apposition of 
the diaphragm. Reprinted with permission 
from Elsevier (37).   
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rotation of the ribs around the axis of the articulations with the vertebral bodies (87, 159) and 
thereby, together with the action of the diaphragm, increases the intra-thoracic volume (40). 
This increase of volume lowers the air pressure in the alveoli to below atmospheric pressure. 
Because air always flows from a region of high pressure to a region of lower pressure, it now 
rushes in through the respiratory tract and into the alveoli. In the alveoli gas exchange, i.e. 
oxygen uptake and carbon dioxide release, takes place. The process of inspiration is further 
supported by the sternocleidomastoids that elevate the sternum, the scalenes that elevate the 
top two ribs and the external intercostals and the pectorals that elevate further ribs and thereby 
open the chest wall. During expiration the thoracic cavity returns to its original volume, 
increasing the air pressure in the lungs, and forcing the air out. During resting breathing, 
expiration is mainly a passive process where the diaphragm moves cranially and returns to its 
initial relaxed position while the rib cage and the anterior abdominal wall move inward. 
Active expiration, e.g. during coughing or physical activity is further supported by the 
abdominal muscles that push the diaphragm up faster, the rectus abdominis that pulls down on 
the lower ribs and the internal intercostals that draw the ribs down. 
 
1.3 Respiratory muscle training and fatigue  
Respiratory muscles are, functionally and morphologically, skeletal muscles. Thus, 
respiratory muscles may fatigue in a similar way as skeletal muscles do, but they also improve 
their performance due to adequate training stimuli (2, 86, 104). Therefore, respiratory muscle 
training may follow the basic training principles acquainted with skeletal muscle training. The 
most important principle is that muscles only adapt when an adequate training stimuli that lies 
above a certain individual threshold is achieved. An adequate training stimulus may include 
an increase of duration, intensity or frequency of training. In accordance to skeletal muscles, 
respiratory muscles can be targeted for strength or endurance by specific training programs 
(93). Nevertheless, the rationale for isolated respiratory muscle training was not generally 
accepted in the last decades. Dempsey and Babcock postulated that the resources of the 
respiratory system are that high that they may not limit exercise performance (45), which was 
supported by many other publications (44, 49, 62, 72, 121, 123). Anyway, during the last two 
decades growing evidence showed that respiratory muscles fatigue during intensive physical 
exercise tasks (32, 98, 99, 110, 124), that respiratory muscle fatigue limits exercise 
performance (103, 108) and that respiratory muscle training increases exercise performance in 
healthy individuals (18-20, 64, 106, 112, 131, 144). Additionally it has been shown that 
physical exercise training induced changes in respiratory muscles and thus even intensive 
physical exercise training may be an adequate training stimulus for improvements in 
respiratory muscle performance (30, 88, 126). Of course respiratory muscle performance may 
also decrease over time due to deconditioning, e.g. when respiratory muscle training is 
stopped (2, 27, 66, 130) . 
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Respiratory muscle strength training in healthy humans 
The principles of respiratory muscle strength training follow those of skeletal muscle strength 
training. Therefore, an adequate in- or expiratory pressure has to be obtained in order to 
achieve a training effect (15). Respiratory muscle strength training can be performed as 
inspiratory, expiratory or combined in- and expiratory muscle training. Nevertheless, in most 
respiratory muscle strength training studies subjects had to perform inspiratory muscle 
strength training (36, 43, 68, 90, 91). Respiratory muscle strength training can be performed 
with resistive loading or with threshold loading (122). During threshold loaded respiratory 
training, inspiratory pressure is independent of the flow rate and therefore the amount of 
resistance can not be altered by changing the breathing pattern, like it would be possible 
during resistive loaded breathing. The threshold loading method is presently the most 
commonly used method (122). Training stimuli showed to be task specific (130). Inspiratory 
muscle strength training significantly improved maximal inspiratory muscle pressure (Pimax) 
(51, 64, 71, 93, 131, 156) and expiratory muscle strength training improved maximal 
expiratory muscle pressure (Pemax) (93, 156). There is some evidence that resistive inspiratory 
muscle training may enhance cycling endurance exercise capacity (64, 131, 132). However, 
Williams et al. did not find any improvements in maximal running performance after resistive 
inspiratory muscle training in competitive athletes (158). 
 
Respiratory muscle endurance training in healthy humans 
Respiratory muscle endurance training is generally performed using normocapnic hyperpnoea 
(for details see 1.8 of this Introduction) (137). Performing normocapnic hyperpnoea training 
requires to maintain a ventilation level of 55-85% MVV for about 30 minutes (111, 137). This 
training has to be conducted 3 to 5 times a week for several consecutive weeks in order to 
increase the time of maximal sustainable normocapnic ventilation, which represents 
respiratory muscle endurance performance (126). Several studies showed that respiratory 
muscles fatigue during intensive endurance exercise tasks (31, 82, 86, 104, 124). Further, it is 
known that fatigued respiratory muscles may limit endurance exercise performance (103, 
108). Therefore, specific respiratory muscle endurance training aiming to increase physical 
endurance exercise performance was assessed in several studies and showed improvements in 
respiratory muscle endurance performance (14, 19, 20, 59, 83, 88, 92, 93, 105, 115, 145, 149). 
Even though if all these studies reported significant increases in respiratory muscle endurance 
performance, not all found improvements in physical exercise endurance capacity after 
respiratory muscle endurance training (14, 59, 115, 143). Studies which investigated effects of 
normocapnic hyperpnoea training through physical exercise endurance tests at a very high 
intensity (i.e. 90-95% of peak oxygen uptake (VO2peak)), did not find any improvements in 
exercise performance (59, 72, 115). Accordingly, VO2peak did not increase in most 
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normocapnic hyperpnoea training studies (19, 20, 59, 92, 106, 115, 145). In contrast to this, 
most studies that assessed effects of normocapnic hyperpnoea training in endurance exercise 
tests at intensities between 60 and 85% VO2peak showed significant increases in endurance 
exercise performance after 4 to 8 weeks of normocapnic hyperpnoea training (19, 20, 83, 106, 
112, 143, 145, 149). Controversies concerning the impact of normocapnic hyperpnoea 
training on exercise performance may also be caused by several other confounding factors 
such as training status of the subjects tested, duration and the amount of muscle mass used 
during the exercise performance test, the concept of the exercise performance test, i.e. 
whether an endurance test at a given intensity or a time-trial to exhaustion was performed, 
duration and intensity of the normocapnic hyperpnoea training and the duration between the 
last normocapnic hyperpnoea training and the exercise performance test. Of course low 
sample sizes may additionally diminish explanatory power of such studies. Unfortunately, all 
the studies mentioned above differed substantially in the factors that may influence the 
outcome of studies that are investigating the effects of normocapnic hyperpnoea training. 
Several studies measured various physiologic parameters in addition to respiratory and 
physical exercise endurance in order to understand the mechanisms by which physical 
exercise endurance is influenced by normocapnic hyperpnoea training (59, 106, 115, 143, 
145, 149). These studies did not find any systematic effects from normocapnic hyperpnoea 
training on exercise performance which may be explained by changes in the heart (106) or the 
lung (149). Concerning changes in blood lactate concentrations after normocapnic 
hyperpnoea training, the literature reveals controversial findings (143, 145). Sonetti et al. 
(143) found no changes in blood lactate concentrations during an incremental or a constant 
work rate test after five weeks of combined respiratory muscle strength and endurance 
training. In contrast to this, Spengler et al. (145) reported significant decreases in blood 
lactate concentrations at the end of both an incremental as well as a constant work rate 
endurance test after four weeks of respiratory muscle endurance training. They speculated that 
these decreases in blood lactate concentrations may be caused by an improved lactate uptake 
by the trained respiratory muscles (145). Respiratory muscles mainly cosist of type I muscle 
fibres (2) which can use lactate as energy source. Thus, respiratory muscles may probably be 
used to fasten lactate removal and thus accelerate recovery after high intensity exercise bouts. 
Nevertheless, this assumption first has to be tested. 
Another interesting approach is the one of Harms et al. about the competing situation between 
limb and respiratory muscles for their share of cardiac output (74-76). It is most likely that 
effects of normocapnic hyperpnoea training reduce oxygen costs of breathing, meaning that at 
the same exercise intensity respiratory muscles need less oxygen, i.e. a lesser percentage of 
cardiac output. Thus, limb muscles may work on a more aerobic level at a higher exercise 
intensity or sustain a given exercise intensity for a longer time. Changes in reflex sympathetic 
activation that reduce blood flow due to diaphragmatic fatigue are discussed as well as a 
factor decreasing exercise performance. This reduction may be caused by a reflex from the 
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diaphragm on the vegetative nervous system causing an increased sympathetic activity which 
may lead to a vasoconstriction in the leg muscles (138, 147). Changes in dyspnea and 
breathlessness or the perception of respiratory muscle effort due to normocapnic hyperpnoea 
training are discussed as a further possible factor that may influence exercise performance 
(19, 155). Nevertheless, physiologic mechanisms through which exercise performance may be 
enhanced after isolated normocapnic hyperpnoea training are not yet known in detail. 
Therefore, at the present time it is not yet possible to arrive at a conclusion regarding the 
effects of normocapnic hyperpnoea training on physical exercise performance in healthy 
individuals.  
 
1.4 SCI and respiratory function 
SCI can result in diminished pulmonary function due to lesion dependent paralysis of 
respiratory muscles. Persons with paraplegia miss function of the abdominal muscles and, 
depending on the lesion level, also of the intercostal muscles. Persons with tetraplegia lack 
most of the expiratory and even some of the auxiliary inspiratory muscles. The diaphragm is 
the main inspiratory muscle and innervated through the N. phrenicus between C3 and C5. 
Therefore, complete lesions above C4 require mechanical ventilation in most cases. The main 
respiratory muscles and their level of innervations are presented in Figure 3. 
inspiratory muscles             expiratory muscles 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: The main respiratory muscles and their innervation; Netter illustration used with permission of 
Elsevier Inc. All rights reserved. 
M.sternocleidomastoideus 
(C2-3) 
Mm. scaleni (C3-8) 
anterior 
medius 
posterior 
Mm. intercostales externi 
(Th1-12) 
Mm. intercostales interni   
(Th1-12) 
 
Mm. intercostales 
interni (Th1-12) 
M. rectus abdominis 
(Th5-12) 
M. obliquus externus 
abdominis (Th5-12) 
M. obliquus internus 
abdominis (Th5-12) 
M. transversus 
abdominis (Th7-12) 
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Respiration seems to be one of the main problems in chronic SCI and especially in tetraplegia 
(78). Respiratory complications such as pneumonia, atelectasis and respiratory failure are 
major causes of morbidity and mortality in subjects with SCI (6, 61, 128). Such complications 
often arise because of an ineffective cough and secretion retention due to paralyzed expiratory 
muscles. They therefore become more severe with higher lesion level and early after injury (8, 
94). Immediately after the event of a SCI 62% of all patients had respiratory complications 
(94) while the most common problems during the first month after injury were atelectasis and 
pneumonia (36%) (128). A longitudinal study assessed survival rates over the first 9 years 
after injury. They reported that in individuals with tetraplegia survival rates increased with 
years post injury and that survival rates were higher in ventilator independent persons 
compared to ventilator dependent (26). Although the mortality rate after an acute SCI 
decreased significantly during the last 40 years (78), a recent prospective mortality study 
including 28’000 persons with SCI in the U.S. reported that respiratory complications were 
the leading cause of death (28%) during the first year after injury and were ranked 3rd (18%) 
beyond the first year after injury (48). Respiratory complications during the first two years 
after injury decreased substantially over the last three decades, but there was no decrease in 
the chronic stage of an SCI (148). Thus, the time succeeding 2 years after injury is important 
for regular screening and prevention of pulmonary complications of persons with chronic 
SCI. Unfortunately little is known about prevention strategies of pulmonary complications 
and their effectiveness in subjects with SCI. 
 
Respiratory function measurements in SCI  
Accuracy of lung function measurement in subjects with SCI is very important, in order to 
answer the question whether they generally show decreases in lung volumes, flows and 
respiratory muscle strength due to lesion dependent paralysis (7, 97, 109). Therefore, Kelley 
et al. examined the degree to which the spirometry testing standards of the American Thoracic 
Society (ATS) were adhered to in a large cohort of subjects with SCI (89). This study showed 
that 83% of all tested subjects with SCI (n = 278) met the ATS acceptability standards and 
even 94% met the ATS reproducibility standards for lung function testing (89). Although a 
rather high percentage of subjects fulfilled able bodied standards, they adapted these 
standards for subjects with SCI in order to not provoke a positive selection bias. The 
exclusion of subjects could confound the assessment of the true effect of SCI on pulmonary 
function. This study and also a preliminary study of the same group (11) showed that 
particularly subjects with cervical, motor complete SCI were not able to meet ATS criteria 
(5). Therefore adaptations were made with respect to the minimum time needed for exhalation 
to measure forced vital capacity (FVC). The originally required 6 seconds of expiration time 
were not maintained and the end of test criteria was reduced to a minimum of a 0.5 s plateau 
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(11). Using these new criteria in subjects with SCI, the reproducibility of the results was now 
even higher (98%) and the acceptability increased to 94% of all subjects tested (89). 
 
Depending on the level and completeness of the lesion, the respiratory function of subjects 
with SCI is affected to different extents, decreasing respiratory function with increasing lesion 
level (7, 96). Therefore, reference equations of able bodied individuals (127) can not be 
applied to subjects with SCI and have to include the lesion level. Lung function seems to 
change over time, showing strong increases during the first year after injury (17, 101) with 
further increases until 10 years after injury, but high decreases thereafter (150). Decreases in 
FVC beyond 10 years after injury seem to be much higher than the known loss in able bodied 
individuals due to increasing age (127, 150). This high decrease may arise due to rib cage 
stiffening especially in subjects without intercostal muscle activity (65, 116). Nevertheless, 
neither are lesion dependent reference equations, nor longitudinal lung function data after SCI 
known for this population. Regarding respiratory muscle strength, even less is known about 
lesion dependent differences and time-courses after SCI. Only one recently published study 
(109) assessed lesion dependent impairments in respiratory muscle pressure generating 
capacity - a measure of respiratory muscle strength - and showed that increasing lesion level 
also decreases maximal inspiratory muscle presssure generation (Pimax) and maximal 
expiratory muscle pressure generation (Pemax), while Pemax was much more affected than Pimax 
compared to able bodied reference values (16). Data of this study were assessed in patients 
between 1 month and 22 years after injury (109). Since lung function showed large changes 
especially early after injury, the same can be expected for respiratory muscle pressure 
generation and thus these data may not be very representative of all subjects or be easily 
compared with subjects at a certain time after injury. Longitudinal changes in respiratory 
muscle pressure generation after SCI have never been investigated in literature so far. 
 
1.5 Respiratory mechanics in SCI  
Respiratory muscle paralysis that occurs to different extents in subjects with SCI also alters 
respiratory mechanics (160). Changes in chest wall mechanics influence compliance of the 
whole respiratory system which may decrease breathing efficiency and especially impair 
coughing. A reduced mobility of the chest wall leads to rib cage stiffening during the chronic 
phase of SCI (116), which may in turn decrease lung volumes and thus also the ability to 
cough (22). Coughing is important, especially in subjects with tetraplegia, in order to clear 
secretion (24). Causes of changes in respiratory compliance after SCI are related to an 
increased abdominal compliance and a decrease in chest wall mobility. Decreases in chest 
wall mobility may occur due to chronically diminished thoracic excursions because of 
inspiratory muscle weakness. This in turn leads to stiffness of tendons, ligaments and 
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Inspiration in able bodied individuals 
Inspiration in spinal cord injured individuals 
ankylosis in the joints of the rib cage which induces stiffness of the whole thoracic cage (53, 
56). Changes in mobility of the chest wall and abdomen induce restrictive ventilatory 
impairments and a paradoxical breathing pattern in subjects with tetraplegia and high 
paraplegia (160). Due to paralyzed intercostal muscle function, the chest wall is drawn inward 
during inspiration and the highly compliant abdominal wall moves outward due to the 
absence of abdominal muscle function (Figure 4). Additionally, postural changes affect 
respiration of subjects with SCI to a much higher degree than in able bodied individuals and 
much more in persons with tetraplegia than in paraplegic individuals (29). While in able 
bodied persons FVC slightly decreases from 
erect to supine, FVC slightly increases in 
subjects with paraplegia and substantially 
increases in subjects with teraplegia by about 
0.4 l, which may lay around 20% of FVC in 
subjects with tetraplegia (29, 54). This 
phenomenon occurs due to the disadvantageous 
position of the diaphragm, which in the sitting 
position is less pushed up by the abdominal 
content because of paralyzed abdominal 
muscles. Thus, in subjects with SCI the 
diaphragm has to operate at a disadvantageous 
force-length relationship (24). 
Figure 4:  Effects of inspiration to the abdominal and thoracic wall in able bodied and tetraplegic individuals 
(paradoxical breathing pattern) ___  resting; ---- active;          passive.  
 
In the supine position, the gravitational force decreases abdominal compliance in tetraplegic 
subjects which causes an advantageous resting position of the diaphragm and thus increases 
lung volumes. 
Respiratory mechanics in able bodied and tetraplegic individuals was intensively studied by 
Estenne & De Troyer since the early eighties (37-42, 53, 58). One of the most interesting and 
clinically relevant topics is expiratory muscle function and cough production in subjects with 
teraplegia which often has been described as fully passive due to expiratory muscle paralysis 
(139, 160). Estenne & De Troyer found that the clavicular portion of the pectoralis major 
muscle plays a major role during coughing and that coughing is an active rather than a passive 
process in subjects with tetraplegia (52). Consequently, they trained the clavicular portion of 
the pectoralis muscle in subjects with tetraplegia and found an increase in expiratory reserve 
volume and an improvement in expiratory muscle function (57). Further, they found that 
during the expiratory phase of coughing the diaphragm is active in subjects with abdominal 
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muscle paralysis and that the paradoxical expansion of the abdomen during coughing is 
induced by the action of the pectoralis major and not by the diaphragm (55). 
 
1.6 Respiratory muscle training in SCI  
The facts described in chapters 1.4 and 1.5 pointed out that the respiratory system of subjects 
with SCI is severely affected. Due to the lesion dependent loss of respiratory muscle 
innervation, the remaining active respiratory muscles have to accomplish the whole work of 
breathing. Thus, these muscles have to work at a higher relative intensity compared to able 
bodied individuals in daily life and especially during physical exercise tasks. There is some 
evidence that the diaphragm fatigues during physical exercise in subjects with tetraplegia 
(141) and that ventilatory muscle endurance can be enhanced by physical endurance exercise 
training in these patients (140). Fatigue of respiratory muscles may also impair cough 
capacity and therefore increase the risk for respiratory complications. Even though this 
hypothesis is not yet confirmed, several authors investigated different types of respiratory 
muscle training in subjects with SCI, aiming to increase pulmonary function and decrease the 
risk of respiratory complications (46, 69, 70, 95). The main findings of respiratory muscle 
training studies in subjects with SCI are summarized in two recent review papers (23, 153). 
The review written by van Houtte et al. included studies about all types of respiratory muscle 
training in SCI. Of the 23 papers that assessed effects of respiratory muscle training in SCI, 
only 6 were controlled trials and thus included in the review (57, 69, 84, 95, 100, 162). 
Unfortunately, a meta-analysis of these studies was not possible due to unreported data and 
heterogeneity in outcome variables (153). However, from the 6 trials included in the 
systematic review they finally concluded that respiratory muscle training showed tendencies 
to increase Pemax and FVC and decrease residual volume (RV). Unfortunately, it was not 
possible to draw conclusions about the effects of respiratory muscle training on Pimax, 
respiratory muscle endurance, quality of life, exercise performance and respiratory 
complications (153). Two of the six controlled studies investigated resistive inspiratory 
muscle training (95, 100), two others used a kind of inspiratory strength-endurance training 
(151, 162), and the other two investigated expiratory muscle training, one by resistive loading 
of respiratory muscles (69) and the other one by pectoralis muscle training (57). Thus, task 
specific effects of different respiratory muscle training methods still remain unclear. The other 
review written by Brooks et al. solely included studies about inspiratory muscle training in 
tetraplegic subjects (23). From the 40 articles retrieved, only three (46, 95, 100) met the 
inclusion criteria of randomized controlled trials and for similar causes as in the review of van 
Houtte et al. (153), a meta-analysis could not be performed and no overall effect could be 
confirmed. The various types and training regimes of the papers included in the systematic 
reviews clearly show that little evidence exists about effects of respiratory muscle training in 
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SCI, although there is some indication of positive influences in able bodied individuals. 
Interestingly, none of the reviewed studies used normocapnic hyperpnoea training. 
 
1.7 Outline of the Thesis 
Aim of the present studies 
Respiration is an essential function in daily life of human beings. Since respiration is affected 
to different degrees in subjects with SCI, the optimal functioning of the remaining part of the 
respiratory system is vitally important to subjects with SCI. Detailed knowledge of lesion 
dependent impairments, trajectories of impairments and differences between able bodied 
subjects and individuals with para- or tetraplegia are important to know. Such knowledge 
should help to individualize interventions and thus improve primary and lifelong care of 
individuals with SCI. Improved respiratory function may lead to better physical functioning, 
improved quality of life and decreased pulmonary function and thus also decreases in health 
care costs. The main aims of this thesis therefore are to evaluate lesion dependent 
determinants of low respiratory function, differences in chest wall mobility between subjects 
with tetrapelgia and able bodied individuals and to investigate the effects of normocapnic 
hyperpnoea training in subjects with SCI in order to improve pulmonary function and exercise 
performance.  
Some cross-sectional research has been performed about impairments in respiratory function 
but mostly in heterogeneous groups of individuals with chronic SCI (7, 96, 97, 109, 146). 
Nevertheless, none of these studies investigated lesion dependent determinants and 
trajectories of lung function and respiratory muscle strength in individuals with SCI over the 
whole range of lesion levels and at a consistent time post injury. Therefore Chapter 2 
evaluates respiratory function in SCI one year after discharge from inpatient rehabilitation and 
presents regression equations for lung function and respiratory muscle strength in subjects 
with motor complete and motor incomplete para- and tetraplegia separately. Further, it 
provides information about associations of lung function with respiratory muscle pressure 
generation in subjects with different levels of SCI.  
Chapter 3 provides additional clinically relevant information about time-courses of lung 
function and respiratory muscle pressure generation during and one year after discharge from 
inpatient rehabilitation. The aim of this study was to compare time-courses of respiratory 
function between the different respiratory parameters as well as between different lesion level 
groups. Respiratory muscle endurance training by means of normocapnic hyperpnoea training 
improved respiratory muscle endurance and in some studies also physical endurance exercise 
performance in able bodied subjects (19, 20, 83, 106, 112, 143, 145, 149). Therefore, 
normocapnic hyperpnoea training may also be an interesting mean to improve respiratory 
function and physical exercise performance in subjects with SCI. Due to the lower amount of 
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respiratory muscle mass in subjects with SCI, normocapnic hyperpnoea training may probably 
not be performed at the same relative intensity level as in able bodied subjects. Since no study 
used normocapnic hyperpnoea training in individuals with SCI, Chapter 4 presents a paper 
about the optimal intensity for normocapnic hyperpnoea training in subjects with para- and 
tetraplegia separately.  
Wheelchair racing athletes with SCI use respiratory muscles concurrently for breathing and 
locomotion. Therefore normocapnic hyperpnoea training may have different effects on 
wheelchair racing performance compared to the ones of cycling in able bodied individuals. 
Thus, Chapter 5 addresses the effects of normocapnic hyperpnoea training on wheelchair 
racing performance in athletes with SCI, by means of a 10 km time-trial. Further, effects on 
lung function and respiratory muscle pressure generation, respiratory muscle endurance and 
VO2peak are assessed as well. 
High blood lactate levels are produced during anaerobic exercise intensities as e.g. short 
distance wheelchair racing. Blood lactate elimination is enhanced using a previously loaded 
large muscle group for active recovery. Normocapnic hyperpnoea exercise is performed by 
respiratory muscles which mainly contain type I fibres, the main lactate consumers. Thus 
normocapnic hyperpnoea may be advantageous as a recovery strategy in order to preserve 
energy sources of the limb muscles. The aim of the study presented in Chapter 6 is to 
investigate the impact of low intensity normocapnic hyperpnoea on blood lactate 
disappearance after exhaustive arm exercise in comparison to passive (rest) and active 
recovery (low intensity arm cranking) using the previously loaded muscle groups.  
A decrease in rib cage mobility due to stiffening is a problem that affects respiratory function 
of subjects with chronic tetraplegia (53, 56) in addition to other problems discussed above. 
We hypothesize that respiratory muscle training may also help to increase rib cage mobility or 
decrease the process of stiffening. Nevertheless, a fast and easily applied method to measure 
rib cage mobility with a high level of reproducibility does not exist. Therefore we developed a 
new method using computed tomography and tested it’s reproducibility in able bodied 
individuals and subjects with chronic tetraplegia. Intra-subject as well as intra- and inter-tester 
reproducibility of our new method to measure rib cage mobility are addressed in Chapter 7.  
Chapter 8 describes differences in breathing mechanics between individuals with chronic, 
motor complete tetraplegia and matched able bodied subjects. The aim of this chapter is to 
evaluate differences in diaphragmatic movements and rib cage mobility between able bodied 
subjects and tetraplegic persons using the method described in chapter 7. Knowledge of such 
differences should help to quantify possible changes which may occur due to respiratory 
muscle training and thus improve knowledge about which training principle, amount and 
intensity is best for which SCI patient group. 
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In Chapter 9 the findings of the chapters 2 to 8 are summarized and general conclusions are 
drawn. Further, the findings of this thesis are discussed and continuative research in the area 
of respiratory muscle training in subjects with SCI with implications for clinical practice is 
suggested. 
 
1.8 Methods applied in this thesis 
Lung function testing 
Lung function measurement is a widely accepted, easy to perform and non-invasive clinical 
tool for the diagnosis and the monitoring of therapy effectiveness or the time-course of a 
disease. The individual is asked to perform different breathing maneuvers which consist of 
slow and forced maximal in- and expirations and some seconds of maximal voluntary 
hyperventilation. FVC is the change in volume of air in the lungs from complete inspiration to 
complete expiration. Forced expiratory volume in one second (FEV1) is the volume of air 
exhaled in the first second of a forced expiration starting from full inspiration. FEV1 often is 
expressed as % of FVC, also known as ‘Tiffenau-Index’. A normal ‘Tiffenau-Index’ is around 
80% whereas a low value provides some evidence of an obstructive impairment. In patients 
with restrictive impairments (e.g. subjects with tetraplegia), the ‘Tiffenau-Index’ may be 
normal or increased. Forced inspiratory volume in one second (FIV1) is the volume of air 
inhaled in the first second of a forced inspiration starting from full expiration. Peak expiratory 
flow (PEF) is the greatest flow that can be sustained on forced expiration starting from full 
inflation of the lungs and is measured in litres per second. PEF may be lowered due to 
weakness of expiratory muscles, thorax deformities and emphysema. Peak inspiratory flow 
(PIF) is the greatest flow that can be sustained on forced inspiration starting from full 
expiration of the lungs. Lung volumes are illustrated graphically on Figure 5.1. Maximal 
voluntary ventilation (MVV) is a measure of maximal ventilatory capacity, i.e. maximal 
voluntary hyperpnoea. MVV is usually measured during 12 or 15 seconds and calculated as 
maximal breathing capacity over one minute, expressed in l/min. Tidal volume (VT) 
represents the volume one in- and exhales during normal quiet breathing at rest. Functional 
residual capacity (FRC) represents the end expiratory lung volume after a normal ‘passive’ 
expiration. At FRC all respiratory muscles are in a more or less relaxed state, i.e. there is 
equilibrium between outward pulling forces of the thorax and inward pulling forces of the 
lungs. FRC can be measured by bodyplethysmography (see below) as intra-thoracic gas 
volume (IGV). Measurement of IGV constitutes the basis for calculation of RV and total lung 
capacity (TLC). Expiratory reserve volume (ERV) is the volume that can be exhaled from 
FRC, using active expiratory muscles. RV is the volume that fills the lungs and airways after 
total expiration, i.e. FRC minus ERV. TLC represents the maximal volume that the lung and 
airways can contain, i.e. RV + FVC. These volumes are shown in Figure 5.2.  
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Quality of measurements 
Normal lung function parameters as shown in Figure 5.1 are determined by spirometry using 
a mouthpiece with a calibrated turbine. Lung function testing is highly dependent on the effort 
put in by the subject and the quality of the tester. At the end of the maneuvers there should be 
no volume displacement over a period of 6 seconds in able bodied subjects (5). Lung function 
testing that does not fulfill this quality feature are frequent and mainly dependent on the tester 
(73). A further quality standard of lung function testing is to perform at least three 
consecutive repetitions of all maneuvers where values are within a range of 5% (127). 
 
The concept of reference equations 
FVC and consequently all other lung function parameters mainly depend on gender, height 
and age. Thus, reference equations for FVC, FEV1 and PEF containing these factors were 
created (127). It is an ongoing debate how accurate these reference equations are, since many 
other factors such as body weight, smoking or diseases like diabetes mellitus may influence 
lung function as well (13, 120).  Nevertheless, the European Respiratory Society accepted and 
published the reference equations of Quanier et al. as European standard measures (127). 
Many others published reference equations for different age- and ethnic groups (1, 85, 107, 
125). Unfortunately, reference equations are only available for FVC, FEV1, PEF, ERV, IGV 
and TLC, but not for FIV1 and PIF (127). 
 
Figure 5.2: Volume curve showing different 
volumes of quiet breathing and maximal in- and  
expiration. 
 
Figure 5.1: Flow-volume curve showing 
parameters of lung function testing. 
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Bodyplethysmography 
Today’s ‘gold standard’ of lung function measurement is bodyplethysmography. In addition 
to normal spirometry, IGV and airway resistances can be determined by 
bodyplethysmography. The measurement principle of bodyplethysmography is based on the 
‘Boyle-Mariotte-Law’ which says that under isothermic conditions, pressure times volume is 
constant (P x V = const.). A Bodyplethysmograph is a hermetically sealed cabin of 700-1000 l 
into which the subject is placed in. The changes of pressure in the cabin are proportional to 
the alveolar pressure. A pneumotachograph measures changes in mouth pressure (i.e. alveolar 
pressure) and cabin pressure during quiet and occluded breathing to determine IGV (i.e. FRC) 
and breathing resistance. A disadvantage of IGV measurement is that the content of the 
gastric bladder is measured as well which often produces ‘false positive’ TLC and RV data. 
This has to be taken into account, especially for follow-up measurements. 
 
Respiratory muscle pressure testing 
The most simple and most common approach of respiratory muscle pressure testing is to 
measure Pimax and Pemax at the mouth when the subject makes maximal efforts against a 
closed airway (129.) The preferred technique to measure Pimax and Pemax is the one described 
by Black and Hyatt (16). They also defined normal values for Pimax and Pemax that depend on 
sex and age (16). The important thing about measuring Pimax and Pemax is that the mouthpiece 
of the measurement device has a small air-leak that prevents glottis closure, to avoid that 
facial muscles are able to contribute to expiratory pressure. In order to generate Pimax, the 
subject exhales to RV and makes a maximal powerful inspiratory effort. To generate Pemax the 
subject inhales to TLC and makes a maximal expiratory effort. Both, Pimax and Pemax should 
be sustained for a few seconds. The basic determinants of respiratory muscle pressure - the 
common measures of respiratory muscle strength - are similar to those of skeletal muscle 
strength and consist of: (129) 
1. The resting length of the muscle prior to contraction (force-length relationship) (67) 
2. Whether or not the muscle is allowed to shorten during contraction  
   (force-velocity relationship) (81) 
3. The strength and frequency of stimulation (force-frequency relationship) 
4. The integrity of the contractile apparatus 
Therefore, the muscle length at which respiratory muscle strength is measured plays an 
important role for the interpretation of the data. Especially in subjects with obstructive or 
restrictive breathing disorders (e.g. tetraplegics), muscles may not be at their optimal length to 
perform maximal efforts. Even if Pimax and Pemax are normally measured at RV and TLC, one 
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has to be aware of the fact that the elastic recoil of the lungs and the chest wall is measured as 
well. Especially Pimax is highly affected by pulmonary recoil forces and thus Pimax measured 
from RV is overestimated by about 30% in healthy able bodied individuals (129). 
Measurement from FRC would resolve this problem, but the disadvantage that FRC is less 
reproducible than TLC and RV equals the advantage of measurement from FRC. Learning 
effects of respiratory muscle strength maneuvers seem to be higher than those for lung 
function measurement (154, 157). Therefore oftentimes, more than three measurements have 
to be performed to get three values within 5%. The higher learning effects of Pimax and Pemax 
maneuvers may occur because these maneuvers are more difficult to perform for the subjects 
than lung function maneuvers. Therefore, some additional and easier to perform tests are 
recommended to measure inspiratory (sniff test) (114) and expiratory (cough test) (10) muscle 
strength. The sniff maneuver is an alternative to Pimax that is more natural and easier to 
perform for most subjects. A sniff maneuver is usually measured from FRC, while the subject 
performs short and sharp sniffs through the nose and the mouth is occluded (79). Sniff nasal 
inspiratory pressure (SNIP) is measured in one nostril which is occluded by the device while 
the other nostril is open. The SNIP test was shown to be reliable and is suggested as an 
additional test for those subjects who show problems in performing Pimax maneuvers (80). The 
cough test consists of performing a maximal cough while measuring the peak flow during this 
maneuver. Since coughing is a common task, most people report fewer problems while 
performing a maximal cough compared to a Pemax maneuver. The cough test may especially 
be helpful for testing individuals with diseases that affect expiratory muscle function. Causes 
of weakness in respiratory muscle pressure generating capacity may be neuromuscular 
disease, mechanical, metabolic and nutritional factors or reduction of neural drive (129). 
Testing of respiratory muscle pressures in addition to lung function measurement seems to be 
highly important in clinical practice, since e.g. severe respiratory muscle weakness alone can 
lead to respiratory failure (21). 
 
Normocapnic hyperpnoea training  
In order to perform isolated endurance training for the respiratory muscles, normocapnic 
hyperpnoea training may be applied. During normocapnic hyperpnoea training, intensive 
isolated hyperventilation is performed as exercise task. Using a specific normocapnic 
hyperpnoea training device, voluntary, non-resistive hyperpnoea with either added CO2 or 
partial re-breathing is performed while minute ventilation, i.e. breathing volume and 
frequency, has to be held constant. The amount of CO2 that one re-breathes has to be adjusted 
so that end tidal CO2 stays around individual resting conditions. Because of the complicated 
equipment needed to perform normocapnic hyperpnoea training, it was not possible to 
perform such training in a home setting initially. Since the year 2001, a commercially 
available mobile normocapnic hyperpnoea training device, called ‘Spiro Tiger’ is available 
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from idiag AG (idiag AG, Müllistr. 18, CH-8320 Fehraltorf, Switzerland; www.idiag.ch). 
This mobile device consists of a hand held unit with a respiratory pouch and a base station 
(Figure 6).  
 
Figure 6: The Spiro Tiger device; reprinted with permission of idiag AG 
 
The size of the pouch is available in different sizes and should be approximately 50% of FVC. 
The first part of exhaled air fills the pouch (2/3 to 3/4 of exhaled air) and the rest is expired 
through the valve. Breathing frequency is adjusted so that normocapnic hyperpnoea training is 
performed between 60 and 70% MVV in able bodied subjects. A visual and acoustic signal 
indicates the breathing frequency on the base station which can be individually programmed 
with the size of the pouch, the target breathing frequency and the training time. The electronic 
device registers the opening time of the valve and thus calculates tidal volume while 
controlling for the correct breathing frequency. Finally, the feedback display provides 
information about minute ventilation and whether the breathing frequency is too high or too 
low. After one or two initial training sessions, where end tidal CO2 partial pressure should be 
controlled by a cardio-respiratory measurement device, normocapnic hyperpnoea training can 
be performed independently. 
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Abstract 
Objective: To assess the influences of personal and lesion characteristics on the impairments 
of lung function and respiratory muscle pressure in subjects with spinal cord injury (SCI), one 
year after discharge from inpatient rehabilitation.  
Methods: This study was performed as cross-sectional, multi-centre study, including eight 
SCI rehabilitation centres. 129 subjects performed lung function measurements and 41 out of 
these performed additional respiratory muscle pressure measurements. Multivariate regression 
equations were calculated for four different groups, i.e. subjects with motor complete 
paraplegia, incomplete paraplegia, motor complete tetraplegia and incomplete tetraplegia.  
Results: While forced vital capacity and forced expiratory volume in 1 s were between 74% 
and 94% of able bodied predicted, peak expiratory flow was only between 54% in complete 
tetraplegics and 75% in incomplete paraplegics. Maximal expiratory muscle pressure showed 
the highest limitations with values between 14% predicted in complete teraplegics and 45% in 
incomplete paraplegics. Lesion level and gender were related to most respiratory variables. 
Age and height were related to lung function parameters only. Body weight and smoking had 
no significant influence on any of the tested parameters.  
Conclusions: Expiratory muscle pressure is the most severely affected parameter within all 
SCI individuals. Motor complete tetraplegics were the subjects with the lowest lung function 
and respiratory muscle pressure generation and may therefore be at higher risk for respiratory 
complications. Clinicians are encouraged to regularly screen lung function and respiratory 
muscle pressure generation as well as motivate patients for respiratory muscle training, 
particularly after inpatient rehabilitation. 
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Introduction   
A spinal cord injury (SCI) causes lesion-dependent losses of respiratory muscle innervation, 
which can lead to impairments in respiratory muscle function (27). Due to paralysis of most 
expiratory muscles in subjects with tetraplegia and high paraplegia, the ability to cough and 
clear secretion is decreased. Because of this, various types of respiratory diseases such as 
dyspnoea, pneumonia, or respiratory failure occur (9). Causes of respiratory complications are 
often multi-factorial and seem to be associated with low respiratory function (33, 15). 
Therefore, detailed knowledge of lesion-dependent impairments and factors determining lung 
function and respiratory muscle pressure in subjects with SCI, two years after injury, should 
be evaluated as a basic indicator for preventative measures. Currently, only little knowledge 
exists about factors influencing respiratory function in SCI. Related studies are limited to the 
assessment of lung function in chronic SCI around 15 to 20 years post injury (5, 21). To our 
knowledge, only limited information is available on respiratory muscle pressure (24) and 
none on its associations to lung function in subjects with SCI. The present study aims to fill 
this gap with respect to subjects in the post-acute stage of SCI by investigating the following 
aspects: 
1) To study lung function and respiratory muscle pressure in relation to lesion level and 
completeness in subjects with SCI, one year after discharge from inpatient 
rehabilitation.  
2) To find determinants (i.e. level and completeness of the lesion, age, gender, height, 
weight and smoking) of lung function, in- and expiratory muscle pressure and 
inspiratory muscle endurance in subjects with SCI. 
3) To find associations between lung function and respiratory muscle pressure 
parameters. 
 
Methods   
This study was part of the Dutch research program ‘Physical strain, work capacity and 
mechanisms of restoration of mobility in the rehabilitation of persons with SCI’ (12).  
 
Subjects 
Persons with SCI were recruited from eight SCI rehabilitation centres in the Netherlands, one 
year after discharge from inpatient rehabilitation. Inclusion criteria were a traumatic SCI, 
wheelchair dependency and an age range between 18 and 65 years. Prior to testing subjects 
were extensively screened by a physician and physical therapist. Potential participants were 
excluded if they had cardio-respiratory disorders (4), a resting diastolic blood pressure higher 
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than 90 mmHg, or a systolic blood pressure higher than 180 mmHg, and if they had one or 
more of the following diseases: COPD; severe atelectasis; lung emphysema with O2-
dependency, a history of pneumothorax, a progressive disease (e.g. ALS, MS), a psychiatric 
problem or no mastery of the Dutch language. Level and completeness of injury were 
determined by a physician according to the American Spinal Injury Association Scale (7). 
Finally, 129 subjects were included in the present study and completed the lung function 
measurements. Out of these 129 subjects, 41 subjects completed additional respiratory muscle 
pressure measurements.  
 
Protocol 
All participants completed an informed consent form after being informed about the testing 
procedure. The Medical Ethics Committee approved all tests and protocols. On the test day, 
participants were asked to consume a light meal only, to refrain from smoking, drinking 
coffee and alcohol at least two hours prior to testing and to void their bladder directly before 
testing. Eight trained paramedical research assistants who worked in the participating 
rehabilitation centres conducted the tests. All research assistants received extensive training in 
how to conduct the tests. The same equipment was used for each measurement, after 
standardized calibration, in the eight participating centres. Personal characteristics were 
derived from questionnaire data and body mass was measured immediately before the 
assessment of respiratory function. 
 
Lung function measurements 
Lung function parameters were measured using a cardio-respiratory measurement device 
(Oxycon Delta, Jaeger, Hoechberg, Germany) which was calibrated before each test. Lung 
function measurements were performed according to a standardized protocol (3) and consisted 
of forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), forced inspiratory 
volume in 1 s (FIV1), peak expiratory flow (PEF) and peak inspiratory flow (PIF). 
Participants had to breathe through a mouthpiece while wearing a nose clip. Each 
measurement was repeated until three measurements were registered within ± 5% of each 
other. The highest value measured for each parameter was then used for further analysis. Age- 
gender- and height-corrected reference values (1) (100% predicted)  for FVC, FEV1 and PEF 
of able bodied subjects were used to compare our measured values. 
 
Respiratory muscle pressure and incremental threshold loading tests 
Peak inspiratory muscle pressure (Pimax) and peak expiratory muscle pressure (Pemax) were 
measured by an electronic manometer (Threshold meter (self made); Dept. of Physiology, 
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Radboud University, Nijmegen, The Netherlands) that fed into a personal computer for the 
recording of the data and which we connected to a mouthpiece with a small leak to prevent 
glottis closure. For measurements of maximal respiratory muscle pressure subjects were in an 
upright sitting position, wearing a nose clip and breathing through a mouthpiece. Pimax was 
measured from residual volume and Pemax was measured from total lung capacity. Subjects 
repeated each manoeuvre until three measurements were recorded within a range of ± 5%. 
Maximum pressures had to be maintained for at least 1 s. The highest plateau pressures (1 s) 
of Pimax and Pemax were used for analysis (32). Age- and gender-corrected reference values of 
able bodied subjects (8) were calculated for our groups of SCI subjects for Pimax and Pemax in 
order to compare the measured values to able bodied subjects 100% predicted. After a 
recovery period of 10 min, a subsequent test was performed to determine inspiratory threshold 
endurance time (tendu) and load (Pendu). This test was conducted with an inspiratory threshold-
loading device (Threshold IMT, Respironics, Herrsching, Germany). All participants started 
at an inspiratory load of 0.7 kPa, which had to be kept up for 1 min with a paced inspiration 
time of 3 s and expiration time of 4 s. Thereafter, the inspiratory load was instantly increased 
by 15% of the individual Pimax and participants had to perform the test for a second minute. 
This procedure was repeated until participants were no longer able to sustain the actual load. 
When the maximal load of the device (4.1 kPa) was achieved, subjects had to sustain this load 
as long as possible with a maximum of 3 min. The duration of the whole test (tendu) and the 
load at test break-off (Pendu) were used for further analysis. 
 
Statistical analysis 
Descriptive statistics (means ± SD) for group characteristics and respiratory function were 
calculated for each parameter and separately for subject groups with a motor complete 
tetraplegia, incomplete tetraplegia, complete paraplegia and incomplete paraplegia. 
Differences in personal and lesion characteristics between the group that performed lung 
function measurements only (n = 88) and the group that performed additional respiratory 
muscle pressure testing (n = 41) were evaluated by unpaired t-tests using Systat (Systat 
Version 10.2; Systat Software Inc., San Jose, USA). Differences between lesion groups for 
able bodied subjects percentage predicted values of FVC, FEV1, PEF, Pimax and Pemax were 
calculated using one-way ANOVA with Bonferroni post-hoc tests (Systat) to localize 
significant differences between groups. Significance was set to p < 0.05.  
In order to determine the relationship between personal and lesion characteristics and lung 
function and respiratory muscle pressure, the multilevel modelling program MLwin (MLwin 
Version 1.1; Centre for Multilevel Modelling, Institute for Education; London, UK) (29) was 
used. Outcome variables were FVC, FEV1, FIV1, PEF, PIF, Pimax, Pemax, Pendu and tendu. The 
hierarchy in the data was based on the individual participants (level 1) who were grouped in 
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the rehabilitation centres (level 2). As potential influencing factors on respiratory function, the 
level (subjects with paraplegia = 1, subjects with tetraplegia = 0) and completeness of the 
lesion (complete = 1, incomplete = 0), gender (male = 1, female = 0), age (years), height (m), 
weight (kg) as well as current smoking (current smoker = 1, non-smoker = 0) and former 
smoking (former smoker = 1, non-smoker = 0) were added one by one to a basic univariate 
multilevel regression model. Independent variables with p-values < 0.1 were included in a 
subsequent multilevel model, which was followed by a backward selection procedure 
excluding non-significant determinants (p > 0.05) in order to create the final multivariate 
model. 
In addition, a multiple linear regression analysis was used to determine whether there were 
significant associations between lung function parameters and respiratory muscle pressure. In 
case of a significant association between these parameters the personal and lesion 
characteristics were checked one by one for their confounding effect. This was defined as a 
change in beta of the independent variable of more than 10%. Eventually, all confounders 
were added to the final model. 
 
Results   
Participants’ characteristics of the lung function group and the respiratory muscle pressure 
group showed no significant differences (Table 1 and 2).  
 
Table 1: Participants’ characteristics of the whole group (lung function testing) 
 
gender 
[male / 
female] 
TPI 
[months] 
age 
[years] 
height 
[m] 
weight 
[kg] 
smoker 
[%] 
Subjects with complete 
tetraplegia 
20 / 6 28.5 ± 5.2 29 ± 10 1.77 ± 0.09 76 ± 16 65 
Subjects with incomplete 
tetraplegia 
10 / 5 22.3 ± 6.2 48 ± 9 1.74 ± 0.07 73 ± 14 60 
Subject with complete 
paraplegia 
48 / 17 22.0 ± 5.1 39 ± 14 1.79 ± 0.09 78 ± 15 46 
Subject with incomplete 
paraplegia 
19 / 4 20.1 ± 3.3 42 ± 16 1.78 ± 0.10 79 ± 20 35 
Whole group 97 / 32 23.0 ± 5.7 38 ± 14 1.78 ± 0.09 77 ± 16 50 
TPI = time post injury 
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Table 2: Participants’ characteristics of the group that performed additional respiratory 
muscle pressure measurements 
 
gender 
[male /  
female] 
TPI 
[months] 
age 
[years] 
height 
[m] 
weight 
[kg] 
smoker 
[%] 
Subjects with complete 
tetraplegia 
6 / 2 28.5 ± 3.1 28 ± 11 1.78 ± 0.08 80 ± 20 38 
Subjects with 
incomplete tetraplegia 
5 / 1 22.7 ± 7.1 49 ± 6 1.76 ± 0.04 77 ± 19 83 
Subject with complete 
paraplegia 
13 / 5 23.1 ± 4.2 36 ± 13 1.80 ± 0.08 79 ± 12 50 
Subject with 
incomplete paraplegia 
8 / 1 21.7 ± 3.7 45 ± 15 1.77 ± 0.12 80 ± 28 44 
Whole group 32 / 9 23.8 ± 4.9 39 ± 14 1.79 ± 0.09 79 ± 18 51 
TPI = time post injury 
 
Lung function 
The means ± SD of the lung function parameters of the measured SCI group as a whole were 
4.09 ± 1.29 l FVC (87 ± 22% pred.), 3.32 ± 1.04 l FEV1 (86 ± 22% pred.), 3.62 ± 1.19 l FIV1, 
5.94 ± 1.88 l/s PEF (67 ± 20% pred.) and 4.97 ± 1.7 1/s PIF. Motor complete subjects 
generally showed lower values than motor incomplete subjects and subjects with tetraplegia 
showed lower values than subjects with paraplegia (Table 3, Figure 1).  
 
Table 3: Mean ± SD [%] of gender, age and height corrected lung function as well as gender 
and age corrected respiratory muscle pressure of able bodied 100% predicted  
 FVC % FEV1 % PEF % Pimax % Pemax % 
Subjects with complete 
tetraplegia 
74 ± 21 76 ± 22 54 ± 17 56 ± 17 14 ± 7 
Subjects with incomplete 
tetraplegia 
94 ± 26* 90 ± 26 73 ± 23* 53 ± 23 25 ± 8 
Subject with complete 
paraplegia 
89 ± 20* 87 ± 20 69 ± 18* 82 ± 24 36 ± 17* 
Subject with incomplete 
paraplegia 
94 ± 20* 92 ± 24 75 ± 20* 56 ± 25 45 ± 12* 
 FVC = forced vital capacity; FEV1 = forced expiratory volume in 1 s; PEF = peak expiratory flow; Pimax =  
 maximal inspiratory muscle pressure; Pemax = maximal expiratory muscle pressure; * = significant difference 
 to subjects with complete teraplegia 
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Figure 1: Measured mean values and standard deviations for forced vital capacity (FVC), forced expiratory 
volume in 1 s (FEV1), forced inspiratory volume in 1 s (FIV1), peak expiratory flow (PEF) and peak inspiratory 
flow (PIF) given for the four lesion-related subgroups. Gender-, age- and height-corrected able bodied subjects 
100% predicted with 95% confidence intervals (CI) are given for FVC, FEV1 and PEF.  
 
All lung function parameters were significantly associated to the level of injury. Men showed 
significantly higher values than women (except for PEF), younger subjects showed higher 
values than older ones and taller subjects showed higher values than smaller ones (except for 
PIF). Smoking and body weight had no significant influence on any of the tested lung 
function parameters (Table 4). Using the regression equations presented in Table 4, allows 
calculating the predicted lung function and respiratory muscle pressure values for any subject 
with SCI that meet the inclusion criteria of this study. The calculation of the predicted FVC of 
e.g. a male subject with motor complete paraplegia, 37 years old, 1.78 m tall and 72 kg body 
weight would be as follows: 
 
FVC = -4.60 (constant) + 0.49 (paraplegia) + 0.83 (male) - (37 x 0.02) (age) + (1.78 x 4.80) 
(height) = 4.524 l 
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Table 4: Regression coefficients (βi) for lung function and respiratory muscle pressure 
parameters from the multivariate multilevel regression analysis 
FVC = forced vital capacity; FEV1 = forced expiratory volume in 1 s; FIV1 = forced inspiratory volume in 1 s; 
PEF = peak expiratory flow; PIF = peak inspiratory flow; Pimax = maximal inspiratory muscle pressure; Pemax = 
maximal expiratory muscle pressure; Pendu = maximal pressure of inspiratory threshold endurance test; tendu = 
time of inspiratory threshold endurance test;  β = regression coefficient for each independent variable; level: 1 = 
subject with paraplegia, 0 = subjects with tetraplegia; completeness: 1 = complete, 0 = incomplete; gender: 1 = 
male, 0 = female; age = years; height = m; * = p<0.05; ** = p<0.01; *** = p<0.001; n.s. = not significant. Note 
that body weight and smoking had no significant influence on any of the tested parameters and are therefore not 
shown in Table 4. 
 
Maximal respiratory muscle pressure test and incremental threshold loading test  
Mean Pimax of the whole group was at 7.54 ± 3.02 kPa (67 ± 25% pred.). Mean Pemax of the 
whole group reached only 6.56 ± 3.58 kPa (32 ± 17% pred.). Respiratory muscle pressure of 
lesion-dependent subgroups was clearly below able bodied subjects 100% predicted after 
correction for gender and age (8) (Table 4, Figure 2). Pimax and Pemax were significantly 
associated with the level and completeness of the lesion as well as with gender (Table 4). 
Subjects with paraplegia showed higher values than subjects with tetraplegia and men showed 
higher values than women. Age, height, body weight and smoking had no significant 
influence on any of the tested respiratory muscle pressure parameters. Pendu was associated 
with lesion level and gender while tendu was influenced by lesion level only (Table 4).  
 
 subjects 
[n] 
β0  
(constant) 
β1  
(level) 
β2  
(compl.) 
β3 
(gender) 
β4 
(age) 
β5  
(height) 
FVC (l) [128] -4.60 0.49* n.s. 0.83*** - 4.80*** 
FEV1 (l) [128] -3.10 0.34* n.s. 0.55** - 3.75*** 
FIV1 (l) [128] -2.98 0.53** n.s. 0.71** - 3.60*** 
PEF (l/s) [128] -7.24 1.00** -1.09*** n.s. -0.025* 8.02*** 
PIF (l/s) [127] 4.56 0.66* n.s. 1.23*** -0.03** n.s. 
Pemax (kPa) [41] 3.59 4.19*** -2.13* 2.01* n.s. n.s. 
Pimax (kPa) [39] 2.92 1.88* 2.04* 2.68** n.s. n.s. 
Pendu (kPa) [38] 2.09 0.75* n.s. 0.91** n.s. n.s. 
tendu (kPa) [38] 3.08 1.36** n.s. n.s. n.s. n.s. 
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Figure 2: Measured mean values and standard deviations for maximal inspiratory pressure (Pimax), maximal 
expiratory pressure (Pemax), maximal load (Pendu) and time (tendu) of the incremental threshold-loading test given 
for the four lesion-related subgroups.  
 
Associations between respiratory muscle pressure and lung function  
Pemax and Pimax were significant determinants of most lung function parameters (Table 5). 
Gender was a confounder for all significant associations and sometimes level and 
completeness of the lesion or age had an additional confounding effect (Table 5).  
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Table 5: Significant associations between lung function and respiratory muscle pressure 
parameters, as well as significant confounders in the multi-variate multilevel regression model  
FVC = forced vital capacity; FEV1 = forced expiratory volume in 1 s; FIV1 = forced inspiratory volume in 1 s; 
PEF = peak expiratory flow; PIF = peak inspiratory flow; Pimax = maximal inspiratory muscle pressure; Pemax = 
maximal expiratory muscle pressure; Pendu = maximal pressure of inspiratory threshold endurance test; tendu = 
time of inspiratory threshold endurance test;  β = regression coefficient for each independent variable; level: 1 = 
subject with paraplegia, 0 = subjects with tetraplegia; completeness: 1 = complete, 0 = incomplete; gender: 1 = 
male, 0 = female; age = years; * = p < 0.05; ** = p < 0.01; *** = p < 0.001; - = no confounder; Note that only 
respiratory muscle pressure parameters with significant associations to lung function parameters are listed and 
height, body weight and smoking were no confounders to any of the tested parameters and are therefore not 
shown in Table 5. 
 
Discussion  
Lung function and respiratory muscle pressure in subjects with different levels of SCI are 
influenced by similar parameters as able bodied subjects (3, 8), i.e. gender, age and height - 
but additionally by the lesion level and in some cases also by completeness of the lesion 
(PEF, Pemax and Pimax). Motor complete tetraplegics are the most severely affected subjects, 
 constant pressure  parameter confounding variables 
 β0 β1  β2 (level) β3 (compl.) β3 (gender) β4 (age) 
FVC (l) 1.93 0.17***  Pemax -0.23 0.40 1.09** - 
 
1.90 0.24***  Pimax - -0.49* 0.65* - 
 
1.34 0.55***  Pendu - - 1.07*** - 
 
2.10 0.24*  tendu -  1.10** - 
FEV1 (l) 1.63 0.12***  Pemax -0.30 0.41 0.92** - 
 
1.93 0.17***  Pimax - - 0.57* -0.013 
 
1.21 0.37**  Pendu - - 0.94** - 
FIV1 (l) 1.89 0.09  Pemax -0.12 0.46 1.08** - 
 
1.45 0.20***  Pimax - - 0.63* - 
 
0.97 0.58***  Pendu - - 0.81* - 
PEF (l/s) 4.71 0.12  Pemax - - 1.26* 0.019 
 
3.39 0.29**  Pimax - -0.70 0.73 - 
PIF (l/s) 2.47 0.28***  Pimax -0.66 - 0.86 - 
 
2.11 0.65*  Pendu -0.44 - 1.21 - 
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with significantly lower FVC and PEF than all other SCI groups, and significantly lower 
Pemax than subjects with paraplegia.  
 
Lung function 
Compared to able bodied subjects’ predicted values, FVC and FEV1 were rather normal in 
subjects with paraplegia, but reduced by around 25% in complete tetraplegics. Regression 
coefficients of age represent a decrease in lung function of 0.2 to 0.3 l per 10 years of age. 
These coefficients for subjects with SCI, one year after discharge from inpatient 
rehabilitation, are in accordance with those for able bodied subjects (1). Cross-sectional 
studies (5, 22) of subjects with chronic SCI, 19 and 16 years post injury, showed lower FVC 
and FEV1 values than those found in our subjects (22). Age and time post injury or the 
combination of both seems to be important factors decreasing respiratory function over time. 
In addition, a decrease in lung function may be possible because of rib cage stiffening, 
particularly in subjects with tetraplegia (13). Nevertheless, neither from our data nor from 
other cross-sectional studies (5, 22) of subjects with chronic SCI a potential decrease in lung 
volumes per year post injury can be extrapolated. Longitudinal studies beyond the first two 
years post injury and over at least 10 years post injury, including large groups of subjects are 
needed to evaluate this interesting aspect.  
 
To produce an effective cough a PEF of at least 5-6 l/s is necessary (16). Results of the 
present study show that the median PEF of subjects with tetraplegia was around 5-6 l/s. This 
indicates that about 50% of this group is not able to produce an effective cough and may 
therefore be at high risk for respiratory tract infections. PEF appears to be a relevant 
parameter for clinical practice. It could be a useful screening parameter in subjects with SCI 
in order to detect a potential risk for respiratory complications at an early stage (i.e. PEF 
below 5 l/s). 
 
Recently, it has been shown that FVC, which also depends on a deep inspiration, correlates 
with voluntary cough capacity in subjects with tetraplegia (19). Even if expiration is the 
weakest part of respiration in SCI, the importance of the inspiratory lung function should not 
be underestimated. A fast and deep inspiration leads to an advantageous position of the 
diaphragm and a higher lung elastic recoil that can help to increase the power of expiration (6, 
30). This may be an important aspect to improve cough capacity, particularly in subjects with 
tetraplegia, where most of the expiratory muscles are paralyzed and who can not produce a 
PEF over 5-6 l/s (33).  
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The finding that smoking did not influence any of the tested parameters was surprising. Since 
50% of the subjects included in this study were active or former smokers, our finding could 
not be a problem of power. Other studies found significant negative influences of smoking on 
lung function in subjects with SCI (5, 23). Influences of smoking on lung function were also 
assessed dichotomously in these studies (5, 23). These subjects were older (mean age of 45 to 
50 yrs) and had a longer duration of injury (16 and 19 years) than subjects in the present 
study. This shows that smoking may have negative consequences particularly in the chronic 
stage of SCI. Thus, smoking cessation should be encouraged as early as possible after SCI. 
 
Maximal respiratory muscle pressure 
Mean Pimax and Pemax were even more below the able bodied subjects’ reference values than 
the values of lung function in all four SCI groups (Table 3). Pemax of all of our groups was 
below 50% of the able bodied subjects predicted. This indicates that Pemax in subjects with 
SCI is strongly affected by the lesion-dependent absence of expiratory muscle innervation. 
The degree to which Pimax is reduced in all lesion level groups shows that it is the respiratory 
muscle pressure rather than the lung function that is more affected in subjects with SCI (Table 
3). As indicated by our data, training of the remaining expiratory (14, 18) as well as 
inspiratory (18, 20) muscles in order to improve the cough effectiveness and to decrease other 
respiratory complications seems to be beneficial (11, 25, 31). 
 
Associations between respiratory muscle pressure and lung function  
We found that an increase of 1 kPa in Pimax is associated with a higher increase in lung 
function than the same increase in Pemax (Table 5). Resistive inspiratory muscle training 
performed by subjects with chronic tetraplegia showed that respiratory muscle pressure 
training over the duration of eight weeks, administered 15 min and twice daily, improved 
Pimax by 2 kPa and Pemax by 1.5 kPa (31). According to our regression equations (Table 5) 
such an increase in Pimax would be associated with an improvement in FVC of 0.48 l or 0.58 
l/s in PEF. Related to our predicted loss in FVC of 0.2-0.3 l per 10 years of age, this increase 
which may be achieved by training seems to justify respiratory muscle training in individuals 
with SCI. Particularly for subjects with tetraplegia, who often show FVC between 1 and 2 l, 
such an increase may improve respiration substantially. Improvements in respiratory muscle 
pressure may therefore be of high importance when the PEF lies around or below the critical 
value for active coughing of 5-6 l/s.  
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Study limitations  
As a result of the inclusion criteria ‘wheelchair-dependent’ for the whole Dutch research 
programm (11), the majority of the participants had a motor complete lesion. Therefore, the 
strength of the calculated models may be higher for subjects with a motor complete lesion 
than for those with incomplete lesions. Because of the higher percentage of men, our models 
may be less accurate for women. Nevertheless, our study represents a normal gender 
distribution within the SCI population (2, 10, 26).  
 
Conclusion  
PEF and Pemax were the most severely affected parameters, especially in subjects with motor 
complete tetraplegia. About 50% of the subjects with motor complete tetraplegia were below 
the critical level of 5-6l/s PEF that is necessary to produce an effective cough and may 
therefore be exposed to an increased risk for respiratory complications. Thus, subjects with 
motor complete tetraplegia should be screened regularly for the prevention of respiratory 
complications including PEF and Pemax measurements. Further, clinicians are encouraged to 
motivate and brief patients for respiratory muscle training especially after inpatient 
rehabilitation. 
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Abstract 
Objective: To investigate the time-courses of lung function and respiratory muscle pressure 
generating capacity after spinal cord injury.   
Methods: 109 subjects with recent, motor complete spinal cord injury were assessed in a 
multi-centre, prospective cohort study. Lung function and respiratory muscle pressure 
generating capacity were measured at first mobilization, at discharge from inpatient 
rehabilitation and one year after discharge. Lung function was measured in all 109 subjects 
and 55 out of these performed additional measurements of respiratory muscle pressure 
generating capacity. Trajectories of respiratory muscle function for different lesion level 
groups were assessed by multivariate multilevel regression models. 
Results: Forced vital capacity, forced expiratory volume in 1 s and maximal inspiratory 
muscle pressure generating capacity significantly increased during and after inpatient 
rehabilitation. Forced inspiratory volume in 1 s, peak inspiratory flow, peak expiratory flow 
and maximal expiratory muscle pressure generating capacity only increased during inpatient 
rehabilitation but not thereafter. Increasing lesion level had a negative effect on all measured 
lung function parameters, as well as on maximal in- and expiratory muscle pressure 
generating capacity. 
Conclusion: Respiratory function improved during inpatient rehabilitation, but only forced 
vital capacity, forced expiratory volume in 1 s and maximal inspiratory muscle pressure 
generating capacity further improved thereafter. Especially expiratory muscle function and 
subjects with tetraplegia should be screened and trained regularly. 
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Introduction 
Pulmonary complications occur in 50-67% of persons with a spinal cord injury (SCI) (17, 25), 
with pneumonia being the most common cause of death in individuals with tetraplegia (15). A 
recent prospective mortality study showed that the respiratory system was responsible for the 
cause of death in 28% of the cases during the first year after injury and in 22% thereafter (21). 
In cross-sectional studies it has been shown that with increasing lesion level lung function 
decreases (52) and respiratory tract infections increase (17).  
In individuals with SCI, the pulmonary system is often affected due to lesion-dependent 
losses of respiratory muscle innervations (2, 3, 31, 38). While persons with paraplegia lack 
proper innervation of the abdominal muscles and, depending on the lesion level, (parts of) the 
intercostal muscles, persons with tetraplegia lack most of the expiratory and even some of the 
auxiliary inspiratory muscles (14). The loss of respiratory muscle innervations mainly 
decreases cough capacity and therefore secretion clearance is reduced especially in subjects 
with high tetraplegia (43). Thus, respiratory muscle pressure generating capacity may be in 
direct relation with respiratory tract infections; however studies to prove this assumption are 
missing. 
Although Fugl-Meyer et al. (18, 20) assessed respiratory function in subjects with SCI as soon 
as the early seventies, still little is known about longitudinal changes of respiratory function in 
SCI. Sinderby et al. (45) studied diaphragmatic function in subjects with tetraplegia early (1-3 
years) and 10 or more years post injury. They found no significant changes in vital capacity 
and transdiaphragmatic pressure from early to more than 10 years post injury. Some small 
studies that evaluated trajectories of lung function early after SCI found strong improvements 
during the first 6 months after injury with smaller improvements thereafter (4, 7, 22, 34). 
Possibly the impact of spinal shock, which usually disappears within the first 4-6 months after 
injury, stabilizes pulmonary function and may therefore be responsible for this finding (35). 
All longitudinal studies show data which is either exclusively including subjects with 
tetraplegia (4, 5, 22, 34) or which is merely assessing a low number of subjects (5, 7, 34). 
As described above, lung function and respiratory muscle pressure generating capacity seem 
to change over time and depend on the level of the lesion (18, 20, 33, 45). Nevertheless, the 
influence of lesion level and time on lung function and respiratory muscle pressure generating 
capacity is not yet approached through a longitudinal perspective.  
A better understanding of lesion-dependence and trajectories of lung function and respiratory 
muscle impairments in persons with recent SCI would allow a better adjustment of 
therapeutic interventions which prevent complications and might further decrease mortality 
rates caused by respiratory tract infections. 
Therefore, the purpose of this study was to describe trajectories of lung function and 
respiratory muscle pressure generating capacity in a large group of subjects with recent SCI 
Chapter 3   
     
 54 
during and one year after inpatient rehabilitation, with respect to lesion level and personal 
factors. Gender, age, height, body weight and smoking were evaluated as personal factors, as 
they may influence respiratory function in addition to lesion characteristics and time. 
 
Methods 
This study was part of the Dutch research program ‘Physical strain, work capacity and 
mechanisms of restoration of mobility in the rehabilitation of persons with SCI’ (13).  
 
Subjects 
Persons with recent SCI from eight SCI rehabilitation centers in the Netherlands participated 
on a voluntary basis in this study between August 2000 and July 2003. Subjects were 
measured at the start of active rehabilitation (t1), at the end of their inpatient rehabilitation (t2) 
and one year after discharge (t3).  
Inclusion criteria for the current study were: an acute, motor complete SCI (ASIA A or B) and 
aged between 18 and 65 years. Potential participants were excluded if they had one or more of 
the following diseases: instable COPD, severe atelectasis, lung emphysema with O2 
dependency or a history of pneumothorax. Subjects were also excluded if they had a 
progressive disease, psychiatric problem or did not have enough knowledge of the Dutch 
language to understand the purpose of the study and the testing methods. Finally, 109 subjects 
were included in the present study and performed lung function measurement. Out of these 
109, 55 subjects completed additional measurements of respiratory muscle pressure 
generating capacity. For investigating the time-courses of lung function and respiratory 
muscle pressure generating capacity, only data of those subjects who could perform the tests 
more than once were included in the analysis (i.e. 109 subjects for lung function and 55 
subjects for respiratory muscle pressure generating capacity). 
Participants’ characteristics of the lung function group and the respiratory muscle pressure 
generating capacity subgroup are presented in Table 1 separately for the different lesion 
groups. There were no significant differences in personal characteristics between those 
subjects who performed only lung function measurements (n = 54) and those who performed 
respiratory muscle pressure generating capacity and lung function measurements (n = 55), (all 
p-values between 0.919 and 0.166).  
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Table 1: Participants’ characteristics of the whole group [n = 109]; (lung function testing) and 
of the subgroup [n = 55] (testing of respiratory muscle pressure generating capacity) 
HT = subjects with high tetraplegia (C3-C5), LT = subjects with low tetraplegia (C6-C8), HP = subjects with 
high paraplegia (T1-T6), LP = subjects with low paraplegia (T7-T12), BMI = body mass index; SCI = spinal 
cord injury 
 
Protocol 
All subjects completed an informed consent form after they received information about the 
testing procedure. The medical ethics committee approved this study. On the test day, subjects 
were asked to consume a light meal only, to refrain from smoking, drinking coffee and 
alcohol at least 2 h prior to testing and to void their bladder directly before testing.  
 
Lung function measurements 
Lung function measurements were conducted using a cardio-pulmonary and respiratory 
testing device (Oxycon Delta, Jaeger, Hoechberg, Germany) which was calibrated before each 
test. Lung function measurements were performed according to a standardized protocol (1). 
 
gender 
[men / 
women] 
age 
[years] 
height 
[m] 
weight 
[kg] 
BMI 
[kg/m2] 
smoker 
before 
injury 
current 
smoker 
Lung function measurements 
HT 14/6 36 ± 14 1.75 ± 0.08 71 ± 16 23.3 ± 5.2 30%      5% 
LT 15/4 33 ± 10 1.79 ± 0.11 69 ± 11 21.6 ± 3.3 79% 26% 
HP 23/7 43 ± 16 1.79 ± 0.09 77 ± 13 24.0 ± 3.1 33% 17% 
LP 29/11 38 ± 13 1.78 ± 0.09 70 ± 12 21.9 ± 3.5 40% 30% 
all subjects with  
SCI 
81/28 38 ± 14 1.78 ± 0.09 72 ± 13 22.6 ± 3.8 47% 23% 
Measurements of respiratory muscle pressure generating capacity 
subjects with 
tetraplegia 
20/6 33 ± 11 1.79 ± 0.10 70 ± 15 22.0 ± 4.4 54% 15% 
subjects with 
paraplegia 
21/8 39 ±14 1.77 ± 0.09 72 ± 12 22.8 ± 3.3 48% 38% 
all subjects with  
SCI 41/14 36 ± 13 1.78 ± 0.09 71 ± 13 22.4 ± 3.8 51% 27% 
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The following parameters were measured: forced vital capacity (FVC), forced expiratory 
volume in 1 s (FEV1), forced inspiratory volume in 1 s (FIV1), peak expiratory flow (PEF) 
and peak inspiratory flow (PIF). Subjects had to breathe through a mouthpiece while wearing 
a nose clip. Each measurement was performed until 3 reproducible measurements within at 
least ± 5 % were registered. The highest measured value of each parameter was used for 
further analysis. In order to compare values of the present study and to get more insight on the 
respiratory impairment of subjects with para-and tetraplegia, we calculated gender-, height- 
and age-corrected 100 % predicted values for able bodied subjects using the regression 
equations of Quanier et al. (40). 
 
Measurements of respiratory muscle pressure generating capacity  
Maximal inspiratory and expiratory muscle pressure generating capacity (Pimax, Pemax) 
measured at the mouth, were performed with a calibrated, respiratory threshold meter 
(Instrumental Department, Radboud University Nijmegen, the Netherlands) connected to a 
personal computer. Pimax and Pemax were measured from residual volume and total lung 
capacity, respectively. Subjects had to breathe through a mouthpiece with a clip on their nose. 
To prevent measurement of muscle force of the cheeks, subjects had to sit with their elbows 
on a table and their hands on the cheeks. A small air leak in the mouthpiece prevented glottis 
closure. The highest pressure that could be maintained for 1 s was determined by the 
computer program. Each measurement was performed until 3 reproducible measurements 
within at least ± 5 % were registered. A rest period of at least 1 min between each effort was 
kept. The best values for Pimax and Pemax were used for analysis. Measurement of maximal 
inspiratory and expiratory pressures (Pimax and Pemax) at the mouth are widely used and 
accepted as measures of respiratory muscle pressure generating capacity (30, 37, 46). 
However, in subjects with SCI changes in abdominal compliance e.g. due to spasticity, may 
influence respiratory muscle pressure generating capacity (42). 
After a resting period of 10 min, a further test was performed in order to determine inspiratory 
threshold muscle endurance time and pressure. This test was conducted with an inspiratory 
threshold meter (Threshold IMT, Respironics, Herrsching, Germany). All subjects started at 
an inspiratory pressure of 0.7 kPa. This pressure had to be kept up for 1 min with a paced 
inspiration time of 3 s and an expiration time of 4 s. When subjects were able to complete 1 
min, inspiratory pressure was immediately increased by 15 % of the individual Pimax and 
subjects completed the second min. This procedure was continued until subjects were no 
longer able to sustain the actual pressure, i.e. when target pressure could no longer be reached 
throughout the inspiration. If the maximal pressure of the device (4.1 kPa) was achieved, they 
had to sustain this pressure as long as possible with a maximum of 3 min. Time of the whole 
test (tendu) and pressure at test break-off (Pendu) were used for further analysis. 
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Statistical analysis 
Descriptive statistics (means ± standard deviations) for group characteristics were calculated 
for each parameter. Characteristics of the subjects who performed lung function 
measurements only (n = 54) and the respiratory muscle pressure generating capacity sub-
group (n = 55) were compared using unpaired t-tests. Significance was set at p < 0.05. T-tests 
were performed with SPSS (Version 13.0; SPSS Inc, 233 S Wacker Dr, 11th Fl, Chicago, IL 
60606, USA). 
For analysis of the longitudinal data, a multilevel modelling program (Centre for Multilevel 
Modelling, Institute of Education, 20 Bedford Way, London WC1H 0AL, UK) (41, 47) was 
used. Multilevel regression analysis is suitable for longitudinal datasets since i) it allows 
dependency of repeated measures within the same person, ii) it accounts for the hierarchy of 
the longitudinal data used in our study where the repeated measurements (level 1) are nested 
within the subjects (level 2) which are nested within rehabilitation centres (level 3), and iii) 
the number of observations per person may vary (47). Outcome variables were FVC, FEV1, 
FIV1, PEF, PIF, Pimax, Pemax, Pendu and tendu. Multilevel analysis was used to assess 1) the time-
courses of lung function and respiratory muscle pressure generating capacity outcome 
measures during and 1-year after inpatient rehabilitation. Time was modeled using 2 
dichotomous dummy variables with t2 as reference, in order to calculate the change during 
(∆t1t2) and after (∆t2t3) inpatient rehabilitation; 2) to assess differences in trajectories for lung 
function data among subjects with different lesion levels. Therefore, four groups were 
defined: HT = subjects with high tetraplegia (C3-C5), LT = subjects with low tetraplegia (C6-
C8), HP = subjects with high paraplegia (T1-T6) and LP = subjects with low paraplegia (T7-
T12). To calculate differences among groups, 3 dummies were used and LT was determined 
as reference group. To assess trajectories of respiratory muscle pressure generating capacity, 
only two groups (paraplegic and tetraplegic) were built in order to not lose statistical power 
since only 55 subjects performed these measurements. 
In a next step interactions between time- and group-dummies were added to the above 
described basic model. Interaction terms were only added to the final model if at least one of 
them was significant (p < 0.05).  
To investigate a possible influence of personal factors, as known from able bodied subjects 
reference equations (6, 40), these factors were added one by one to the model: gender (male = 
1, female = 0), age (years), height (m), weight (kg), former smoker, i.e. before injury (0 = 
non-smoker; 1 = former smoker) and current smoker (0 = non-smoker; 1 = current smoker) 
and evaluated whether they showed a significant (p < 0.10) influence on the outcome 
variables. After adding all significant (p < 0.10) personal factors to the basic model of time 
and group-dummies, a backward elimination technique was used until only determinants 
remained with a p-value < 0.05. Based on the final model, estimates for lung function and 
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respiratory muscle pressure generating capacity were calculated for the 4 lesion groups (lung 
function) and for subjects with para- and tetraplegia (respiratory muscle pressure generating 
capacity), respectively. 
 
Results 
There was no heterogeneity across the eight centres in any of the tested respiratory function 
parameters, i.e. that one centre systematically found higher or lower values for one parameter. 
Specific estimates for trajectories of these parameters were calculated for men only, and with 
subjects mean age (38 years) and height (1.78 m) (Figure 1 and 2). Presented models can be 
used to calculate estimated values for subject X at a certain time point after injury. For 
example, calculation of predicted FVC for a male subject with high tetraplegia, 38 years old 
and 1.78m tall, one year after inpatient rehabilitation would be as follows: 
FVC = β of constant + β of ∆t2-t3 + β of gender + (age [years] x β of age) + (height [m] x β 
of age)  
Presented in numbers this is:  
FVC = -3.62 + 0.179 - 1.070 + 0.692 + (38 x -0.014) + (1.78 x 4.12) = 2.98 l.  
 
Longitudinal changes 
FVC and FEV1 increased in all four groups until one year after discharge from inpatient 
rehabilitation (Figures 1a, 1b). At discharge from inpatient rehabilitation FVC and FEV1 were 
no more significantly lower than able bodied subjects’ reference values, i.e. within able 
bodied subjects 95% confidence intervals, for all groups except HT (Figures 1a, 1b). In 
contrast, FIV1, PEF and PIF generally seemed to remain constant during the first year after 
discharge from inpatient rehabilitation (Table 2; Figure 1c-1e). None of the four groups 
reached 100% of able bodied subjects’ predicted values for PEF throughout the analyzed 
time-course. For FIV1 and PIF, significant differences in time-courses between groups were 
found. During inpatient rehabilitation, FIV1 increased significantly less in subjects with 
paraplegia (HP and LP) compared to subjects with tetraplegia (HT and LT) and PIF of the LP 
group increased significantly less than the other three groups (Table 2). Calculated estimates 
of Pemax and Pimax for subjects with para- and tetraplegia all remain below 100% of able 
bodied subjects’ age- and gender-corrected reference values until one year after discharge 
from inpatient rehabilitation (Figure 2). Pimax showed significant increases during and after 
inpatient rehabilitation, while Pemax showed significant increases only in subjects with 
paraplegia during inpatient rehabilitation (Figure 2). Pendu significantly increased during, but 
not after inpatient rehabilitation. Estimates for tendu did not change over time (Table 3). 
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Figure 1a 
 
 
 
 
 
 
 
 
 
Figure 1b 
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Figure 1d 
 
 
 
 
 
 
 
 
 
 
 
Figure 1e 
 
 
 
 
 
 
 
 
 
 
Figures 1a - 1e: Calculated estimates from the final multilevel regression models for time-courses (t1 = start of 
active rehabilitation, t2 = end of inpatient rehabilitation, t3 = one year after t2) of lung function parameters (1a) 
forced vital capacity, 1b) forced expiratory volume in 1 s, 1c) forced inspiratory volume in 1 s, 1d) peak 
expiratory flow, 1e) peak inspiratory flow) for the four lesion level groups separately; HT = subjects with high 
tetraplegia (C3-C5), LT = subjects with low tetraplegia (C6-C8), HP = subjects with high paraplegia (T1-T6), LP 
= subjects with low paraplegia (T7-T12). Values were calculated for males with average age and height of the 
tested group. Age, gender and height corrected able bodied subjects reference values (100% predicted) with 95% 
confidence intervals (CI) are given for forced vital capacity, forced expiratory volume in 1 s, and peak expiratory 
flow. 
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Figure 2: Calculated estimates from the final multilevel regression models for time-courses (t1 = start of active 
rehabilitation, t2 = end of inpatient rehabilitation, t3 = one year after t2) of inspiratory (Pimax) and expiratory 
(Pemax) muscle pressure generating capacity for men with paraplegia and tetraplegia  
 
Influence of lesion level 
HT showed significantly lower FVC, FEV1, FIV1 and PEF values than LT while these values 
were significantly higher for LP than LT (Figure 1a-1d). There were no significant differences 
between LT and HP in any of the tested lung function parameters (Table 2). Pemax, Pimax and 
Pendu were lower in subjects with tetraplegia compared to subjects with paraplegia. There were 
significant differences in time-courses of Pemax between subjects with paraplegia and subjects 
with tetraplegia, while Pemax of subjects with tetraplegia did not change over time, Pemax of 
subjects with paraplegia increased during inpatient rehabilitation but decreased thereafter 
(Figure 2). Estimates for tendu showed no significant differences between groups (Table 3). 
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Table 2: Regression coefficients (β values) and standard errors (SE) for the final multilevel regression model describing effects of time,  
lesion and personal characteristics on the different lung function parameters [N = 109] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FVC = forced vital capacity; FEV1 forced expiratory volume in 1 s; FIV1 = forced inspiratory volume in 1 s; PEF = peak expiratory flow; PIF = peak inspiratory flow; β = 
regression coefficient for each independent variable; SE = standard error of this regression coefficient; ∆t1-t2 / ∆t2-t3 = time dummies with t2 as reference; HT = high 
tetraplegic; LT = low tetraplegic; HP = high paraplegic; LP = low paraplegic; ∆HT-LT / ∆LT-HP / ∆LT-LP = group dummies with LT as reference; gender: 0 = women; 1 = 
men; age = years; height = m; ∆t1-t2xHTLT / ∆t1-t2xHPLT / ∆t1-t2xLPLT / ∆t2-t3xHTLT / ∆t2-t3xHPLT / ∆t2-t3xLPLT = interaction terms time x group; * = significant 
influencing factor; n.s. not significant 
 FVC (l) FEV1(l FIV1 (l) PEF (l/s) PIF (l/s) 
 β (SE) β (SE) β (SE) β (SE) β (SE) 
constant -3.620 (1.549) -2.485 (1.338) -3.173 (1.502) -2.612 (2.644) -0.756 (2.554) 
∆t2-t1 -0.632 (0.080)* -0.498 (0.062)* -0.971 (0.162)* -0.891 (0.127)* -1.472 (0.290)* 
∆t2-t3 0.179 (0.057)* 0.103 (0.046)* 0.046 (0.119) 0.073 (0.118) -0.096 (0.278) 
∆HT-LT -1.070 (0.235)* -0.768 (0.206)* -0.785 (0.245)* -1.173 (0.376)* -0.898 (0.438)* 
∆LT-HP 0.311 (0.226) 0.085 (0.187) 0.119 (0.241) 0.399 (0.418) 0.155 (0.413) 
∆LT-LP 0.708 (0.206)* 0.505 (0.171)* 0.536 (0.221)* 1.152 (0.395)* 0.217 (0.378) 
gender 0.692 (0.192)* 0.513 (0.167)* 0.472 (0.183)* 0.844 (0.303)* 0.920 (0.317)* 
age -0.014 (0.005)* -0.021 (0.005)* -0.012 (0.005)* n.s. -0.019 (0.009)* 
height 4.120 (0.908)* 3.355 (0.784)* 3.694 (0.880)* 4.054 (1.531)* 3.178 (1.495)* 
∆t1-t2xHTLT n.s. n.s. 0.200 (0.219) n.s. 0.420 (0.396) 
∆t1-t2xHPLT n.s. n.s. 0.399 (0.204)* n.s. 0.614 (0.369) 
∆t1-t2xLPLT n.s. n.s. 0.538 (0.194)* n.s. 0.940 (0.349)* 
∆t2-t3xHTLT n.s. n.s. 0.139 (0.173) n.s. -0.162 (0.403) 
∆t2-t3xHPLT n.s. n.s. 0.074 (0.157) n.s. 0.158 (0.367) 
∆t2-t3xLPLT n.s. n.s. 0.263 (0.143) n.s. 0.574 (0.335) 
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Table 3: Regression coefficients (β values) and standard errors (SE) for the final multilevel 
regression model describing effects of time and personal characteristics on different 
parameters of respiratory muscle pressure generating capacity [n = 55] 
Pimax = maximal inspiratory muscle pressure generating capacity; Pemax = maximal expiratory muscle pressure 
generating capacity; Pendu = maximal pressure of inspiratory threshold endurance test; tendu = time of inspiratory 
threshold endurance test; β = regression coefficient for each independent variable; SE = standard error of this 
regression coefficient; t1 = start of active rehabilitation, t2 = end of inpatient rehabilitation; t3 = 1 year after 
discharge from inpatient rehabilitation; ∆t1-t2 / ∆t2-t3 = time dummies with t2 as reference; lesion: 0 = tetraplegic, 
1 = paraplegic; gender: 0 = women; 1 = men; ∆t1-t2 x lesion, ∆t2-t3 x lesion = interaction terms time x lesion; * = 
significant influencing factor; n.s. = not significant 
 
Influence of personal factors 
Personal factors such as gender, age and height had significant influences on most lung 
function parameters, with the exception of age having no influence on PEF, i.e. PEF was the 
only parameter which seems not to decrease with age. Body mass and smoking had no 
significant effect on any of the measured parameters (Table 2). Calculated age- and height-
corrected able bodied subjects 100% predicted (95% CI of reference values) for men were 
4.93 (3.93-5.93) l FVC, 4.06 (3.17-4.90) l FEV1 and 9.44 (7.45-11.43) l/s PEF (Figures 1a, 1b, 
1d). Pimax and Pemax were only influenced by gender which resulted in higher estimates for 
men than for women, while Pendu and tendu were not influenced by any of the tested personal 
factors (Table 3).  
 
Discussion     
The most important finding of this study is that inspiratory and especially expiratory muscle 
pressure generating capacity is affected to a great extent after a SCI. Results clearly show that 
respiratory function improved with time during inpatient rehabilitation. Expiratory muscle 
 
 
Pimax (kPa) 
β    (SE) 
Pemax (kPa) 
   β    (SE) 
Pendu (kPa) 
β     (SE) 
tendu (min) 
   β     (SE) 
constant 3.982 (0.748) 2.079 (0.935) 2.993 (0.213) 4.240 (0.381) 
∆t2-t1 -1.444 (0.387)* -0.508 (0.759) -0.689 (0.200)* -0.853 (0.504) 
∆t2-t3 1.177 (0.538)* 0.645 (0.716) 0.090 (0.198) -0.553 (0.415) 
lesion 2.015 (0.641)* 5.078 (0.988)* 0.538 (0.261)* 0.409 (0.370) 
gender 2.183 (0.702)* 1.583 (0.753)* n.s. n.s. 
∆t1-t2 x lesion n.s. -1.945 (0.920)* n.s. n.s. 
∆t2-t3 x lesion n.s. -1.874 (0.916)* n.s. n.s. 
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pressure generating capacity also increased during inpatient rehabilitation, but it already 
decreased during the first year after inpatient rehabilitation. Especially in subjects with 
tetraplegia, respiratory muscle pressure generating capacity should be screened and trained 
regularly after inpatient rehabilitation. 
 
Longitudinal changes  
This study showed that FVC, FEV1 and Pimax increased until one year after inpatient 
rehabilitation while FIV1, PEF and PIF remained constant or even decreased (Pemax) after 
inpatient rehabilitation. Interestingly, positive associations of Pimax to FVC and FEV1 were 
found in different studies (26, 45), which supports our findings of similar trajectories of these 
three parameters. 
There are several factors which change over time after an acute SCI, such as changes in 
muscle tone, spasticity, a lower chest wall and a higher abdominal compliance (10, 23). 
Further, factors such as postural changes, trunk stabilisation and changes in physical activity 
levels are known to influence respiratory function and may therefore influence trajectories of 
respiratory function as well (12, 16, 44, 49). Increasing spasticity and chest wall stiffness 
occur over time in subjects with SCI (10, 23). Together with possible decreases in physical 
activity levels after inpatient rehabilitation, this may have avoided further increases in FIV1, 
PEF, PIF and Pemax between t2 and t3. The higher abdominal compliance especially in subjects 
with tetraplegia and high paraplegia changes functional residual capacity, since the diaphragm 
is less pushed up due to the missing tone of abdominal muscles (48). This on the one hand 
reduces inspiratory capacity and therefore FVC, FIV1, PIF and Pimax, but on the other hand 
also pulmonary recoil pressure of the diaphragm, which helps to improve expiratory muscle 
function, i.e. FEV1, PEF, and Pemax (29). Further, it is known that besides its function as a 
respiratory muscle, the diaphragm also acts as a trunk extensor and therefore supports trunk 
stabilization in subjects with tetraplegia (44). Therefore, a standardized measurement position 
is of vital importance. 
Subjects with para- and tetraplegia showed significant improvements in Pendu only during 
inpatient rehabilitation. This may result from improvements of the general physical fitness 
due to physical activities performed during inpatient rehabilitation. Unfortunately there is no 
data available about the exact amount of physical exercise training during inpatient 
rehabilitation.  
 
Influence of lesion level  
As expected and already shown in earlier studies (20, 32, 33, 36), we also found significant 
influences of lesion level on lung function and respiratory muscle pressure generating 
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capacity in subjects with recent SCI; the higher the lesion level, the lower the respiratory 
function (Figures 1 and 2). Therefore, separate regression equations for subjects with SCI and 
especially for different lesion level groups, as presented in this paper, seem to be justified. 
Fishburn et al. found increases in respiratory tract infections with increasing lesion levels 
(17). Further, respiratory tract infections seem to be associated with the ability to cough as 
well as with PEF and Pemax (9, 17, 39). Coughing is important for airway clearance and 
prevention of pulmonary complications (24, 50). Fugl-Meyer further reported that a PEF of at 
least 5-6 l/s is necessary to produce an effective cough (19). Even if this is much below able 
bodied subjects 100% predicted values, our subjects with high tetraplegia did not reach this 
level throughout the whole analyzed time-course (Figure 1d). Therefore, subjects with a high 
motor complete tetraplegia seem to be at high risk for respiratory tract infections. For the 
optimization of cough capacity, inspiratory muscle function should be considered as well. A 
deep inspiration increases pulmonary recoil pressure and is therefore an important 
precondition of an effective cough (28).  
 
Influence of personal factors  
The influence of personal factors such as gender, age and height on respiratory function is 
generally known from able bodied subjects reference equations (6, 40). In the present study, 
gender had a significant effect on all lung function parameters, leading to 0.5-0.7 l higher 
FVC, FEV1 und FIV1 and 0.8-0.9 l/s higher PEF and PIF estimates for men than for women 
(Table 2). Gender differences in the able bodied population are somewhat higher for FVC (0.9 
l) and PEF (2.1 l/s). However, relative to the lower values in subjects with SCI, gender 
differences seem to be quite similar (40). Regarding respiratory muscle pressure generating 
capacity, gender has a large effect in able bodied subjects (6) with 30% higher Pimax and 38% 
higher Pemax estimates for men than for women. In our Dutch SCI sample, gender even had a 
5% higher effect on respiratory muscle pressure generating capacity than in able bodied 
subjects, resulting in differences of 35% for Pimax and 43% for Pemax (Table 3).  
To our knowledge there are only few studies addressing issues regarding ageing and SCI (51). 
Furthermore, studies assessing the interaction of ageing and respiratory function in SCI are 
non existent. The influence of ageing on lung function, i.e. the decline in respiratory function 
with age, seems to be even lower in subjects with SCI (-0.012 to -0.021 l per year; Table 2) 
than in the able bodied population (-0.026 to -0.043 l per year) (40). Nevertheless, this study 
only assessed changes during the first two years after injury. To really get reliable data on 
influences of ageing on lung function for subjects with SCI, longitudinal studies of at least 10 
years are needed.  
Height only had, similar to able bodied subjects reference equations, significant influences on 
lung function, but not on respiratory muscle pressure generating capacity (Table 2). Keeping 
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in mind the absolute lower values of subjects with SCI, influences of height on lung function 
seem to be quite similar to the able bodied subjects population (40). 
In accordance to able bodied subjects reference equations, body mass had no significant effect 
on any of the measured parameters, probably since most of our subjects were within the range 
of normal body mass index (Table 1). It is known that in obese able bodied subjects lung 
function is diminished (8, 11, 27). Nor former, neither current smoking had any significant 
effect on the tested lung function and respiratory muscle pressure generating capacity 
parameters. One possible reason for that finding could be that many subjects stopped smoking 
after SCI (Table 1). Results of two other studies provided equivocal findings concerning 
effects of smoking on lung function in SCI (2, 32).  
 
Clinical relevance 
The results of the present study clearly show that during inpatient rehabilitation lung function 
and respiratory muscle pressure generating capacity generally increase without specific 
respiratory muscle training but are on a very low level in subjects with high tetraplegia. 
Changes in muscle tone, spasticity, chest wall and abdominal compliance, body position and 
physical exercise training are factors that may additionally affect trajectories of respiratory 
function, especially during the initial time after injury. Individuals with high tetraplegia are 
those at the highest risk for respiratory complications, since they do not reach the lower limit 
to produce an effective cough. Therefore, regular screening and early training interventions in 
at least subjects with high, motor complete tetraplegia is important. Since the commonly used 
screening parameters FVC and FEV1 are the least affected, especially PEF, Pemax and Pimax 
should also become part of regular lung function testing. 
 
Conclusion 
All estimates for lung function and maximal respiratory muscle pressure generating capacity 
showed significant increases during inpatient rehabilitation, but to a different extent. During 
the first year after discharge from inpatient rehabilitation, only FVC, FEV1 and Pimax further 
improved, while all other parameters remained constant or even decreased (Pemax). Subjects 
with high tetraplegia generally showed the highest impairments while PEF and Pemax were the 
most affected parameters in all groups of subjects with SCI. Thus, this study should motivate 
health care professionals to improve follow up measurements as well as patient-motivation 
and possibilities for training of the SCI population. 
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Abstract 
Objective: Respiratory muscle endurance of able bodied persons, assessed by normocapnic 
hyperpnoea at 70% of their maximal voluntary ventilation, usually ranges from 10-20 min. 
The aim of this study was to find the level of ventilation that patients with paraplegia and 
tetraplegia can sustain for 10-20 min to later be used as the guideline for respiratory muscle 
endurance training.  
Methods: Two groups, 8 patients with paraplegia and 6 patients with tetraplegia participated 
in this pilot study with crossover setting. Respiratory muscle endurance tests were performed 
at 3 different intensities of normocapnic hyperpnoea, i.e. 20, 40 and 60% maximal voluntary 
ventilation. Subjects performed partial rebreathing from a bag to assure normocapnia. 
Respiratory endurance was separately analyzed for patients with para- and tetraplegia.  
Results: Mean respiratory endurance times were 46.0, 18.9 and 4.2 min at 20, 40 and 60% 
maximal voluntary ventilation in patients with tetraplegia and 51.8, 38.8 and 12.2 min in 
patients with paraplegia. The duration differed significantly at 60% maximal voluntary 
ventilation between groups.  
Conclusion: Minute ventilation to perform respiratory muscle endurance training can be set 
around 40% of maximal voluntary ventilation for patients with tetraplegia and around 60% of 
maximal voluntary ventilation for patients with paraplegia as these levels can be sustained for 
10-20 min.  
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Introduction 
Complete spinal cord injury (SCI) results in diminished pulmonary function, due to paralysis 
of respiratory muscles depending on the lesion level (13). While persons with paraplegia lack 
abdominal muscle function and lesion-dependent also intercostal muscle function, persons 
with tetraplegia lack most of the expiratory and even some of the auxiliary inspiratory 
muscles (7). This may lead to faster fatigue of the respiratory pump in subjects with SCI 
during physical activity, as well as to a restricted pulmonary capacity (23). Furthermore, 
persons with SCI are generally at higher risk for progressive respiratory insufficiency 
compared to able bodied people (14). Pulmonary complications are a major cause of death, in 
particular for persons with tetraplegia surviving the first 6 months after the trauma (9). The 
fact that patients with SCI activate their remaining respiratory muscles in daily life less than 
able bodied persons, due to the lack of whole-body physical activity, may also explain the 
weakened respiratory system (20), particularly for persons with tetraplegia. Therefore, special 
attention should be given to the functioning and improvement of their respiratory pump. 
Leith & Bradley (15) showed that respiratory muscle strength and endurance can be 
specifically increased by appropriate respiratory muscle training in able bodied subjects. So 
far, studies showing an improvement of respiratory muscle function in patients with SCI 
focussed on respiratory resistance or resistance endurance training (11, 12, 21, 28). However, 
for these patients, respiration causes major problems during physical activity (29) and for 
patients with tetraplegia even during the night (e.g. sleep apnoea) (5, 6, 18, 22). Therefore, 
respiratory endurance seems to be more critical than respiratory muscle strength. Sedentary as 
well as trained able bodied subjects (24) significantly increased the endurance of respiratory 
muscles as well as whole-body exercise endurance by means of normocapnic hyperpnoea 
training at 60-70% of their individual maximal voluntary ventilation (MVV). In view of these 
effects in able bodied subjects, normocapnic hyperpnoea training is expected to be even more 
beneficial for persons with weak respiratory muscles, such as people with SCI, but data is 
missing for this group. 
Therefore, the first step to adapt normocapnic hyperpnoea training for persons with SCI is to 
test respiratory endurance in this group of subjects at different minute ventilations, i.e. 
different intensities. We hypothesize that, due to the partly lacking respiratory muscle mass, 
the minute ventilation that can be sustained for 10-20 min, an appropriate duration for 
normocapnic hyperpnoea training in this group of patients, will be higher for patients with 
paraplegia than for patients with tetraplegia. To test this hypothesis, patients with paraplegia 
as well as tetraplegia performed respiratory endurance tests by means of exhaustive 
normocapnic hyperpnoea at three different intensities. 
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Methods  
Thirty-three patients, 22 with paraplegia and 11 with tetraplegia, who were hospitalized in a 
SCI rehabilitation center for first rehabilitation between September 2001 and July 2004, met 
the inclusion criteria (see below). Of these, 3 had no interest to participate and 16 were 
excluded according to the exclusion criteria (see below). Finally, 8 patients with paraplegia 
and 6 patients with tetraplegia were enrolled in the study. Characteristics of these subjects are 
shown in Table 1. Inclusion criteria were age between 18 and 45 years with an acute 
traumatic, motor complete lesion (ASIA A or B). Exclusion criteria were asthma, chronic 
obstructive pulmonary disease, pneumonia, tracheotomy, bronchial or urinary infections, 
irregular medication, peanut or latex allergy and epilepsy. In order to reach more or less stable 
ventilatory function after injury, we enrolled patients with paraplegia 4 to 6 months after 
injury and patients with tetraplegia 6 to 8 months after injury (1, 16). Prior to the start of the 
study, all patients were informed in detail and gave their written informed consent. The ethics 
committee of the canton Lucerne, Switzerland approved the study. 
Table 1: Characteristics of patients with paraplegia and tetraplegia   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TPI = time post injury; mt = month; m = man; w = woman; C = cervical lesion; T = thoracic lesion;  
L = lumbar lesion; SD = standard deviation 
sex age 
[years] 
height 
[m] 
weight 
[kg] 
TPI 
[mt] 
lesion 
level 
smoker 
paraplegia       
m 30 1.80 75 6 T4 no 
m 22 1.78 62 4 T5 no 
w 26 1.68 53 4 T5/6 no 
m 23 1.98 83 4 T6 yes 
m 39 1.70 80 5 T10 no 
m 26 1.82 72 4 T11 no 
m 32 1.85 70 4 T11 no 
m 45 1.78 73 4 L1 no 
Mean ± SD 31 ± 8 1.80 ± 0.09 71 ± 10 4 ± 1   
tetraplegia       
w 22 1.73 52 7 C4 no 
w 39 1.53 41 6 C5 no 
m 21 1.87 70 6 C6 no 
m 21 1.83 59 7 C7 yes 
m 22 1.75 69 7 C7 no 
m 22 1.72 58 6 C7 no 
Mean ± (SD) 25 ± 7 1.74 ± 0.12 58 ± 11 7 ± 1   
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Equipment 
Vital capacity (VC), peak inspiratory and expiratory flows (PIF, PEF), forced in- and 
expiratory volumes in 1 s (FIV1, FEV1) and MVV over 12 s were measured by a metabolic 
chart (Oxycon α, Jaeger, Hoechberg, Germany), using a turbine for volume measurements and 
fast-responding gas analysers. The system had been calibrated with a 3-litre syringe and 
certified mixed calibration gas before each test. Maximal inspiratory and expiratory pressures 
(Pimax, Pemax) were measured by a hand-held mouth pressure meter (Micro MPM, Micro 
Medical Ltd, Chatham Kent, UK) including a small air leak to prevent glottis closure.  
Respiratory muscle endurance tests, i.e. normocapnic hyperpnoea to exhaustion, were 
performed using a special partial rebreathing device (SpiroTiger, idiag AG, Fehraltorf, 
Switzerland) providing target respiratory frequency and tidal volume. During respiratory 
muscle endurance tests, end-tidal CO2 partial pressure and ventilatory variables were 
monitored and recorded breath by breath (Oxycon α, Jaeger, Hoechberg, Germany) to verify 
normocapnia and target ventilation. Heart rate was measured by oximetry (OxyTip, Datex-
Ohmeda 3900, Louisville, USA) on the right middle finger and blood pressure by 
plethysmography (Finapress blood pressure Monitor, Ohmeda 2300, BOC Healthcare, 
Englewood, Colorado, USA) on the left middle finger, placing the left forearm on heart level 
(see Figure 1 for experimental setup). Blood samples (20 µl) were drawn from an earlobe and 
analyzed for blood lactate concentration enzymatically (Super GL Ambulance, Ruhrtal Labor 
Technik, Moehnesee, Germany). Perception of breathlessness and respiratory effort were 
indicated by the subjects at rest and at the end of each test on a visual analogue scale ranging 
from 0 to 10.  
 
Figure 1: Experimental setup 
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Protocol 
Every patient reported six times to the laboratory, with an interval between visits of at least 72 
h. During the first three sessions, lung function as well as Pimax (from residual volume) and 
Pemax (from total lung capacity), both measures of respiratory muscle strength, were assessed. 
Each measurement was repeated three to six times until values did not differ more than ± 5%. 
The best effort within these limits was recorded. All respiratory measurements were 
conducted according to the spirometry testing standards in SCI (13) in an upright sitting 
position in the patient’s own wheelchair. After lung function and respiratory muscle strength 
measurements, the normocapnic hyperpnoea training device was adjusted to one of the three 
intensities corresponding to 20, 40 or 60% of each patient’s individual MVV. Subjects were 
then familiarised with the technique to perform normocapnic hyperpnoea and they were also 
trained to use the visual analogue scale.  
During the last three sessions, subjects performed one respiratory muscle endurance test each 
day at 20, 40 or 60% of their MVV, in random order. During respiratory muscle endurance 
test sessions, they were verbally encouraged to keep the target minute ventilation (VE) of the 
corresponding intensity. The test was stopped either by the patient due to exhaustion or by the 
experimenter, if VE was more than 5 l/min lower than the target value for more than 30 s or if 
the test duration reached 60 min. Patients had to abstain from caffeine 24 h before each test. 
Information about nutrition, sleep, physical activity and medication 24 h prior to each test 
were collected by a questionnaire.  
Heart rate and blood pressure were registered at rest, every 2 min during and at the end of 
each test. Blood samples for blood lactate analyses were drawn at the same timepoints. Blood 
pressure measurements were performed in patients with paraplegia only, as sympathetic 
activity regulating blood pressure is absent in patients with tetraplegia and thus blood pressure 
is influenced by other factors (e.g. micturition) causing random fluctuations (26).  
 
Statistics  
Between-group differences in respiratory muscle endurance, absolute VE during respiratory 
muscle endurance tests, breathlessness, respiratory effort, heart rate, blood pressure and blood 
lactate concentration, were tested using Wilcoxon’s rank sum tests. Systolic vs. diastolic 
increases in blood pressure between rest and test break off were also tested with Wilcoxon’s 
rank sum tests. The Friedman two-way analysis of variance was used to assess within-group 
differences of respiratory muscle endurance test variables between tests at the three different 
intensities. For heart rate, blood pressure, breathlessness and respiratory effort, differences 
between rest and test break off were calculated for further analyses. Significance was 
accepted at p < 0.05. Statistical analyses were performed with a computer software package 
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(Systat, Version 10.2; Systat Software Inc.; Point Richmond, CA, USA). Values are presented 
as mean ± SD. 
 
Results 
Spirometry and respiratory muscle strength 
Lung function and respiratory muscle strength of patients with para- and tetraplegia are 
presented in Table 2. All variables were significantly higher in patients with paraplegia 
compared to patients with tetraplegia.  
 
Table 2: Lung function and respiratory muscle strength for patients with para- and tetraplegia 
presented as mean ± standard deviation 
VC = vital capacity; FEV1 = forced expiratory volume in 1 s; FIV1 = forced inspiratory volume in 1 s; PEF = 
peak expiratory flow; MVV = maximal voluntary ventilation; Pimax = maximal inspiratory pressure; Pemax = 
maximal expiratory pressure 
 
Respiratory muscle endurance test: duration and respiratory assessments  
Respiratory muscle endurance test duration at 60% MVV was significantly higher in patients 
with paraplegia compared to patients with tetraplegia being 12.2 ± 9.0 vs. 4.2 ± 3.4 min 
(Figure 2).  
 
 
 
 
 
 
 
 patients with paraplegia  patients with tetraplegia p value 
VC (% pred) 100.5 ± 22.4 59.3 ± 21.9 0.007 
FEV1 (% pred) 100.9 ± 22.6 58.2 ± 18.6 0.007 
FIV1 (% pred) 104.8 ± 26.3 60.8 ± 21.5 0.012 
PEF (% pred) 106.5 ± 23.5 57.0 ± 12.0 0.002 
MVV (% pred) 127.4 ± 32.7 68.0 ± 19.0 0.003 
Pimax (% pred)   81.4 ± 14.6 59.0 ± 14.4 0.010 
Pemax (% pred) 
 
  42.3 ± 18.1 20.7 ± 5.5 0.004 
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Figure 2: Median (lines inside boxes) and lower and 
upper quartiles (lower and upper edge of boxes) and 
range (whiskers) for duration of respiratory endurance 
test at different intensities for patients with paraplegia 
(PP) and for patients with tetraplegia (TP). MVV = 
maximal voluntary ventilation, O = outlier  
     
 
 
Durations of respiratory muscle endurance tests at 40% MVV (38.8 vs. 18.9 min; p = 0.053) 
and 20% MVV (51.8 vs. 46.0 min; p = 0.391) did not differ significantly between groups. 
Within groups, respiratory muscle endurance test durations were significantly different 
between intensities (p = 0.006 for both groups). At 20% MVV, 6 patients with paraplegia and 
2 patients with tetraplegia were stopped by the experimenter as they reached 60 min. Due to 
the higher absolute MVV of patients with paraplegia, their average VE during respiratory 
muscle endurance tests was significantly higher at 20%, 40% and 60% MVV compared to 
patients with tetraplegia (Figure 3). Within both groups, VE was significantly different 
between intensities (p < 0.001 for patients with paraplegia and p = 0.007 for patients with 
tetraplegia). 
 
 
 
 
 
 
 
 
Figure 3: Median (lines inside boxes) and lower and 
upper quartiles (lower and upper edge of boxes) and 
range (whiskers) of minute ventilation during 
respiratory endurance tests at different intensities for 
patients with paraplegia (PP) and for patients with 
tetraplegia (TP). MVV = maximal voluntary 
ventilation  
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Perception of breathlessness did not differ between intensities for patients with paraplegia and 
tetrapelgia (p = 0.159 and p = 0.449). In patients with paraplegia, perception of respiratory 
effort was significantly higher at the end of respiratory muscle endurance tests at 60% (p = 
0.005) and 40% (p = 0.034) MVV than at the end of the respiratory muscle endurance test at 
20% MVV while it did not differ between intensities in patients with tetraplegia (p = 0.368) 
(Table 3).  
 
Respiratory muscle endurance test: cardiovascular measurements 
At rest, mean heart rate was 91 ± 12 bpm in patients with paraplegia and 74 ± 14 bpm in 
patients with tetraplegia. While blood pressure was not assessed in patients with tetraplegia 
(for details please see methods), in patients with paraplegia resting systolic blood pressure 
was 134 ± 28 mmHg and diastolic blood pressure was 74 ± 11 mmHg. Increases in systolic 
blood pressure between intensities were not significantly different (p = 0.159). Diastolic blood 
pressure increased significantly more during respiratory muscle endurance tests at 60% 
compared to 20% MVV (p = 0.005) and during 60% compared to 40% MVV (p = 0.034). 
Increases in diastolic blood pressure between 20% and 40% MVV were not significantly 
different (Table 3). Furthermore, at 60% MVV the increase in systolic blood pressure, was 
significantly larger than the increase in diastolic blood pressure (p = 0.012) while increases in 
systolic vs. diastolic blood pressure did not differ at 40% (p = 0.483) and 20% MVV (p = 
0.726). 
 
Table 3: Differences (∆) between rest and end of respiratory endurance tests at different 
intensities for patients with para- and tetraplegia presented as mean ± SD. 
Symbols: * Significant difference to 20% MVV;† Significant difference to 40% MVV;° Significant difference to 
∆ diastolic blood pressure at the same intensity. Note that there were no significant differences between groups 
of para- and tetrapelgic patients. Abbreviations: MVV = maximal voluntary ventilation; NA = not applicable 
 
patients with paraplegia [n = 8] patients with tetraplegia [n = 6]  
Intensity 
(%MVV) 20%                40%               60% 20%                40%               60%  
∆ heart rate (bpm)  11±11 30±14 32±22 20±17 34±19 24±16  
∆ systolic blood 
pressure (mmHg)  11.6±24.5 24.1±24.3 43.1±18.1° NA NA NA 
∆ diastolic blood 
pressure (mmHg) 14.1±10.5 16.9±9.7 23.3±12.9*† NA NA NA 
∆ breathlessness 
(points) 5.0±3.3 4.4±3.2 5.6±3.8 2.6±3.6 3.0±3.4 3.4±3.3 
∆ respiratory 
effort (points) 4.1±2.5 7.2±3.1 9.0±1.8*† 6.7±3.0 7.9±2.9 7.9±1.7 
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Respiratory muscle endurance test: blood lactate concentration 
Blood lactate concentrations of the 3 tests are shown in Figure 4A for patients with paraplegia 
and Figure 4B for patients with tetraplegia. In patients with paraplegia, blood lactate 
concentrations during as well as at the end of respiratory muscle endurance tests decreased 
significantly compared to resting levels at 20% MVV (p = 0.005) as well as at 40% MVV (p 
= 0.034). At 60% MVV, blood lactate concentration did not change throughout the test 
(Figure 4A). In patients with tetraplegia, blood lactate concentrations decreased significantly 
compared to resting values during as well as at the end of the respiratory muscle endurance 
test at 20% MVV only (p = 0.014). At 40% and 60% MVV, blood lactate concentration did 
not change throughout the test (Figure 4B). Blood lactate concentrations did not differ 
between groups at identical intensities (p = 0.180 - 0.564).  
 
Figure 4 A     Figure 4 B 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Time-course of blood lactate concentration (mean and SD) in A) patients with paraplegia and B) 
patients with tetraplegia at different intensities of the respiratory endurance tests (RET). MVV = maximal 
voluntary ventilation 
 
Discussion 
Respiratory muscle endurance and optimal training intensity 
This study confirms our hypothesis that respiratory muscle endurance is reduced in patients 
with SCI compared to able bodied subjects, more so with higher lesion levels. While able 
bodied subjects can breathe for 30 min at > 60% of their individual MVV (2, 3, 25), patients 
with paraplegia  only sustained this intensity for an average of 12.2 min while patients with 
tetraplegia only reached 4.2 min on average. Thus, when aiming for normocapnic hyperpnoea 
training durations of 10-20 min (as proven feasible for respiratory training in this group of 
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patients) (8, 12, 17, 21, 27, 28), VE can be set around 60% MVV for patients with paraplegia 
but needs to be reduced to around 40% MVV for patients with tetraplegia. Although the 
perception of breathlessness was quite similar at the end of all tests in both groups, motivation 
to perform respiratory muscle endurance tests may also have influenced performance in these 
patients with SCI, shown by rather large inter-individual differences of respiratory muscle 
endurance test durations at given intensities. The above-mentioned guidelines should 
therefore be taken as starting levels in order to adjust the individual optimal training intensity.  
It is noteworthy that respiratory endurance of patients with SCI is decreased compared to able 
bodied subjects, although the VE values were based on individual subjects' MVV (19). For 
patients with tetraplegia, MVV was significantly below that of able bodied subjects. The 
decreased endurance may reflect a certain degree of muscle atrophy, occurring due to the 
immobilisation of the patients during the first weeks after injury (4). Furthermore, in patients 
with SCI, breathing and thus respiratory muscles are stimulated only little during daily 
activities due to the smaller muscle mass available compared to able bodied persons that are 
walking, running and lifting objects (20). In addition, the potential of shifting between the 
uses of different respiratory muscles allowing some recovery at sub-maximal ventilations is 
reduced.  
 
Lung function and respiratory muscle strength 
While lung function of patients with paraplegia was similar to able bodied subjects, 
respiratory muscle strength was lower than normal with Pimax being around 20% and Pemax 
around 60% lower than predicted from values assessed in able bodied persons. In patients 
with tetraplegia, however, lung function and inspiratory muscle strength were reduced to 
about 60% of predicted while expiratory muscle strength was only around 20% predicted. As 
hyperpnoea consists of repeated forced in- and expirations, maximal strength of these muscles 
(and the loss of it in the course of the task) is likely a factor affecting endurance as well. This 
assumption is supported by the fact that respiratory muscle endurance was reduced in subjects 
with paraplegia in the presence of reduced muscle strength and despite normal lung function, 
including FIV1, FEV1 and MVV. 
 
Cardiovascular responses to respiratory muscle endurance tests 
While blood pressure was not assessed in patients with tetraplegia due to the sympathetic 
autonomic impairment at this lesion level (10), both systolic and diastolic blood pressure 
increased significantly in patients with paraplegia during respiratory muscle endurance tests 
with a tendency to larger changes with increasing VE. Also, systolic blood pressure increased 
to a larger extent than diastolic blood pressure at 60% MVV, suggesting that stroke volume 
increased during this task. This cardiovascular challenge, in particular during breathing at 
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60% MVV, strongly suggests that respiratory endurance training at this intensity will result in 
significant training effects.  
 
Blood lactate metabolism 
Interestingly, blood lactate concentrations decreased during respiratory muscle endurance 
tests at 20% and 40% MVV for patients with paraplegia and at 20% MVV for patients with 
tetraplegia, likely meaning that working muscles increasingly consumed blood lactate as an 
energy source. This shift in the balance of lactate production vs. consumption relative to 
resting conditions may result from the increased activity of respiratory muscles also using 
blood lactate as a fuel and/or the increased activity of the heart muscle, one of the major blood 
lactate consumers. The fact that blood lactate did not change during breathing at 60% MVV in 
patients with paraplegia and at 40% and 60% in patients with tetraplegia shows, in turn, that 
anaerobic metabolism was increasingly needed to achieve the work, also showing that 
patients with tetraplegia reached this limit 'earlier', i.e. at a lower intensity than patients with 
paraplegia. This, in turn, supports our previous suggestion that the higher the lesion, the 
smaller the ability of the still innervated respiratory muscles to share the work and to recover 
in-between. The continuous work then likely results in a faster development of fatigue and the 
necessity to recruit fast twitch fibres running on anaerobic metabolism.  
These metabolic changes during respiratory muscle endurance tests together with the 
cardiovascular changes observed suggest that respiratory muscle endurance training - if 
performed in form of normocapnic hyperpnoea training at 60% MVV (patients with 
paraplegia) and 40% (patients with tetraplegia) - will result in significant training effects, e.g. 
increased respiratory muscle endurance likely accompanied by increased aerobic metabolism. 
Increased respiratory muscle endurance will, in turn, not only reduce the sensation of 
breathlessness during tasks of heavy breathing, e.g. driving uphill, but also the shift towards 
increased aerobic metabolism (as observed in able bodied after this kind of training (25)) 
might help to reduce early arm muscle fatigue resulting from intramuscular acidosis. In 
addition, lung function of patients with tetraplegia is likely to improve, which would then 
result in improved airway clearance and reduction of pulmonary complications.  
 
In conclusion, this study showed that respiratory muscle endurance of patients with 
tetraplegia is reduced compared to patients with paraplegia. The optimal intensity for patients 
with SCI to perform normocapnic hyperpnoea training for 10-20 min should be set at VE 
around 60% MVV for patients with paraplegia and around 40% MVV for patients with 
tetraplegia. Due to inter-individual differences, however, this intensity should then be adapted 
individually using the above mentioned values as guidelines.  
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Abstract 
Objective: Respiratory muscle endurance training has been shown to improve both, 
respiratory muscle endurance and cycling exercise time at the anaerobic threshold in able 
bodied subjects. Since effects of respiratory muscle endurance training on upper extremity 
exercise performance have not yet been investigated, we evaluated the effects of respiratory 
muscle endurance training on 10 km time-trial performance in wheelchair-racing athletes.  
Methods: 12 competitive wheelchair racing athletes participated in this pilot study. Two 
matched-pair groups were built according to subjects’ lesion level. The training group (T) 
performed 30 sessions of respiratory muscle endurance training during 30 min each. The 
control group (C) did no respiratory muscle training. Differences in 10 km time-trial 
performance pre- vs. post- intervention were the main outcome measure. 
Results: In T, the time on the 10 km time-trial decreased significantly pre- vs. post-
intervention (27.1 ± 9.0 vs. 24.1 ± 6.6 min); this did not occur in C (23.3 ± 2.8 vs. 23.2 ± 2.4 
min). No between groups difference was present (p = 0.150). Respiratory muscle endurance 
increased significantly within T (9.1 ± 7.2 vs. 39.9 ± 17.8 min) and between groups, but not 
within C (4.3 ± 2.9 vs. 6.6 ± 7.0 min) pre- vs. post intervention. VO2peak showed no significant 
within- nor between-groups differences. Expiratory muscle strength increased significantly 
within T (p = 0.028) but not within C and nor between groups.  
Conclusion: Six weeks of respiratory muscle endurance training enhanced respiratory muscle 
endurance. There was a strong trend with a large observed effect size of d = 0.87, towards 
improved performance in the 10 km time-trial after six weeks of respiratory muscle endurance 
training.  
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Introduction 
In able bodied subjects the respiratory system was generally accepted as a non exercise 
limiting factor, as maximal voluntary ventilation is never reached during exercise (11, 26). 
Nevertheless, fatigued respiratory muscles prior to maximal running exercise reduced 
performance and oxygen uptake compared to the same test without prior respiratory muscle 
exercise (23). If fatigued respiratory muscles can limit exercise performance, respiratory 
training should compensate this effect. In fact, four weeks of respiratory muscle endurance 
training during 30 min, 5 times a week increased respiratory muscle endurance more than 
450% and leg cycling exercise time at the anaerobic threshold by 38% in trained able bodied 
subjects (6). 
Effects of respiratory muscle endurance training on upper body exercise performance have 
not yet been evaluated. Upper extremity exercise has been shown to change ventilatory 
muscle recruitment and breathing pattern compared to leg exercise (8, 9). This change 
decreased physical exercise endurance performance due to the concurrent work of upper body 
muscles for breathing and exercising (8). Wheelchair racing athletes, using only muscles of 
the upper extremities seem to be an ideal group to study the effects of respiratory muscle 
endurance training on upper body endurance exercise performance. Additionally, a spinal 
cord injury (SCI) causes lesion dependent functional loss of respiratory muscles (13, 25). 
Subjects with paraplegia mainly miss the abdominal muscles which are important for a forced 
expiration needed during physical activity (32). The lower total amount of active respiratory 
muscle mass in subjects with SCI leads, among other effects, to an impairment of respiratory 
muscle endurance (28) which may additionally affect the disability in physical endurance 
exercise performance. Therefore, we investigated respiratory muscle endurance training in 
wheelchair racing athletes. We hypothesize that respiratory muscle endurance training can 
improve ventilatory muscle endurance and upper body exercise performance on a 10 km time-
trial in athletes with paraplegia. 
 
Methods 
Subjects  
Inclusion criteria were wheelchair dependency, regular training and experience in wheelchair 
racing competitions. Exclusion criteria were tetraplegia and irregular medication. Twelve 
competitive wheelchair racing athletes met the above mentioned criteria and participated in 
the study. A training group (T) and a control group (C) of 6 athletes each were built. Subjects 
were divided by matched-pairs concerning lesion level. Race classification was considered as 
well in order to build 2 comparable groups. Subjects’ characteristics for T and C including 
anthropometric and training data are presented in Table 1.  
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The study was approved by the local ethics committee and written informed consent has been 
given by each subject prior to the start of the study. Subjects were asked to abstain from 
caffeine intake on all test days (30). Test preparation (e.g. sleep, nutrition and training during 
the last 24 h prior to each test) was reported and kept constant within subjects. Subjects were 
asked for identical test preparation and to perform no strenuous workouts the day before a 
test. Personal training schedule during the test- and training-phase was kept constant, recorded 
by each athlete and controlled to be kept constant. The whole study was performed during the 
winter months when wheelchair racing athletes mainly perform aerobic workout sessions. 
 
Study design 
Initially, all subjects reported to the laboratory on 4 separate occasions for baseline testing. 
All sessions were at least 48 h apart. Baseline testing included lung function measurements, a 
VO2peak test, a 10 km time-trial and a respiratory muscle endurance test by means of 
normocapnic hyperpnoea (for descriptions of each test see below). Thereafter, T-subjects 
performed respiratory muscle endurance training by means of normocapnic hyperpnoea for 6 
weeks, while C-subjects did no respiratory muscle training (for detailed description of 
respiratory muscle endurance training see below). Otherwise, both groups followed their 
usual wheelchair training during the whole study. After 6 weeks, the 4 baseline testing 
sessions were repeated in the same order, except familiarization trials. About 3 to 5 days lay 
in between the last respiratory muscle endurance training and the first test after the training 
session, to allow respiratory muscles to sufficiently recover from respiratory muscle 
endurance training (6). 
 
Lung function measurement 
Session one included lung function and respiratory muscle strength measurements according 
to the standards of the ATS (2) by bodyplethysmography (MasterScreen Body, Jaeger, 
Hoechberg, Germany). Total lung capacity (TLC), residual volume (RV), forced vital 
capacity (FVC), forced expiratory volume in 1 s (FEV1), the ratio between FEV1 and FVC, 
peak expiratory flow (PEF) maximal voluntary ventilation during 12 s (MVV) were 
measured. Maximal inspiratory muscle pressure (Pimax) was measured from RV and maximal 
expiratory muscle pressure (Pemax) was measured from TLC. A small air leak in the 
measurement device prevented from glottis closure. The whole system was calibrated 
immediately before each test. The measurement device calculated percent of reference values 
(1) for FVC, TLC, RV, PEF, FEV1 and MVV. For calculation of percent predicted of 
respiratory muscle pressure measurements (Pimax and Pemax), the reference values of Black 
and Hyatt (5) were used. After lung function measurement, an instruction and familiarization 
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trial with the respiratory muscle endurance training device (SpiroTiger medical, Idiag AG, 
Fehraltorf, Switzerland) completed the first session.  
 
VO2peak test  
During the second testing session, a VO2peak test was performed in the athlete’s own racing 
wheelchair, which was fixed to a treadmill (Saturn HP Cosmos, Munich, Germany) with a 
mobile lever arm. Tires of the wheelchairs were pumped to a pressure of 1000 kPa before the 
test. This test started at a speed of 10 km/h and an inclination of 0.7%. Every 3 min, speed 
increased for 2 km/h until volitional exhaustion. Oxygen uptake (VO2), carbon dioxide 
production (VCO2), minute ventilation (VE), respiratory frequency (fR) and tidal volume (VT) 
were measured breath-by-breath and averaged over 15 s by an ergospirometer (Oxycon alpha, 
Jaeger, Hoechberg, Germany). Values were measured using a turbine for volume 
measurements and fast-responding gas analyzers (O2 paramagnetic, CO2 infrared). The 
system was calibrated with a 3 l syringe and certified mixed calibration gas immediately 
before each test. VO2peak was determined from the highest VO2 average of a 15 s period. Heart 
rate was measured continuously (Polar heart rate monitor, POLAR S610i, Kempele, Finland) 
and maximal heart rate was analyzed using the corresponding analyzing software of the heart 
rate monitor (Polar Precision Performance SW, Version 4.00.020, Kempele, Finland). Blood 
samples (20 µL) were collected from the earlobe before, at the end of the test and 2 min after 
test break off. Lactate concentrations were analyzed enzymatically (Super GL Ambulance, 
Ruhrtal Labor Technik, Moehnesee, Germany). Athletes were asked to indicate their 
individual dyspnoea, perceived respiratory exertion and perceived physical exertion 
immediately after test break off by means of a visual analogue scale (21). After the VO2peak 
test, subjects completed a second familiarization trial with the respiratory muscle endurance 
training device. 
 
10 km time-trial  
On the third test session athletes had to complete a 10 km time-trial which was performed in 
the athlete’s own racing chair on a nearly frictionless training roller (Spinner, New Hall’s 
Wheels, Cambridge, USA). Tires of the wheelchairs were pumped to a pressure of 1000 kPa 
before the test. After a standardized warm-up of 2 km at an intensity of 55-60% of the 
maximal speed during the VO2peak test, they had to complete 10 km as fast as possible. VO2, 
VCO2, VE, fR, VT, end tidal pressure for CO2 (PetCO2), heart rate, lactate, degree of 
dyspnoea, perceived respiratory exertion and perceived physical exertion were measured in 
analogy to the VO2peak test. Mean values of the whole 10 km time-trial for VO2, VE, fR, VT 
and PetCO2 were calculated from all 15 s average values during the test. Mean VO2 during 
the 10 km time-trial was calculated and presented as % of VO2peak. Mean heart rate of the 
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time-trial was calculated by the heart rate analyzing software tool (Polar Precision 
Performance SW, Version 4.00.020, Kempele, Finland). No information about velocity, heart 
rate or exercise time was given to the athletes during the test, except for notification of each 
accomplished km. After a rest of 20 min, subjects completed a third familiarization trial with 
the respiratory muscle endurance training device. 
 
Respiratory muscle endurance test  
On the fourth session, subjects had to perform a respiratory muscle endurance test with the 
respiratory muscle endurance training device (SpiroTiger, idiag AG, Fehraltorf, Switzerland). 
Instrument adjustment as described below was made during the familiarization trials after the 
lung function test, the VO2peak test and the 10 km time-trial. Target fR and VT are paced by 
visual feedback on the respiratory muscle endurance training device. Feedback is given on a 
hand-held monitor while subjects perform partial rebreathing, breathing in and out of a bag in 
order to aim for normocapnic conditions. The size of the bag was adjusted to about 50% of 
the subject’s FVC (22). Breathing frequency was adjusted to reach a target VE which could be 
maintained for 5 to 10 min during pre-tests, corresponding to an intensity of 65-75% of the 
individual MVV value. Respiratory muscle endurance training levels around these intensities 
have been shown to significantly increase respiratory muscle endurance and physical exercise 
performance in trained able bodied subjects (6, 29). During the respiratory muscle endurance 
tests, an ergospirometer (Oxycon alpha, Jaeger, Hoechberg, Germany) was used to measure 
and monitor PetCO2, VE, fR and VT breath-by-breath using a metabolic chart. The system was 
calibrated with a 3 l syringe and certified mixed calibration gas immediately before each test. 
Heart rate, dyspnoea, perceived respiratory exertion and perceived physical exertion were 
measured in analogy to the VO2peak test. Blood samples for lactate analysis were taken before, 
every 2 min during the respiratory muscle endurance test and at test break off. Sample size, 
analyzing and calibration details were the same as in the other tests described above. The test 
was stopped either by the experimenter if target VE could no longer be maintained or by the 
athlete due to exhaustion. After 6 weeks of respiratory muscle endurance training (T) or no 
respiratory muscle training (C), respiratory muscle endurance tests were performed at the 
same target VE as at baseline testing. If athletes reached 60 min, the tests were stopped by the 
experimenter. 
 
Respiratory muscle endurance training 
Each subject of T conducted 30 training sessions of 30 min each (5 sessions per week, during 
6 subsequent weeks). Respiratory muscle endurance training was performed at an intensity 
which could be maintained for 30 min but not longer; therefore VE was adapted after baseline 
testing and increased individually during the training process in order to reach an exhausting 
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training intensity. One of the 5 training sessions per week was performed in the laboratory to 
control and adjust training intensity in order to reach the maximal possible training effect. 
Training time and volume of respiratory muscle endurance training sessions performed at 
home were saved by the respiratory endurance training device and controlled after the weekly 
training sessions in the laboratory.  
 
Statistical analysis  
Results are presented as mean ± standard deviation (SD). Wilcoxon’s rank-sum tests were 
used to evaluate within groups differences between pre- and post-intervention values for all 
measured data. Additionally, between groups differences for baseline testing as well as 
changes from pre- to post-intervention were calculated using Mann-Whitney-U tests. 
Significance was tested with an alpha level of p < 0.05. Statistical analyses were performed 
with a computer software package (Version 10.2; Systat Software, Inc.; Point Richmond CA, 
USA). 
 
Results 
Baseline data 
Anthropometric and wheelchair exercise training data showed no significant differences 
between T and C (Table 1). Baseline testing showed no significant differences in all measured 
values between T and C for the respiratory muscle endurance test and the VO2peak test. 
Baseline values of the 10 km time-trial were significantly different between T and C for 
respiratory equivalent for O2 only (p = 0.04). Baseline lung function measurements showed 
significant higher TLC (p = 0.015) and a significant lower FEV1/FVC ratio (p = 0.026) and 
PEF (p = 0.030) for T compared to C.  
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Table 1: Anthropometric and training data of the training (T) and the control group (C) 
m = man; w = woman; L = lumbar lesion; T = thoracic lesion; ASIA = American Spinal Injury Association;  
y = years; SD = standard deviation; Note that there were no significant differences between groups. 
 
Respiratory muscle endurance training data 
Compliance of the respiratory muscle endurance training was excellent being 100%. T-
subjects performed respiratory muscle endurance training at a mean intensity of 64 ± 14% of 
their individual MVV level during the first week and at 73 ± 16% of MVV during the last 
week of respiratory muscle endurance training. VE increased from 80.4 ± 25.6 l/min during 
the first week to 92.6 ± 32.3 l/min during the last week of respiratory muscle endurance 
training.  
 
Pre- vs. post-tests data 
Respiratory muscle endurance  
Respiratory muscle endurance increased significantly by 332% in T (p = 0.028) after 
respiratory muscle endurance training, while C showed a non-significant increase of 53%. A 
significant difference in effect existed between groups (p = 0.016) (Table 2). The break-off 
level for respiratory muscle endurance tests at 60 min was reached by 2 subjects of T in the 
post-intervention trial. Thus, these tests were stopped before exhaustion.  
 
Group 
 
sex 
height 
[m] 
weight 
[kg] 
age 
[y] 
lesion 
level / 
ASIA 
race 
class 
lesion 
since [y] 
training  
[h/week] 
training 
since [y] 
T m 1.78 60 46 T4 / B T53 26 14 24 
T w 1.50 40 34 T6 / A T52 24 5 12 
T m 1.88 67 29 T6 / A T53 1.5 5 1 
T w 1.70 46 18 L1 / C T54 4 6 2 
T m 1.65 50 31 L1 / C T54 10 7.5 7 
T m 1.73 60 18 L3 / C T54 18 8.5 6 
mean ± 
SD  
1.70 
± 0.13 
54 
± 10 
29  
± 10   
14 
± 10 
7.5 
± 3.6 
9 
± 9 
C m 1.73 60 40 T5 / A T53 18 8.5 16 
C m 1.65 65 40 T6 / A T53 13 8 10 
C m 1.70 58 19 T8 / C T53 9 6 3 
C w 1.65 50 20 T12/B T54 11 6 5 
C m 1.68 69 24 L1 / C T54 24 2.5 8 
C m 1.55 57 27 L3 / C T54 27 6.5 13 
mean ± 
SD  
1.66 
± 0.06 
60  
± 7 
28 
± 10   
17 
± 7 
6.3 
± 2.1 
9 
± 5 
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Table 2: Mean ± standard deviation of values during respiratory muscle endurance tests 
VE = minute ventilation; VAS = visual analogue scale [points]; Note that ‘Mean’ values are means over the 
whole test duration; ° Significant between groups difference (change between pre- and post- test); † Significant 
within group difference 
 
Lung function and respiratory muscle strength 
There were no significant changes between pre- and post- tests for all measured lung function 
values as well as for Pimax within and between groups. Pemax increased significantly by 25% 
within T (p = 0.028) but showed no significant differences within C (+ 8%) and nor between 
groups comparisons (Table 3).  
 
 
 
 
 
 
 
 
 
 
Training group [n = 6] Control group [n = 6] 
 Pre Post Pre Post 
Time of respiratory muscle 
endurance tests [min] 9.1 ± 7.2 39.9 ± 17.8° † 4.3 ± 2.9 6.6 ± 7.0 
Mean heart rate
 
[bpm] 124 ± 13 122 ± 11 130 ± 17 128 ± 19 
Mean VE [l/min] 91 ± 28 91 ± 28 107 ± 18 107 ± 17 
Mean tidal volume
 
[l] 2.52 ± 0.90 2.58 ± 0.90 2.82 ± 0.63 2.83 ± 0.60 
Mean breathing frequency
 
[min-1] 37 ±  4 35.7 ± 4.8 38 ± 3 38 ± 3 
Mean end tidal CO2 [kPa] 3.9 ± 0.7 3.7 ± 1.3 3.2 ± 1.0 3.4 ± 1.0 
Dyspnoeaend [VAS] 3.7 ± 3.7 4.6 ± 3.9 5.8 ± 2.5 4.8 ± 4.4 
Perceived resp. exertionend [VAS] 8.1 ± 1.4 9.5 ± 0.8 6.5 ± 2.5 6.2 ± 3.1 
Perceived phys. exertionend [VAS] 5.7 ± 2.7 7.1 ± 2.9 7.1 ± 1.6 5.0 ± 3.9 
Lactaterest [mmol/l] 1.3 ± 0.7 1.3 ± 0.5 1.2 ± 0.6 0.9 ± 0.2 
Lactatemean [mmol/l]  1.8 ± 0.7 1.6 ± 0.7 1.8 ± 0.6 1.5 ± 0.6 
Lactateend [mmol/l]  1.9 ± 0.8 1.3 ± 0.6 1.9 ± 0.5 1.5 ± 0.8 
Chapter 5 
   
 94 
 
Table 3: Mean ± standard deviation of lung function measurements by bodyplethysmography 
as % predicted 
 
 
 
 
 
 
 
 
 
 
 
TLC = total lung capacity, RV = residual volume, FVC = forced vital capacity, FEV1 = forced expiratory 
volume in 1 s, PEF = peak expiratory flow, MVV = maximal voluntary ventilation, Pimax = maximal 
inspiratory muscle pressure, Pemax = maximal expiratory muscle pressure; Note that there were no 
significant differences in changes from pre- to post-test between groups; * Significant between groups 
difference (baseline testing); † Significant within group difference  
 
10 km time-trial 
10 km time-trial performance showed significant within group differences for T (p = 0.046) 
but not for C (Table 4). Between groups comparisons were not significantly different (p = 
0.150). Individual results of the 10 km time-trial pre- vs. post-intervention are shown in 
Figure 1. While 5 of 6 subjects of T decreased exercise time, only 2 subjects of C did so. The 
effect size of the 10 km time-trial was d = 0.87. 
 Training group [n = 6] Control group [n = 6] 
 Pre Post Pre Post 
TLC [%] 89.2 ± 14.9* 90.7 ± 21.8 69.2 ± 8.0 74.3 ± 17.1 
RV [%] 171.6 ± 31.0 176.5 ± 35.7 144.1 ± 29.6 138.6 ± 38.0 
FVC [%] 85.3 ± 29.0 88.5 ± 31.3 94.6 ± 30.9 95.8 ± 26.0 
FEV1 [%] 84.5 ± 26.6 87.4 ± 28.4 101.7 ± 27.5 103.2 ± 23.1 
FEV1/FVC [%] 102.1 ± 10.8* 102.7 ± 11.2 114.2 ± 10.8 113.6 ± 8.8 
PEF [%] 76.8 ± 20.6* 83.3 ± 28.1 104.8 ± 13.3 112.9 ± 19.2 
MVV [%] 124.8 ± 61.9 134.4 ± 66.7 118.8 ± 12.6 126.3 ± 15.3 
Pimax [%] 90.8 ± 29.3 102.3 ± 17.7 104.2 ± 16.7 104.5 ± 17.7 
Pemax [%] 46.4 ± 11.3  59.8 ± 11.2 † 52.4 ± 16.2 56.3 ± 15.4 
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Figure 1: Individual results of the relationship between times of 10 km time-trial pre- (y-axis) 
 vs. post- (x-axis) respiratory muscle endurance training 
 
Mean decrease in 10 km time-trial performance was 11.1% in T, while mean decrease in C 
was only 0.8%. There was a significant between groups difference in mean VE (p = 0.025) 
pre- vs. post- intervention, and a significant within T increase in VT (p = 0.046) (Table 4). 
Mean VE for all T- and C-subjects during 10 km time-trials were between 40 and 48% of 
MVV values. Lactate concentrations at the end and 2 min after the end of the 10 km time-trial 
were significantly different within T (p = 0.046) as well as between groups (p= 0.016) (Table 
4).  
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Table 4: Mean ± standard deviation of the 10km time-trial data  
VO2 = oxygen uptake; VE = minute ventilation; VAS = visual analogue scale [points]; * Significant between 
groups difference (baseline testing); ° Significant between groups difference (change between pre- and post-
tests); † Significant within group difference; Note that ‘Mean’ values are calculated means over the whole 10 km 
time-trial. 
 
VO2peak test 
Peak oxygen consumption as well as all other measured values (shown in Table 5) of the 
VO2peak test showed no significant differences pre- vs. post-intervention for within as well as 
between groups comparisons.  
 
 
 
 
 
 
 
 
 
 
 
 
Training group [n = 6] Control group [n = 6] 
 Pre Post Pre Post 
Time of 10 km time-trial [min] 27.1 ± 9.0 24.1 ± 6.6 † 23.3 ± 2.8 23.2 ± 2.4 
Mean VO2 as % of VO2peak 71.5 ± 9.9 77.1 ± 12.2 77.8 ± 4.6 74.6 ± 7.7 
Mean heart rate [bpm] 161 ± 13 168 ± 15 173 ± 11 172 ± 14 
Mean VE [l/min] 52.6 ± 18.6 64.6 ± 27.9 ° 75.5 ± 24.3 68.3 ± 19.0 
Mean tidal volume [l] 1.28 ± 0.33 1.47 ± 0.51 † 1.43 ± 0.69 1.40 ± 0.56 
Respiratory equivalent for O2 30.6 ± 2.3* 28.5 ± 3.9 24.6 ± 2.0 25.8 ± 3.4 
Mean breathing frequency [min-1] 41.5 ± 11.6 44.8 ± 13.2 57.5 ± 17.9 52.5 ± 9.1 
Mean end tidal CO2 [kPa] 3.3 ± 0.2 3.3 ± 0.3 2.9 ± 0.4 3.0 ± 0.2 
Dyspnoeaend [VAS] 3.5 ± 3.7 4.4 ± 3.5 3.6 ± 3.8 5.1 ± 3.8 
Perceived respiratory exertionend [VAS] 6.3 ± 3.4 7.5 ± 3.7 6.3 ± 2.5 6.6 ± 3.2 
Perceived physical exertionend [VAS] 7.5 ± 2.3 8.7 ± 2.7 8.8 ± 1.8 8.4 ± 1.9 
Lactaterest [mmol/l] 1.2 ± 0.4 1.2 ± 0.6 1.2 ± 0.4 1.0 ± 0.4 
Lactateend  [mmol/l]  5.7 ± 3.7 7.4 ± 4.4° † 8.7 ± 4.3 7.2 ± 3.5 
Lactate2min post  [mmol/l]  5.9 ± 3.9 7.2 ± 4.4° † 8.1 ± 3.9 6.9 ± 3.3 
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Table 5: Mean ± standard deviation of VO2peak test values 
 
VO2peak = peak oxygen uptake, VE max = maximal minute ventilation, VAS = visual analogue scale [points]; Note 
that there were no significant differences in changes from pre- to post-tests between groups. 
 
Discussion 
Summary of major findings 
This study showed that respiratory muscle endurance training has a positive effect on 
respiratory muscle endurance of wheelchair racing athletes, but much less effects on exercise 
performance. Six weeks of respiratory muscle endurance training significantly increased 
respiratory muscle endurance in trained athletes with paraplegia. Further, this study provides 
first evidence that respiratory muscle endurance training may also increase upper extremity 
exercise performance, showing significant within T decreases in exercise time on a 10 km 
time-trial (effect size d = 0.87).  
 
Spirometry and respiratory muscle endurance test 
Baseline testing of lung function (Table 3) indicates that FVC, FEV1, FEV1/FVC, PEF, MVV 
and Pimax are close to normal and that T may have more potential to improve lung function by 
respiratory muscle endurance training than C, since FEV1/FVC and PEF were significantly 
lower in T than in C. Nevertheless, post lung function results provide evidence that this 
difference was no confounding factor on outcomes of this study, since neither within nor 
between groups differences showed any significance for all lung function values pre- vs. post-
intervention. The more or less normal lung function values in paraplegic athletes are most 
likely the result of regular physical exercise training, which may possibly compensate the loss 
 
Training group [n = 6] Control group [n = 6] 
 Pre Post Pre Post 
VO2peak [ml/min/kg] 41.2 ± 10.6 40.3 ± 6.8 38.4 ± 7.7 37.4 ± 6.9 
Heart ratemax [bpm] 185 ± 16 184 ± 14 191 ± 7 190 ± 6 
VEmax  [l/min] 96 ± 31 94 ± 30 109 ± 22 114 ± 25 
Tidal volumemax  [l] 1.97 ± 0.61 1.96 ± 0.56 2.08 ± 0.69 2.03 ± 0.82 
Breathing frequencymax  [min-1] 60 ± 13 62 ± 14 77 ± 20 76 ± 21 
Dyspnoeaend [VAS] 2.7 ± 2.1 3.6 ± 2.6 2.4 ± 3.1 5.5 ± 3.9 
Perceived respiratory exertionend [VAS] 6.1 ± 3.4 7.7 ± 3.0 5.5 ± 3.1 6.7 ± 3.2 
Perceived physical exertionend [VAS] 8.3 ± 1.7 8.9 ± 1.2 8.9 ± 1.2 9.0 ± 1.1 
Lactaterest [mmol/l] 1.2 ± 0.5 1.2 ± 0.4 1.3 ± 0.1 0.9 ± 0.3 
Lactateend  [mmol/l]  8.7 ± 3.7 8.3 ± 2.3 9.0 ± 1.8 8.7 ± 2.5 
Lactate2minpost  [mmol/l]  7.9 ± 3.4 8.0 ± 2.3 8.9 ± 1.3 8.3 ± 2.2 
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of some respiratory muscle function (32) leading to nearly normal lung function values. 
Despite normal lung function in our SCI subjects, Pemax was severely decreased (Table 3). 
Decreases in Pemax occur due to the loss of abdominal muscle function and lesion dependent 
intercostal muscle function loss (32). Interestingly, Pemax seems to be positively influenced by 
respiratory muscle endurance training since it significantly increased within T. Thus, 
respiratory muscle endurance training may also be an interesting option for sedentary subjects 
with SCI or during SCI rehabilitation to improve expiratory muscle strength.  
Our results show that respiratory muscle endurance training improves respiratory muscle 
endurance in athletes with paraplegia to a comparable extent as in able bodied individuals (6, 
7). Results of C reveal that there was no learning effect between pre- and post-intervention 
values.  
 
10 km time-trial 
T-subjects showed a significant within group difference with a mean decrease in time of 11% 
over a 10 km time trial, which has a practical relevance for wheelchair racing competitions. 
Unfortunately, the high inter-individual variability (in combination with the small groups) 
caused a non-significant between groups difference (p = 0.150). Nevertheless, there was a 
strong trend with a large observed effect size of d = 0.87, towards improved performance in 
the 10 km time-trial after six weeks of respiratory muscle endurance training.  
The reproducibility of an exercise test to measure physical performance is an important factor 
to reduce variability of results. While most of respiratory muscle endurance training studies 
performed in able bodied subjects were conducted by constant load cycling endurance tests to 
exhaustion (6, 7), our athletes had to complete a time-trial since reproducibility has been 
shown to be much higher in time-trials (CV 3.4%) than in sub-maximal endurance exercise 
tests (CV 26.6%) (14, 15). Additionally, a time-trial is more competition like than a sub-
maximal endurance test and therefore more meaningful to competitive athletes. Probably 
other individual differences as day-to-day variation, lesion level, muscle fibre type 
distribution or motivational aspects contributed to the inter-individual differences. 
This study is the first investigating effects of respiratory muscle endurance training on upper 
extremity exercise performance. During upper body exercise, similar muscles are innervated 
for movement and breathing and therefore these muscles are concurrently used. It has been 
shown that ventilatory pattern change during upper body exercise, and exercise endurance is 
decreased compared to leg exercise (8). Therefore, improvements in respiratory muscle 
endurance may have a positive influence on upper body exercise performance. Probably this 
was only the case in some of the tested athletes of the present study. The lesion dependent 
differences in the amount of innervated upper body muscle mass differs between athletes and 
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may therefore provide a source of variation in exercise performance and potential to increase 
upper body endurance performance.  
The difference in ventilatory work during upper body exercise compared to leg exercise is 
another important factor to be considered. Studies of upper body and/or leg exercise have 
shown that arm-cranking exercise at maximal effort only needs between 70 to 80% of total VE 
needed during maximal leg cycling exercise (4, 10, 27). While T-subjects showed a mean VE 
level of 40.4% MVV during the pre- and 46.5% MVV during the post- time-trial, able bodied 
subjects performed cycling endurance tests at VE levels between 56 to 64% MVV before 
respiratory muscle endurance training and were even able to reduce VE during the test after 
respiratory muscle endurance training to 39-51% MVV (6, 7, 29). The lower percentage of 
maximal VE levels found in wheelchair racing athletes during a 10 km time-trial may fatigue 
respiratory muscles to a lesser extent than those of able bodied subjects during cycling at a 
comparable exercise time. Thus, although respiratory muscle endurance increased, respiratory 
muscle fatigue during the 10 km time-trial may not be the limiting factor in some of our 
wheelchair racing athletes. Probably a time-trial over 20 km or even the marathon distance 
would provide more consistent results. 
Other studies investigating respiratory muscle endurance training in able bodied subjects 
found that some of the tested subjects showed a higher VE during physical exercise testing 
after respiratory muscle endurance training, compared to the same test before respiratory 
muscle endurance training (6, 18). Interestingly, endurance exercise time of a constant load 
test was decreased in these subjects with increased VE levels, while endurance exercise time 
of those subjects who had a lower VE after respiratory muscle endurance training was 
increased. Results of T in the present study demonstrate a similar pattern since the subject 
with the highest improvement in the 10 km time-trial performance had a lower mean VE and 
the only subject of T who’s 10 km time increased showed the highest mean increase in VE 
during the time-trial post respiratory muscle endurance training. This finding could occur 
either due to the hyperpnoea performed for respiratory muscle endurance training which may 
lead to a higher VE during physical exercise by conditioning of respiratory regulation which is 
known to have certain plasticity (17), or due to insufficient recovery time after respiratory 
muscle endurance training (6). This fact may be a further source of individual variation 
between subjects.  
 
VO2peak 
VO2peak did, as expected, not increase after respiratory muscle endurance training in the 
present study. Similar results have been reported in many other studies (3, 6, 7, 16, 19, 24, 
29). To increase VO2peak it has been shown that training on a very high intensity level is 
necessary and that one achieves a higher increase in VO2peak due to intermittent exercise rather 
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than due to endurance exercise training (12, 20, 31). Thus, an increase in VO2peak could not be 
expected, nor due to respiratory muscle endurance training, and neither due to physical 
exercise training since subjects hold their wheelchair training constant on an aerobic intensity 
level.  
 
Limitation 
The fact that the results of the 10 km time-trial were not statistically significant between 
groups is most likely due to large inter-individual differences and small groups. Although the 
groups were small, they were quite well matched for lesion level.  
 
Clinical relevance  
This study reveals that respiratory muscle endurance can be increased in competitive athletes 
with paraplegia by isolated respiratory muscle endurance training. Our results show 
preliminary indices which may be interesting for the rehabilitation of patients with spinal cord 
injury, especially the significant within T increase in Pemax. 
 
Conclusion 
This study showed that six weeks of respiratory muscle endurance training performed by 
competitive wheelchair racing athletes increased respiratory muscle endurance. Since there 
was a large observed effect size of d = 0.87, there is evidence that six weeks of respiratory 
muscle endurance training may also improve upper body exercise performance.  
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Abstract 
Objective: To investigate the impact of low intensity isocapnic hyperpnoea on blood lactate 
disappearance after exhaustive arm exercise in comparison to passive and active recovery 
using the previously loaded muscle group. 
Methods: Eighteen healthy, non-smoking and physically active male subjects participated in 
this randomized crossover trial. Subjects performed three arm cranking tests to volitional 
exhaustion on 3 different days at least 48 h apart. Arm exercise was randomly followed by 30 
min of passive recovery, active arm cranking at 30% of peak power output or ventilatory 
recovery by means of isocapnic hyperpnoea at 30% of their individual maximal voluntary 
ventilation. Blood lactate concentrations were measured every 2 min during recovery. Blood 
lactate disappearance during the three different recovery strategies was the main outcome 
measure of this study. 
Results: No significant differences for blood lactate concentrations were found between the 
three interventions passive recovery, arm cranking and ventilatory recovery during the whole 
measurement period. Peak lactate concentrations were 11.09 ± 1.98 mmol·l-1 for passive 
recovery, 11.13 ± 1.44 mmol·l-1 for arm cranking and 11.25 ± 1.93 mmol·l-1 for ventilatory 
recovery. At the end of the recovery period measured lactate concentrations were 4.35 ± 1.56 
mmol·l-1 for passive recovery, 3.77 ± 1.60 mmol·l-1 for arm cranking and 4.09 ± 1.35 mmol·l-1 
for ventilatory recovery. Moreover, all other parameters measured were not significantly 
different, with the exception of higher average recovery heart rates during arm cranking (116 
± 9 bpm) and ventilatory recovery (111 ± 7 bpm) compared to passive recovery (93 ± 11 
bpm).  
Conclusion: Low intensity isocapnic hyperpnoea seems not to enhance blood lactate 
disappearance after exhaustive arm exercise compared to passive or active recovery using the 
previously loaded muscle group. The magnitude of the involved muscle mass appears critical 
to effective active recovery. 
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Introduction 
Exhaustive anaerobic exercise leads to a large production of lactate and hydrogen ions in the 
exercising muscles causing a concomitant decrease in intracellular pH (3, 16). This acidosis 
impairs the ability for muscle contraction and glycolytic enzyme activity leading to reduced 
exercise performance (16). In order to regain optimal performance as soon as possible, fast 
lactic acid elimination is crucial for athletes, particularly if there are repeated, high intensity 
bouts of exercise within a short period of time such as competitions in swimming, athletics or 
wheelchair racing (24, 25). 
In general, blood lactate elimination is accelerated by active recovery of the previously loaded 
muscle group at moderate intensities (1, 5, 14, 15, 25, 30, 33). In practice, due to restricted 
infrastructural possibilities or a densely packed schedule during a competition, active 
recovery is not always possible. Moreover, active recovery using the previously loaded 
muscle group may impair subsequent exercise performance as energy stores become 
additionally depleted (11), early resynthesis of muscle glycogen is compromised, and time for 
an optimal refilling of glycogen stores is shortened (9). This might have negative 
consequences for subsequent exercise performance, especially in sports or situations where it 
is not possible to use another muscle group for active recovery purposes (e.g. leg exercise 
after upper body exercise) as is the case in spinal cord injured athletes. 
Type I fibres are able to metabolize lactate (7, 18, 23). As respiratory muscles mainly consist 
of type I fibres (17, 19, 26), we hypothesized that respiratory muscles may have the potential 
to enhance blood lactate elimination. If this is the case, respiratory muscles might be used as 
an easy to handle tool to accelerate blood lactate elimination without affecting glycogen 
resynthesis in previously exhausted limb muscles. The aim of the present study was to 
investigate the impact of low intensity isocapnic hyperpnoea on blood lactate disappearance 
after exhaustive arm exercise and to compare these data with results of conventional active 
and passive recovery protocols. An acceleration of blood lactate elimination by active 
recovery strategies (moderate arm cranking exercise and isocapnic hyperpnoea) was expected 
compared to that of passive recovery. 
 
Methods 
Subjects 
Eighteen trained, male and non-smoking subjects participated in this study. Their average age 
was 30 ± 5 years, height 178 ± 7 cm, weight 72 ± 9 kg, weekly physical training volume 5.6 ± 
3.3 h and peak oxygen uptake (VO2peak) for arm cranking 42 ± 7 ml·min-1·kg-1. Subjects were 
asked not to perform any strenuous exercise and eat food rich in carbohydrates the day before 
testing as well as to abstain from caffeine intake on the test days. The study was approved by 
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the local ethics committee. Written informed consent of the subjects was obtained prior to the 
start of the study. 
 
Experimental Procedure 
Two preliminary sessions preceded the three main test trials. During the first preliminary 
session, standard spirometric data, including forced vital capacity (FVC), forced expiratory 
volume in 1 s (FEV1), peak expiratory flow rate (PEF) and maximal voluntary ventilation 
over 12 s (MVV) were obtained by an ergospirometric device (Oxycon Alpha, Jaeger, 
Hoechberg, Germany). Afterwards, a familiarization trial for isocapnic hyperpnoea by partial 
rebreathing from a bag was completed (SpiroTiger, idiag AG, Fehraltorf, Switzerland). Bag 
size corresponded to about one third of subjects’ FVC. Subjects were breathing at a preset 
respiratory frequency to reach target minute ventilation (see below).  
The second preliminary session consisted of 30 min continuous isocapnic hyperpnoea at a 
minute ventilation corresponding to 30% MVV and served to make sure that subjects were 
able to sustain this load over 30 min. To assure the predetermined target ventilation, tidal 
volume, breathing frequency and end tidal partial pressure for carbon dioxide were monitored 
by means of the above mentioned metabolic cart. If necessary, subjects were guided to keep 
preset tidal volume and breathing frequency to achieve the target ventilation. 
All three main tests started with a 2 min resting period for baseline data determination. 
Subjects were seated in a chair connected to an arm cranking ergometer (Ergometrics 800 SH, 
Ergoline, Bitz, Germany). After this resting period subjects started arm cranking at 20 W. 
Then, the workload was increased by 5 W every 20 s until subjects’ volitional exhaustion. 
Respiratory variables at rest and during the exercise tests were sampled breath by breath via a 
face mask by an Oxycon Pro (Jaeger, Würzburg, Germany). This device was calibrated for 
gas and volume according to the manufacturers’ recommendations immediately before each 
test. The three main tests were at least 48 h apart. 
During arm cranking, the pedal axis of the ergometer was aligned with the shoulder joint axis 
and subjects were positioned such that the elbow was slightly flexed at maximal reach. Five 
minutes after test cessation, subjects followed one of three recovery strategies in a 
randomized order. These strategies were passive recovery, active recovery by arm cranking or 
ventilatory recovery by means of isocapnic hyperpnoea for 30 min. Whilst subjects sat 
relaxed on a chair for passive recovery, they were either arm cranking at 30% of the 
previously reached maximal workload (arm cranking) or breathing at 30% MVV with the 
SpiroTiger device (ventilatory recovery) as an active recovery strategy.  
Capillary blood for enzymatic lactate analysis (Super GL Ambulance, Ruhrtal Labor Technik, 
Möhnesee, Germany) was sampled from an earlobe at rest, immediately after cessation of the 
exercise test and every 2 min until the end of the recovery phase. Heart rate was determined 
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by a heart rate monitor (Polar S610, Polar, Kempele, Finland) throughout the whole test and 
recovery period. Immediately after cessation of the arm cranking exercise test, subjects were 
asked to rate their perceived exertion by means of a Borg scale, with 6 indicating ‘no’ and 20 
‘maximal’ exhaustion (6). 
 
Statistics 
Data points of the measured lactate concentrations of the three different recovery strategies 
were fitted to the following bi-exponential curve, as described in detail elsewhere (13): 
)e(1A)e(1ALa(0)La(t) tγ2tγ1 21 ⋅−⋅− −⋅+−⋅+=  
La(t) denotes the time dependent lactate concentration with La(0) being the lactate 
concentration at the start of recovery. The form of this equation suggests that the lactate 
kinetics during recovery can be described by two main processes, one with a high-velocity 
constant (γ1) describing the appearance (A1> 0) of lactate in the bloodstream and the other 
with a low-velocity constant (γ2) describing its disappearance (A2< 0). 
The parameters were calculated using a commercially available computer software package 
(SYSTAT, Version 10, SPSS Inc., Richmond, California) with the regression method of least 
mean squares. 
An analysis of variance for repeated measures was applied to compare γ1 as well as γ2 between 
the different intervention strategies (passive recovery, arm cranking, ventilatory recovery). In 
addition, VO2peak, peak power, rating of perceived exertion as well as maximal and average 
recovery heart rates were analyzed in the same way. If significance was found, a post-hoc test 
with Bonferroni correction was used to locate significant differences. Results are given as 
mean ± SD. Values were considered to be significantly different if p < 0.05. 
Ventilatory threshold of the exercise test preceding arm cranking was calculated from carbon 
dioxide output (VCO2) and VO2 values according to the V-slope method (4). 
 
Results 
The mean of the subjects’ FVC was 5.8 ± 1.1 l (115% predicted), FEV1 4.6 ± 0.7 l (109% 
predicted), PEF 11.4 ± 1.4 l·s-1 (119% predicted) and MVV 207 ± 30 l·min-1 (140% 
predicted). Peak power output, VO2peak, maximal heart rate and rating of perceived exertion 
did not differ significantly between tests (Table 1).  
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Table 1: Values measured (mean ± standard deviation) at the end of exhaustive arm cranking 
tests before starting different recovery strategies. 
Note that there were no significant differences between tests 
 
Blood lactate curves are shown in Figure 1. The low-velocity constants (γ2) describing blood 
lactate disappearance were 0.052 ± 0.031 min-1 for passive recovery, 0.072 ± 0.035 min-1 for 
arm cranking and 0.053 ± 0.032 min-1 for ventilatory recovery (p = 0.138) indicating that 
blood lactate elimination rate constants after exhaustive arm ergometry were not significantly 
different among the three different recovery strategies. Average recovery heart rates during 
arm cranking (116 ± 9 bpm) and ventilatory recovery (111 ± 9 bpm) were significantly higher 
compared to average heart rate during passive recovery (93 ± 11 bpm). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Mean blood lactate elimination curves for differrent recovery strategies after an exhaustive arm 
cranking exercise test (AET). 
 
 Subsequent recovery strategy: 
 passive arm cranking isocapnic hyperpnoea 
Peak power [W] 148 ± 25 148 ± 23 147 ± 23 
Peak oxygen uptake [ml·min-1·kg-1] 41.7 ± 7.3 40.6 ± 4.8 41.7 ± 8.0 
Maximal heart rate [bpm] 176 ± 12 176 ± 10 176 ± 11 
Rate of perceived exertion (Borg)  18.3 ± 1.4 18.3 ± 1.4 18.2 ± 1.2 
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Average workload during arm cranking was 44.2 ± 7.3 W corresponding to 29.9 ± 1.0% of 
peak power output. This workload was clearly below the ventilatory threshold at 55.8 ± 
14.5% of VO2peak, which corresponded to an absolute workload of 88.1 ± 30.0 W.  
During ventilatory recovery subjects were ventilating 61.6 ± 9.3 l·min-1 (29.8 ± 0.9% of 
MVV) at an average breathing frequency of 26.2 ± 3.7 min-1. Average end tidal partial 
pressure for carbon dioxide was 32.8 ± 5.1 mmHg. 
 
Discussion 
The main finding of this study is that there were no significant differences in blood lactate 
disappearance after exhaustive arm cranking exercise due to the different recovery strategies. 
This was surprising, as a superior impact of active recovery strategies (arm cranking and 
ventilatory recovery) on blood lactate elimination was expected compared to passive 
recovery. Different reasons may explain this observation and are discussed below. 
 
Arm cranking for active recovery 
Active recovery at moderate intensities by means of the previously loaded muscle groups is 
known to accelerate blood lactate elimination compared to passive recovery (1, 5, 14, 15, 25, 
30, 33). Although arm cranking showed a nearly 40% faster low-velocity constant (γ2) 
compared to passive recovery and ventilatory recovery, no statistically significant differences 
(p = 0.138) were found between the different recovery strategies. This might be due to 
relatively large inter-individual differences between subjects (Figure 1) but may also have 
other reasons which are discussed below. 
In contrast to the above mentioned studies where leg exercise was applied, we used arm 
cranking exercise for recovery. Slower blood lactate kinetics for arm exercise compared to leg 
exercise were also reported by Thiriet et al. (32). Obviously, the magnitude of the involved 
muscle mass appears to be critical to an effective active recovery. In fact, arm muscle mass in 
a group of 29 years old men was found to be only 40% of leg muscle mass (7.1 kg vs. 17.7 
kg) (27). Taking further into account the higher proportion of type I fibres (17, 31) combined 
with the bigger muscle mass involved during leg exercise, it seems not to be surprising that 
results are different for leg muscles as opposed to arm muscles with regard to lactate 
elimination. The large proportion of type II fibres in arm muscles (17, 31) limits the capacity 
to oxidize lactate per se. In combination with the relatively small muscle mass of the arms, 
lactate elimination is additionally compromised compared to leg muscles.  
If the chosen intensity for arm cranking had been too high, lactate elimination would have 
been decelerated. However, considering the measured mean recovery heart rate of 116 bpm 
during arm cranking (Table 1) compared to other active recovery heart rates reported in the 
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literature (14, 25, 32), it seems very unlikely that our recovery intensity of 30% of maximal 
power output was too high. Moreover, a recovery load of 30% of maximal power output was 
suggested to be within the optimal range for active recovery and was successfully applied in 
the past (10, 22, 32). Further, the chosen recovery workload was far below the ventilatory 
threshold, which supports the assumption of an optimal active recovery intensity. 
However, the present active recovery design by means of arm cranking (instead of using 
previously unloaded leg muscles) was chosen, since there are situations, where it is not 
possible to use another muscle group for active recovery purposes as it is the case e.g. in 
spinal cord injured athletes.  
 
Ventilatory recovery for active recovery 
With regard to the muscle fibre type composition of arm vs. respiratory muscles, one can 
hypothesize that ventilatory recovery is superior to arm cranking and passive recovery in 
accelerating blood lactate disappearance. However, this assumption was not supported by the 
present findings. Although respiratory muscles mainly contain type I fibres (17, 19, 26), the 
total muscle mass involved in ventilation is quite small and thus oxidative capacity is limited. 
Diaphragmatic muscle mass was found to be only 262 g (2) compared to the above mentioned 
7 kg of arm muscle mass (27). Even if the auxiliary respiratory muscles worked actively 
during ventilatory recovery, it seems to be a very small active muscle mass to engage in 
lactate oxidation. This might be the main reason why the ventilatory recovery strategy failed 
to enhance blood lactate elimination.  
A further reason might be, that the chosen intensity of isocapnic hyperpnoea at 30% MVV 
was too low to cause a sufficient effect on lactate metabolisation over 30 min. On the other 
hand, a higher intensity of isocapnic hyperpnoea may have led to respiratory muscle fatigue, 
which compromises subsequent exercise performance (20, 21). Martin and coworkers (21) 
showed that intense isocapnic hyperpnoea at 66% of the mean MVV reduces subsequent 
running performance. It has to be taken into account that during upper body exercise, some of 
the respiratory muscles of the rib cage have to partake in nonventilatory functions (8). Thus, a 
recovery strategy like isocapnic hyperpnoea integrating all respiratory muscles should be 
performed at a moderate intensity, to avoid the development of rib cage muscle fatigue, which 
otherwise might compromise subsequent arm cranking performance. The fact that average 
recovery heart rate during ventilatory recovery was close to the heart rate values during arm 
cranking and significantly higher than during passive recovery underlines that the chosen 
intensity of isocapnic hyperpnoea at 30% MVV seems to be adequate and comparable to the 
intensity during arm cranking. Hence, it is questionable if a higher intensity of isocapnic 
hyperpnoea (e.g. 40-50% MVV) would provide faster lactate removal without causing 
respiratory muscle fatigue.  
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Perhaps specifically trained respiratory muscles would have provided faster blood lactate 
elimination. This assumption is supported by the finding of Spengler et al. (29), who 
demonstrated lower blood lactate concentrations at the end of exhaustive cycling exercise 
after 4 weeks of isocapnic hyperpnoea training. It was suggested by the authors that the 
decrease in blood lactate concentration was most likely caused by an enhanced lactate uptake 
of the trained respiratory muscles. In contrast, others observed no changes of blood lactate 
concentrations after respiratory muscle training (28). As the respiratory muscles of our 
subjects were not specifically trained, it may be interesting to see if there would be 
differences in the potential for lactate elimination after a respiratory muscle endurance 
training period. Further investigations are needed to answer this question.  
 
Preliminary exercise and lactate elimination 
It has been shown that the intensity of preliminary exercise influences kinetics of subsequent 
lactate elimination (17) and thus might falsify results. For the present study, data of the three 
arm cranking tests to exhaustion preceding the three recovery interventions refute this 
assumption. No differences were found in peak power, VO2peak, maximal heart rate or peak 
lactate concentration between tests (Table 1), which implies that preceding exhaustive 
exercise was comparable for each testing session.  
 
Conclusions 
Low intensity isocapnic hyperpnoea seems not to enhance blood lactate disappearance after 
exhaustive arm exercise compared to passive or active recovery with the previously loaded 
muscle group. The magnitude of the involved muscle mass appears to be critical to an 
effective active recovery represented by the fact that also arm cranking failed to significantly 
enhance blood lactate elimination. 
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Abstract  
Background: In various health conditions such as neuromuscular diseases, rib cage mobility 
decreases. Changes in rib cage mobility should be measured before and after interventions to 
mobilize or strengthen the respiratory pump. Thus, an accurate and easy to perform test is 
needed.  
Methods: We analyzed single slice computed tomography scans of the chest to assess the 
reproducibility of maximal in- and expiration in 10 able bodied individuals and 10 subjects 
with tetraplegia. Computed tomography scans were performed twice in the supine position, 
with a repositioning of subjects in-between. At maximal in- and expiration, two slices at the 
fourth and ninth vertebral body were recorded. Intra-costal areas, anterior-posterior distances 
between sternum and vertebral body as well as transversal distances were measured. Intraclass 
correlation coefficients and Bland & Altman plots were calculated for intra-subject 
reproducibility at maximal in- and expiration as well as for intra- and inter-tester 
reproducibility of three independent testers, each of them analyzing all data twice.  
Results: Mean differences between the two measurements expressed as percent of their mean 
were 2.3 ± 1.3% in able bodied individuals and 2.1 ± 1.3% in subjects with tetraplegia. All 
intraclass correlation coefficients were above 0.95 and thus showed very high reproducibility. 
Conclusion: Computed tomography of the chest is a reproducible method to assess rib cage 
mobility in humans. 
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Introduction  
The coordinated action of respiratory muscles affects respiratory mechanics in humans (17). 
Respiratory mechanics depends on the mobility of the thoracic cage, which is determined by 
the compliance of the abdomen and the mobility of the rib cage. Rib cage mobility decreases 
in various health conditions, such as chronic obstructive pulmonary disease, ankylosing 
spondylitis, pulmonary emphysema, multiple sclerosis, amyotrophic lateral sclerosis, spinal 
cord injury or kyphoscoliosis (2, 16, 18). Decreases in rib cage mobility often become chronic 
and thus lead to stiffness of the whole rib cage (11) which may increase the risk for 
respiratory failure and further respiratory complications (7). 
In order to prevent patients from rib cage stiffness or even increase rib cage mobility, many 
different active and passive therapeutic methods exist (12, 15, 20). To evaluate the usefulness 
of a certain therapy, accurate measurement methods of rib cage mobility are needed. In a 
clinical setting they need to be easy and fast to perform as well as comfortable for the 
patients. High reproducibility has to be proven and measurement errors have to be known, (3) 
before using a method to evaluate outcomes of different therapeutic interventions.   
Several methods to assess rib cage mobility have been described in literature, such as optical 
mapping, (22) chest circumference measurements, (4) optoelectronic plethysmography, (1) 
magnetic resonance imaging (9) or computed tomography (CT) (6). They all differ in 
reproducibility, costs and outcome measures. Even if optical mapping and optoelectronic 
plethysmography may provide interesting data about respiratory mechanics, they are rather 
laborious to perform and quite expensive. Chest circumference measurement may be the 
fastest, cheapest and easiest to perform of the methods mentioned above, but outcome 
measures provide rather less detailed information about rib cage mobility. CT may be an 
interesting instrument to assess rib cage mobility especially in subjects with respiratory 
diseases, due to the short time of breath-holding needed for CT acquisition, which only takes 
about five seconds. Further, new equipment and protocols allow keeping radiation dose of 
single slice CT very low.  
The aim of this study was to assess the reproducibility of follow up measurements from a new 
method to test rib cage mobility, using single slice CT scans in healthy humans and patients 
with known restrictions in rib cage mobility. Subjects with tetraplegia were included in this 
study as a group of patients with known restrictions in rib cage mobility and therefore 
represent an interesting group to test the reproducibility of chest CT in addition to able bodied 
subjects.  
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Methods 
All subjects were recruited from the same SCI rehabilitation centre, 10 able bodied subjects 
from the clinic staff and 10 subjects with tetraplegia. Inclusion criteria were: men or women 
between 20 and 65 years of age. Subjects with tetraplegia were included if they had a motor 
complete cervical lesion (C) for more than one year. Exclusion criteria were: pregnancy, 
severe scoliosis, tracheotomy or assisted ventilation. All participants were informed about the 
procedures and potential risks of the study prior to giving their written informed consent. The 
study was approved by the local ethics committee. 
We analyzed CT scans of the rib cage to assess reproducibility of maximal in- and expiration 
in able bodied individuals and subjects with tetraplegia. CT scans were performed on a high 
resolution scanner (Somatom Sensation 40; Siemens, Germany). Subjects were lying down 
straight in supine position with the arms adjacent to the upper body. Detailed instructions 
about the whole procedure were given to the subjects prior to the acquisition of images. 
Subjects were instructed to maximally breathe in and hold their breath until the acquisition of 
the first image. First of all, an anterior-posterior topogram (512-512 pixel) was assessed in 
order to localize the exact position of slices (Figure 1). Two slices, one at the inferior end 
plate of the fourth thoracic vertebral body (T4) and another at the superior end plate of the 
ninth thoracic vertebral body (T9) were recorded in order to get information about the 
mechanics of the upper and lower rib cage. For the acquisition of the two slices at T4 and T9, 
subjects were instructed to perform a maximal inspiration and then to hold their breath until 
completion of the scans (for about five seconds each). Scans were performed at 120 kV and 
the tube current modulated for radiation dose reduction (‘care-dose protocol’), with a slice 
thickness of 1mm and a field of view of 500, reconstruction Kernel B25s smooth++.  
 
 
 
 
 
 
 
 
Figure 1: Topogram showing localization 
of slices at the fourth (T4) and ninth (T9) 
thoracic vertebra.  
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After completion of the topogram and the two slices at maximal inspiration, the whole 
procedure was repeated at maximal expiration. Therefore subjects were instructed to perform 
a maximal expiration and hold their breath until data acquisition was completed. All 
measurements were performed twice with a repositioning of the patient in-between, in order 
to calculate intra-subject reproducibility of maximal in- and expiration including possible 
differences from positioning. Intraclass correlation coefficients (ICCs) and Bland & Altman 
limits of agreement were calculated for intra-subject reproducibility at maximal in- and 
expiration as well as for intra- and inter-tester reproducibility of three independent testers, 
each of them analyzing all data twice. 
Slices at maximal in- and expiration were analyzed for intra-costal areas as well as for 
anterior-posterior (AP) distances (between middle of inner margins of sternum and vertebral 
body) and transversal diameters of the rib cage by visual selection of the area and distances as 
shown in Figure 2. Visual selection and calculation of intra-costal (lung) areas and distances 
was done using ‘Osiris’ medical imaging software (21). Every picture was analyzed twice by 
three independent testers in a blinded way, with at least 24 h between the analysis in order to 
calculate intra- and inter-tester reproducibility. 
 
 
Figure 2: Single slice CT scan showing selection of intra-costal area, anterior-posterior distance between 
sternum and vertebral body and transversal diameter of the rib cage. 
 
Chapter 7   
    
 118 
 
All data were analyzed by ICCs for intra-subject reproducibility as well as for intra- and inter-
tester reproducibility in order to compare our data with other methods from the literature (13, 
24). An ICC of 1.0 indicates that the total variance of a measurement is entirely a result of the 
differences between subjects, and there is no variance from the measurement method and 
error (8). ICCs above 0.75 generally represent acceptable reproducibility, those greater or 
equal to 0.90 indicate clinically valuable reproducibility (13). Intra-subject reproducibility 
was calculated from mean values of both calculations of all three testers by ICCs from data 
produced by a one-way analysis of variance (ANOVA) described in detail elsewhere (23). 
Data are shown as ICCs including 95% confidence intervals of ICCs. Intra-tester 
reproducibility was calculated from data produced from a one-way ANOVA for differences 
between the first and second analysis of the same pictures from all three testers together. 
Inter-tester reproducibility was calculated from data produced from a two-way ANOVA for 
all pictures analyzed by the three independent testers. 
 
In addition, Bland & Altman plots (3) for intra-costal areas were drawn to assess the mean 
difference (bias) between the two scans of each patient against their mean and the limits of 
agreement (mean ± 2 standard deviations (SD) of the difference). The limits of agreement 
represent the measurements error which has to be known for a practical use of this method. 
Thus, changes due to an intervention have to exceed limits of agreement in order to represent 
real changes. Results of Bland & Altman plots are presented graphically as separate plots for 
intra-costal areas at T4 and T9 and at maximal in- and expiration. Separate limits of 
agreement for able bodied individuals and subjects with tetraplegia were calculated for intra-
subject reproducibility of maximal in- and expiration, in order to assess the measurements 
error of all measured parameters. To compare the reproducibility of our method to other 
methods, we calculated differences between the two measurements as percentage of their 
mean for each individual subject and present these data as group means ± SD for each 
parameter and subjects with tetraplegia and able bodied individuals separately. 
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Results 
Characteristics of the able bodied and the tetraplegic group did not differ significantly (Table 
1).  
 
Table 1: Means ± standard deviations of subject’s characteristics of the able bodied and the 
tetraplegic group. 
Parameter able bodied group tetraplegic group p-value 
sex [men/women] 8 / 2 8 / 2 - 
age [years] 46.8 ± 11.5 47.4 ± 12.7 0.30 
height [m] 1.77 ± 0.07 1.76 ± 0.06 0.36 
body mass [kg] 80 ± 7 75 ± 12 0.13 
lesion level - C4 - C7 - 
time post injury [years] - 13.6 ± 8.2 - 
 
Mean differences of all measured parameters between the two measurements expressed as 
percent of their mean were 2.1 ± 1.3% (0.7 to 5.2 %) in subjects with tetraplegia and 2.3 ± 
1.3% (0.8 to 4.7%) in able bodied individuals, representing small errors for both groups 
(Table 2).  
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Table 2: Data of Bland & Altman plots showing group means ± standard deviations, limits of 
agreement (± 2 SD of intra-subjects differences) and mean individual differences between the 
two measurements expressed as percent of their absolute mean for able bodied individuals 
and tetraplegic subjects separately. 
SD = standard deviation; T = thoracic vertebra; AP = anterior-posterior 
 
Intra-subject reproducibility of maximal in- and expiration was very high with ICCs between 
0.97 and 0.99 in able bodied individuals and subjects with tetraplegia (Table 3). Intra-tester 
reproducibility was very high as well with all ICCs between 0.99 and 1.0 (Table 4). Inter-
tester reproducibility, i.e. reproducibility between the three independent testers, was all 
between 0.97 and 1.00 and thus did not substantially influence data (Table 5). 
 able bodied subjects tetraplegic subjects 
 mean ± SD 
limits of 
agreement 
Diff. 
(%) 
mean ± SD 
limits of 
agreement 
Diff 
(%) 
Inspiration       
area at T4 [mm2] 30337±5081 -2649→3511 2.3±2.7 20449±4931 -1438→910 1.8±0.6 
area at T9 [mm2] 45599±6282 -1934→2775 1.7±0.9 35162±3346 -858→1499 1.7±1.3 
AP distance at T4 
[mm] 101±18 -7→9 4.2±3.9 75±16 -4→5 2.3±1.6 
AP distance at T9 
[mm]  138±19 -6→8 4.7±4.6 108±14 -4→3 5.2±3.7 
transversal dia-
meter at T4 [mm] 246±14 -5→7 0.9±0.9 218±17 -6→5 1.1±0.6 
transversal dia-
meter at T9 [mm] 281±15 -7→8 0.9±1.1 266±14 -8→4 0.8±1.1 
Expiration       
area at T4 [mm2] 19139±7049 -2404→2415 1.9±2.0 16303±3990 -2027→2376 1.2±0.8 
area at T9 [mm2] 36248±5973 -1638→893 2.5±1.8 31183±3936 -1352→1442 1.6±1.7 
AP distance at T4 
[mm] 67±27 -6→7 3.0±3.4 63±11 -6→8 2.2±1.2 
AP distance at T9 
[mm] 111±21 -8→5 3.2±2.8 96±14 -4→5 4.2±2.7 
transversal dia-
meter at T4 [mm] 220±18 -9→9 1.6±1.3 205±19 -10→8 1.8±1.2 
transversal dia-
meter at T9 [mm] 264±12 -5→4 0.7±0.6 261±14 -6→7 0.9±0.8 
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Table 3: Results of intra-subject reproducibility showing ICCs with 95% CIs for able bodied 
and tetraplegic subjects. 
ICC = intraclass correlation coefficient; CI = confidence interval; T = thoracic vertebra; AP = anterior-posterior 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 able bodied subjects  tetraplegic subjects 
 ICC 95% CI  ICC 95% CI 
Inspiration      
    area at T4 0.974 0.892 →0.975  0.997 0.984→0.996 
    area at T9 0.991 0.956 →0.990  0.993 0.956 →0.991 
    AP distance at T4 0.987 0.946 →0.988  0.995 0.973 →0.994 
    AP distance at T9 0.990 0.954 →0.990  0.996 0.987 →0.995 
    transversal diameter at T4  0.978 0.920→0.994  0.988 0.957→0.997 
    transversal diameter at T9  0.971 0.894→0.993  0.979 0.923→0.995 
Expiration      
    area at T4 0.992 0.970 →0.993  0.980 0.936 →0.977 
    area at T9 0.997 0.980 →0.997  0.991 0.971 →0.989 
    AP distance at T4 0.996 0.984 →0.996  0.973 0.911 →0.968 
    AP distance at T9 0.994 0.996 →0.994  0.994 0.980 →0.993 
    transversal diameter at T4 
[mm] 
0.971 0.896→0.993  0.972 0.896→0.993 
    transversal diameter at T9 
[mm] 
0.981 0.931→0.995  0.970 0.890→0.992 
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Table 4: Results of intra-tester reproducibility showing ICCs with 95% CIs for able bodied 
and tetraplegic subjects. 
ICC = intraclass correlation coefficient; CI = confidence interval; T = thoracic vertebra; AP = anterior-posterior 
 
 
 
 
 
 
 
 
 
 
 
 
 
 able bodied subjects  tetraplegic subjects 
 ICC 95% CI  ICC 95% CI 
Inspiration      
    area at T4 1.000 1.000 →1.000  1.000 1.000 →1.000 
    area at T9 1.000 1.000 →1.000  1.000 0.999 →1.000 
    AP distance at T4 0.999 0.995 →0.998  1.000 0.999 →1.000 
    AP distance at T9 0.999 0.997 →0.999  0.999 0.997 →0.999 
    transversal diameter at T4  0.999 0.997→1.000  0.998 0.991→0.999 
    transversal diameter at T9  0.996 0.986→0.999  0.997 0.990→0.999 
Expiration      
    area at T4 1.000 1.000 →1.000  1.000 1.000 →1.000 
    area at T9 1.000 1.000 →1.000  0.999 0.997 →0.999 
    AP distance at T4 1.000 0.999 →1.000  0.999 0.996→0.999 
    AP distance at T9 0.999 0.998 →0.999  0.999 0.997 →0.999 
    transversal diameter at T4 0.998 0.991→0.999  0.999 0.995→1.000 
    transversal diameter at T9  0.994 0.977→0.998  0.994 0.977→0.998 
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Table 5: Results of inter-tester reproducibility showing ICCs with 95% CIs for able bodied 
and tetraplegic subjects.  
ICC = intraclass correlation coefficient; CI = confidence interval; T = thoracic vertebra; AP = anterior-posterior 
 
Additional information about reproducibility of maximal in- and expiration of able bodied 
individuals and subjects with tetraplegia is presented by Bland & Altman plots for intra-costal 
areas in Figures 3a-d. Mean differences show that there is no systematic error in the 
assessments of intra-costal areas (Figure 3).  
 able bodied subjects  tetraplegic subjects 
 ICC 95% CI   ICC 95% CI 
Inspiration      
    area at T4 1.000 0.999 →1.000  0.997 0.989 →0.998 
    area at T9 1.000 0.999 →1.000  1.000 0.999 →1.000 
    AP distance at T4 0.999 0.997 →0.999  0.997 0.993 →0.998 
    AP distance at T9 0.995 0.991 →0.997  0.999 0.997 →0.999 
    transverse diameter at T4  0.998 0.993→0.999  0.995 0.986→0.999 
    transverse diameter at T9  0.947 0.860→0.985  0.983 0.953→0.995 
Expiration      
    area at T4 1.000 0.994 →1.000  0.998 0.972 →0.998 
    area at T9 1.000 0.999 →1.000  0.999 0.996 →0.999 
    AP distance at T4 0.999 0.998 →0.999  0.998 0.997→0.999 
    AP distance at T9 0.999 0.998 →0.999  0.999 0.998 →0.999 
    transverse diameter at T4  0.996 0.989→0.999  0.976 0.935→0.994 
    transverse diameter at T9  0.996 0.990→0.999  0.976 0.934→0.993 
   
 
Fig. 3a)          Fig. 3b)   
 
 
 
 
 
 
 
 
Fig. 3c)         Fig. 3d) 
 
 
 
 
 
 
 
 
Figure 3a-d: Bland & Altman plots showing intra-subject reproducibility of intra-costal area in able bodied subjects and subjects with tetraplegia at maximal expiration 
(Figures 3a + 3c) and at maximal inspiration (Figures 3b + 3d). The solid lines represent the mean difference between the first and second measurement. The two dashed lines 
graphically represent the limits of agreement (± 2 SD) for able bodied and tetraplegic subjects as one group. Abbreviations: T4 = fourth thoracic vertebra; T9 = ninth thoracic 
vertebra. 
25 000 3 000 0 3 500 0 4 000 0 450 00 500 00
-3 000
-2 000
-1 000
0
1 000
2 000
3 000
4 000
- 2  S D
+  2  S D
m ean
D
i
f
f
e
r
e
n
c
e
s
 
o
f
 
i
n
t
r
a
-
c
o
s
t
a
l
 
a
r
e
a
(
T
9
)
 
a
t
 
m
a
x
i
m
a
l
 
e
x
p
i
r
a
t
i
o
n
 
[
m
m
2
]
A ve ra ge  in tra -co s ta l a rea  (T 9 ) a t m ax im a l exp ira tion  [m m 2]
 ab le  bod ied
 te trap le g ic
3 00 00 3 50 00 4 00 00 4 50 00 5 00 00 5 50 00
-300 0
-200 0
-100 0
0
100 0
200 0
300 0
400 0
- 2  S D
+ 2 S D
m ean
D
i
f
f
e
r
e
n
c
e
s
 
o
f
 
i
n
t
r
a
-
c
o
s
t
a
l
 
a
r
e
a
(
T
9
)
 
a
t
 
m
a
x
i
m
a
l
 
i
n
s
p
i
r
a
t
i
o
n
 
[
m
m
2
]
A v era ge  in tra -co sta l a re a  (T 9 ) a t m a x im a l in sp ira tio n  [m m 2]
 a b le  b od ie d
 te tra p le g ic
5000 10000 15000 20000 25000 30000 35000 40000
-3000
-2000
-1000
0
1000
2000
3000
4000
- 2  S D
+ 2  S D
m ean
D
i
f
f
e
r
e
n
c
e
s
 
o
f
 
i
n
t
r
a
-
c
o
s
t
a
l
 
a
r
e
a
(
T
4
)
 
a
t
 
m
a
x
i
m
a
l
 
e
x
p
i
r
a
t
i
o
n
 
[
m
m
2
]
A ve ra ge  in tra -cos ta l a rea  (T 4 ) a t m a x im a l e xp ira tion  [m m 2]
 ab le  b od ied
 te tra p le g ic
15000 20000 25000 30000 35000
-3000
-2000
-1000
0
1000
2000
3000
4000
- 2  S D
+ 2  S D
m ean
D
i
f
f
e
r
e
n
c
e
s
 
o
f
 
i
n
t
r
a
-
c
o
s
t
a
l
 
a
r
e
a
(
T
4
)
 
a
t
 
m
a
x
i
m
a
l
 
i
n
s
p
i
r
a
t
i
o
n
 
[
m
m
2
]
A ve rage  in tra -cos ta l a rea  (T 4 ) a t m ax im a l in sp ira tio n  [m m 2]
 a b le  b od ie d
 te trap leg ic
124
 
Reproducibility of computed tomography 
   
 
 125 
Discussion   
This study showed that single slice CT provides a reliable assessment tool for follow up 
measurements of rib cage mobility in humans. CT is clinically established and easy to 
perform. Intra-subject reproducibility of this method was shown to be excellent with ICCs all 
at or above 0.97. Mean difference between the two measurements expressed as % of their 
mean was 2.1 ± 1.3% in subjects with tetraplegia and 2.3 ± 1.3% in able bodied individuals, 
supporting a high reproducibility of the method presented and evaluated in this paper. 
 
Reproducibility  
Reproducibility of the measurement method is of high importance for practical use of rib cage 
mobility measurements in before-after trials or to assess courses of diseases. Until today, 
several measurement methods have been evaluated and described in literature (1, 22). Optical 
mapping is rather laborious to perform and was only evaluated for the reproducibility of 
volume measurements but not for rib cage mobility (22). Morgan et al. found a 5% 
underestimate in vital capacity from the flow volume loop by optical mapping and an up to 
10% margin within subject systematic error (22). A rather new and very interesting method to 
assess rib cage mobility is optoelectronic plethysmography (1). Even if discrepancies between 
spirometry and optoelectronic plethysmography was only 1.7 ± 5.9%, the required equipment 
is quite expensive and the method is rather laborious and time consuming to operate (1). 
Chest circumference measurement is a very common and easily performed method to assess 
rib cage mobility (4, 14, 19). Its reproducibility has been tested in a very similar way to the 
present study, but in a very small sample of about five subjects. Even though they reported 
high ICCs between 0.81 and 0.91, the range of thoracic excursions between maximal in- and 
expiration was high (1.0 to 7.8 cm). Compared to that the mean SD of 0.6 cm is considerable 
(4), which puts the sensitivity of this method into question. An intervention study with asthma 
patients assessed changes by chest circumference measurements and reported mean increases 
of 0.8 cm and 0.9 cm of the lower and upper thoracic excursions (5). Compared to the 
methods described in literature, mean differences between the two measurements in our study 
are rather small. Reproducibility of the intra-costal area and transverse diameters was very 
high with differences of 0.7 to 2.5% of their mean (Table 1). Therefore the reproducibility of 
our method is even better than optoelectronic plethysmography which showed a mean error of 
1.7 ± 5.9% (1). Due to the very high reproducibility, we conclude that our method is useful to 
detect even small changes in follow up measurements of rib cage mobility.  
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Rib cage mechanics 
Compared to chest circumference measurements, CT provides interesting additional 
possibilities to study rib cage mechanics. The slice at T4 was chosen in order to get 
information about the function of respiratory muscles of the upper thorax and neck and its 
influence on rib cage mobility. The scalenes for example are known to expand the rib cage 
and the lung (10). Thus, increased strength of the scalenes would be apparent in area and/or 
distances at the T4 level. The slice at T9 was chosen in order to show consequences of 
diaphragmatic and intra-costal muscle action on rib cage motion. Especially in subjects with 
diseases that lead to rib cage stiffening and changes in compliance of the whole respiratory 
system, e.g. in tetraplegia, additional information from the measurement at T9 may help to 
assess rib cage mobility more precisely.  
 
Limitations 
We are aware of the fact that there is a certain radiation dose applied to individuals during CT 
measurements used in this study. Taking this into account, we used a so called ‘care dose 
protocol’ where radiation dose is kept as low as possible and we only recorded four slices of 
the rib cage. The radiation dose of our protocol (four slices) is comparable to four 
transatlantic flights, which should not give any cause for concern. 
 
Clinical relevance 
Our method provides an easy and fast to perform tool for the precise measurement of rib cage 
mobility. For future practical use, e.g. for reporting possible effects of different interventions 
on rib cage mobility, limits of agreement should be taken into account as measurements error 
(3). Thus, possible changes in before-after trials of intra-costal area, AP distances and 
transverse diameters at maximal in- and expiration have to exceed limits of agreement to 
represent real changes. In order to reach the maximal reproducibility in practice, some 
learning trials of maximal in- and expiration manoeuvres are recommended. Reproducibility 
can even be increased if all pictures within one subject are analysed by the same tester, 
although intra-tester reproducibility is very high.  
 
Conclusion 
Single slice chest CT is a reliable method for follow up measurements, to assess rib cage 
mobility in humans, with all ICCs at or above 0.95. The low mean differences between the 
two measurements confirm that our method is even better than those with the highest 
reproducibility among the methods described in literature.  
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Abstract 
Objective: Due to respiratory muscle paralysis chest wall mechanics is severely altered in 
individuals with tetraplegia. The aim of this study was to compare mobility of the rib cage 
and the diaphragm between able bodied persons and individuals with chronic tetraplegia with 
lesions between C5 and C8. 
Methods: 10 able bodied and 10 motor complete chronic tetraplegic individuals, matched for 
gender, age and height, participated in the study. All individuals underwent lung function 
testing and computed tomography of the thorax. At maximal in- and expiration, an overview 
of the thorax and two slices at the bottom plate of the fourth thoracic vertebra (T4) and the 
cover plate of the ninth thoracic vertebra (T9) were recorded. Differences between maximal 
inspiration and maximal expiration for diaphragm and rib cage mobility were calculated.  
Results: Rib cage mobility was significantly higher in able bodied than in tetraplegic 
individuals for ∆ intra-costal area at T4: 100 cm2 (CI 69-132 cm2) vs. 39 cm2 (CI 19-60 cm2), 
∆ intra-costal area at T9: 118 cm2 (CI 83-152 cm2) vs. 49 cm2 (CI 18-79 cm2), ∆ anterior-
posterior distance at T4: 2.8 cm (CI 1.6-3.9 cm) vs. 1.2 cm (CI 0.5-2.0 cm), ∆ anterior-
posterior distance at T9: 3.4 cm (CI 2.2-4.5 cm) vs. 1.4 cm (CI 0.5-2.3 cm) and ∆ transverse 
diameter at T4: 1.8 cm (CI 1.3-2.2 cm) vs. 0.2 (CI -0.2-0.7 cm). Diaphragm mobility and ∆ 
transverse diameter at T9 showed no significant differences between able bodied and 
tetraplegic subjects: 5.2 cm (CI 3.8-6.6 cm) vs. 4.9 cm (CI 3.5-6.0 cm) and 2.6 cm (CI 1.8-3.5 
cm) vs. 1.4 cm (CI 0.6-2.2 cm). 
Conclusion: This study showed that compared to able bodied individuals, rib cage mobility 
of chronic, motor complete tetraplegic individuals is significantly reduced but still present, 
while complicance of the diaphragm has not altered compared to able bodied individuals.  
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Introduction    
Mobility of the chest wall is an important determinant of breathing capacity in humans (17). 
Chest wall mobility is determined by the mobility of the rib cage and the abdominal 
compliance. Rib cage mobility can be decreased due to various respiratory diseases and cause 
further problems resulting in pulmonary complications (4, 15, 18). In individuals with 
tetraplegia, decreases in rib cage mobility mainly occur due to the loss of inter-costal muscle 
innervation (11). With ongoing lesion duration the rib cage stiffens, which consequently leads 
to additional impairments in pulmonary function (16). The high rate of respiratory 
complications in individuals with tetraplegia and the concomitant high mortality rate of 24% 
who die due to complications of the respiratory system, may also be influenced by 
impairments in rib cage mobility (6). 
It is known that in individuals with tetraplegia lung function and respiratory muscle strength 
is decreased compared to able bodied persons (3, 14, 23, 25). Nevertheless, Morgan et al. 
found that total chest wall displacement could not be predicted from vital capacity (20). Thus, 
sensitivity of lung function testing is not specific enough to assess breathing mechanics in 
subjects with tetraplegia. We recently evaluated a new method to assess rib cage mobility by 
single slice computed tomography (CT) which is easy and fast to perform. Intra-subject as 
well as intra- and inter-tester reproducibility were shown to be high (Chapter 7) (22). 
The aim of this study was to quantify differences of upper and lower rib cage mobility as well 
as diaphragm movement between able bodied persons and individuals with chronic 
tetraplegia, and to set these differences in relation to spirometry. Detailed knowledge of 
differences between able bodied and tetraplegic individuals may contribute to a better 
understanding of altered breathing mechanics in tetraplegic individuals. Possible changes in 
rib cage mobility due to respiratory interventions should then be quantified and set in relation 
to able bodied values. This may help to apply the most adequate interventions aiming at 
increased rib cage mobility.  
 
Methods  
Ten individuals with tetraplegia were recruited from one spinal cord injury rehabilitation 
clinic. For each participant with tetraplegia, one able bodied subject of the same gender and 
comparable age (± 2 years) and height (± 2 cm) was recruited from the clinic staff in order to 
build matched-pairs. Inclusion criteria were: healthy men and women, aged between 20 and 
65 years. Individuals with tetraplegia were included if they had a motor complete cervical (C) 
lesion for more than one year. Exclusion criteria were: pregnancy, severe scoliosis, 
tracheostomy, assisted ventilation, chronic obstructive pulmonary disease, actual respiratory 
tract infection or any other respiratory disease. The study was approved by the local ethics 
committee. All participants were informed about the procedures and potential risks of the 
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study, prior to giving their written informed consent. Individuals were asked to abstain from 
caffeine intake on all test days (26).   
 
Lung function testing 
The first session included lung function and respiratory muscle pressure measurements in the 
sitting position, according to the standards of the American Thoracic Society (1) by means of 
bodyplethysmography (MasterScreen Body, Jaeger, Hoechberg, Germany). Total lung 
capacity (TLC), residual volume (RV), expiratory reserve volume, functional residual 
capacity (FRC), forced vital capacity (FVC), forced expiratory volume in 1 s, peak expiratory 
flow and maximal voluntary ventilation during 12 s were measured. The whole system was 
calibrated immediately before each test. Maximal inspiratory muscle pressure over 1 s was 
measured from RV and maximal expiratory muscle pressure was measured from TLC 
(MicroRPM, MicroMedical Limited, Kent, UK). A small air leak in the measurement device 
prevented glottis closure.  
 
Computed tomography (CT) 
Computed tomography scans were performed according to the method described in chapter 7. 
Additionally, the raw data for diaphragatic movement were calculated by visual selection of 
the left and right diaphragmatic dome at maximal in- and expiration (Figure 1). Coordinates 
of the diaphragmatic dome were imported to a self-written excel program and the vertical 
distance between the highest points at maximal in- and expiration were defined as 
diaphragmatic movement (Figure 1).  
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Figure 1: Calculation of 
diaphragmatic movement 
as the vertical distance 
between top positions of 
the diaphragm at maximal 
inspiration and maximal 
expiration. The same spinal 
process on both images 
was chosen as reference 
point in order to overlay 
the two images. 
 
 
Statistics 
Results of individuals’ characteristics, lung function and respiratory muscle pressure 
measurements are given as mean ± SD. Results of diaphragm and rib cage mobility are 
presented as means with 95% confidence intervals (CI). Differences between maximal in- and 
expiration, i.e. diaphragm movement (left and right separately), AP distances and transverse 
diameter at T4 and T9, as well as intra-costal areas at T4 and T9, were calculated for each 
subject. Means and 95% CI for these parameters of the able bodied and the tetraplegic groups 
were calculated separately as well. Differences of all measured parameters between matched 
pairs of able bodied individuals and individuals with tetraplegia were calculated by Wilcoxon 
rank-sum-tests using Systat, (Systat Software Inc.; Version 10.2; Point Richmond CA; USA). 
Significance level was set at p < 0.05. 
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Results 
There were no significant differences for age, height and weight between the matched-pairs 
groups (Table 1).  
 
Table 1: Comparison of subjects’ characteristics (group means ± standard deviations) of able 
bodied individuals and subjects with tetraplegia. 
Parameter individuals with 
tetraplegia 
able bodied 
individuals 
p value 
age [years] 47.4 ± 12.7 46.8 ± 11.5 0.30 
height [m] 1.76 ± 0.06 1.77 ± 0.07 0.36 
weight [kg] 75 ± 12 80 ± 7 0.13 
gender 8 m / 2 w 8 m / 2 w  
time post injury [years] 13.6 ± 8.2 -  
 
Lung function was measured in the sitting position and showed significantly lower lung 
volumes and respiratory muscle pressure in individuals with tetraplegia compared to able 
bodied persons, with the exception of non-significant differences in RV. Expressed as 
percentage of TLC, RV was 41.5% in individuals with tetraplegia and 31.5% in able bodied 
persons (Table 2). FRC relative to TLC did not differ between the two groups and was 53.7% 
in individuals with tetraplegia and 52.2% in the able bodied group (Table 2). 
 
Table 2: Comparison of lung function and respiratory muscle pressure parameters (group 
means ± standard deviations) of able bodied individuals and subjects with tetraplegia.  
Parameter  individuals with tetraplegia 
[n = 10] 
able bodied individuals 
[n = 10] 
p value 
TLC [l] 5.47 ± 1.14 7.90 ± 1.42 0.007* 
RV [l] 2.27 ± 0.87 2.49 ± 0.40 0.72 
ERV [l] 0.67 ± 0.32 1.63 ± 0.92 0.011* 
FRC [l] 2.94 ± 0.88 4.12 ± 1.13 0.037* 
FVC [l] 2.91 ± 1.13 5.31 ± 1.29 0.005* 
FEV1 [l/s] 2.52 ± 1.17 4.18 ± 1.07 0.005* 
PEF [l/s] 4.85 ± 2.77 8.13 ± 2.17 0.013* 
MVV [l/min] 95.2 ± 55.0 159.1 ± 53.7 0.005* 
MIP [kPa] 8.43 ± 4.41 11.37 ± 2.35 0.037* 
MEP [kPa] 7.06 ± 2.74 14.90 ± 3.72 0.008* 
* = significant difference between groups; TLC = total lung capacity; RV = residual volume; ERV = expiratory 
reserve volume; FRC = functional residual capacity; FVC = forced vital capacity; FEV1 = forced vital capacity 
in 1 s; PEF = peak expiratory flow; MVV = maximal voluntary ventilation; MIP = maximal inspiratory pressure; 
MEP = maximal expiratory pressure 
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No significant differences in diaphragm movement between able bodied and tetraplegic 
individuals were found by CT topograms. In contrast to this, all parameters of rib cage 
mobility at T4 were significantly lower in the tetraplegic than in the able bodied group (Table 
3). Mean changes of intra-costal areas and AP distances of tetraplegic individuals were all 
around 40% (39-43%) of the able bodied individuals’ values. Changes in mean transverse 
diameter between maximal in- and expiration of tetraplegic individuals at T4 was only 11% of 
the able bodied groups’ mean. At T9 solely the changes in intra-costal areas and AP distances 
were lower in individuals with tetraplegia, but no significant differences were seen between 
able bodied and tetraplegic subjects concerning changes of the transverse diameter (Table 3). 
Mean changes in transverse diameter of the tetraplegic group was 54% of the mean able 
bodied value. 
 
Table 3: Means (95% confidence intervals) for diaphragm movement and rib cage mobility at 
T4 and T9 in individuals with tetraplegia and able bodied persons. 
T = thoracic; AP = anterior-posterior; * = significant difference between groups (p < 0.05) ∆ = difference 
between maximal in- and expiration 
 
Discussion  
The most important finding of this study is that, in contrast to others (10, 21), we did not find 
any decrease in AP diameter during inspiration, showing that no paradoxical breathing pattern 
was present in the 10 chronic tetraplegic individuals tested. Further, diaphragm movements 
and RV showed no significant differences between tetraplegic individuals and able bodied 
persons, representing a fully intact diaphragmatic function in motor complete tetraplegics 
with C5 to C8 lesions. It also seems that the ‘piston effect’ and the appositional effect of the 
diaphragm on the thoracic wall are still present in subjects with chronic tetraplegia. 
Parameter individuals with 
tetraplegia 
able bodied 
individuals 
p value 
Diaphragm right [cm] 4.6 (3.5-5.7) 5.2 (3.8-6.6) 0.44 
movement left [cm] 4.9 (3.8-6.0) 5.2 (3.8-6.6) 0.65 
     
T4 ∆ intra costal area [cm2] 39 (19-60) 100 (69-132) 0.009* 
 ∆ AP distance [cm] 1.2 (0.5-2.0) 2.8 (1.6-3.9) 0.028* 
 ∆ transverse diameter [cm] 0.2 (-0.2-0.7) 1.8 (1.3-2.2) 0.005* 
     
T9 ∆ intra costal area [cm2] 49 (18-79) 118 (83-152) 0.017* 
 ∆ AP distance [cm] 1.4 (0.5-2.3) 3.4 (2.2-4.5) 0.013* 
 ∆ transverse diameter [cm] 1.4 (0.6-2.2) 2.6 (1.8-3.5) 0.093 
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Diaphragm mobility 
In the supine position, there seems to be no altered force-length relationship of the diaphragm, 
since our results showed no differences in diaphragm mobility between tetraplegic and able 
bodied individuals. According to changes in the transversus distance at T9, it seems that the 
‘piston effect’ and the appositional effect of the diaphragm on the thoracic wall are still 
present in subjects with chronic tetraplegia. These effects occur in spite of a diminished 
fulcrum function of the abdominal content due to the paralysed anterior abdominal wall and in 
spite of the possible stiffness of the rib cage. FVC in individuals with tetraplegia was shown 
to be higher in the supine than in the sitting position (12), and trans-diaphragmatic pressures 
at end expiration was reported to be normal in tetraplegic individuals (9). This finding 
supports our data, indicating that diaphragmatic function is more or less maintained after a 
lesion below the fifth cervical spinal cord.  
In the sitting position diaphragmatic movement mainly determines FVC and depends on the 
resting position of the diaphragm, i.e. FRC (8). In individuals with motor complete 
tetraplegia, the abdomen is highly compliant due to the absence of abdominal muscle 
innervation (27). Thus, the diaphragm is less pushed up by the abdominal content than in the 
supine position. Therefore, the capacity of the diaphragm to move caudally may be impaired 
(5). The flattened diaphragmatic position and a concomitant shift in muscle fibre orientation 
causes some loss of the expiratory effect of the diaphragm in tetraplegic individuals (7). 
Nevertheless, in the chronic stage of a tetraplegia the diaphragm may adapt to this altered 
situation to regain a better force-length relationship. 
 
Rib cage mobility 
Chronic tetraplegia is represented by rib cage stiffening (13, 16), which is confirmed by the 
lower rib cage mobility in tetraplegic compared to able bodied individuals in the present 
study. While others (16) found a reduced mobility of the rib cage to about 66% of the 
mobility of able bodied individuals in subjects with stable tetraplegia, mean changes in intra-
costal area and AP distances of tetraplegic individuals in the present study were only around 
40% of the mean able bodied group values (Table 3). In this previous study subjects were 
between 4 month and 4 years after injury (16), while our subjects were at least one year post 
injury with a mean lesion duration of 13.6 years. The lower, but still not absent rib cage 
mobility in our subjects supports the assumption that the rib cage stiffens with ongoing lesion 
duration. 
It is evident that in able bodied individuals a higher difference at T9 than at T4 between 
maximal in- and expiration of all measured parameters was present (Table 3). In individuals 
with tetraplegia only the transverse distance at T9 showed higher changes than parameters at 
T4, between maximal in- and expiration. This supports our finding of a nearly intact 
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diaphragmatic movement in individuals with tetraplegia in the supine position, and the 
appositional effect of the diaphragm as an extensor of the lower thoracic wall through the 
zone of apposition (7, 24). Due to gravitational forces, this expanding action may have larger 
effects on the transverse diameter than on the AP distance in the supine position. Taking the 
commonly known paradoxical breathing pattern of individuals with tetraplegia into account 
(13), the contracting diaphragm may pull the upper rib cage inward. Due to the lack of inter-
costal and abdominal muscle function this would be represented by negative AP distances at 
T4 between maximal in- and expiration. Since we found no such effects, stiffening may have 
limited paradoxical motion of the rib cage in our subjects with chronic tetraplegia. Thus, 
stiffening of the rib cage may also serve as an advantage (16). On the other hand, in 
individuals with tetraplegia, the upper part of the rib cage may gain volume due to an 
increased strength of the Mm. scalenes and Mm. sternocleidomastoids which pulls the upper 
rib cage up and outward. This may probably be improved by respiratory muscle training, if it 
is applied before the rib cage stiffened.  
 
Respiratory function 
Our results demonstrate a typically restrictive breathing pattern in the tetraplegic group (2) 
which may be caused by a lower inspiratory drive and the absence of innervations of the main 
expiratory muscles. The only parameter without a significant difference between able bodied 
and tetraplegic individuals was RV. Generally, RV is known to be higher in individuals with 
tetraplegia due to the lack of expiratory muscle innervation and a concomitant decrease or 
absence of expiratory reserve volume (3, 14). Nevertheless, relative to TLC, which is also 
significantly lower in tetraplegic compared to able bodied subjects, RV was 10% higher in the 
tetraplegic group compared to able bodied individuals (41.5 vs. 31.5%). FRC was 
significantly reduced in tetraplegic compared to able bodied persons (Table 2). These findings 
may be due to a decrease in the outward pull of the rib cage resulting from the loss of 
intercostal muscle activity in individuals with tetraplegia (9).  
 
Clinical relevance 
This study provides data quantifying the absolute differences of upper and lower rib cage 
mobility between individuals with tetraplegia and able bodied persons. These data can be seen 
as ‘baseline’ values to compare rib cage mobility of other groups of patients, but also to set 
changes due to specific respiratory interventions in relation to differences between the two 
groups. In order to maintain or even increase rib cage mobility in tetraplegic individuals, we 
postulate that interventions such as physiotherapy and respiratory muscle training should start 
as early as possible after injury to avoid stiffening. Furthermore such an intervention should 
concentrate on training of the accessory respiratory muscles and not only on the diaphragm. 
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Passive interventions in order to maintain mobility of the rib cage and to prevent stiffening 
may be indicated, especially in subjects who are not able or willing to perform active 
respiratory interventions. 
 
Conclusion 
This study showed that rib cage mobility of individuals with chronic, motor complete 
tetraplegia is significantly reduced to about 40% of the mobility of able bodied individuals, 
but the rib cage still moves. In contrast to earlier studies, we did not find a paradoxical 
breathing pattern and the ‘piston effect’ as well as the appositional effect of the diaphragm on 
the thoracic wall are still present in individuals with chronic tetraplegia. Movements of the 
thoracic wall in subjects with tetraplegia may primarily be caused by diaphragmatic function 
which did not show any significant differences to able bodied individuals. This study provides 
data of absolute differences in rib cage mobility and diaphragmatic movement between able 
bodied and tetraplegic subjects, which can be used for tetraplegic individuals to set changes in 
rib cage mobility in relation to able bodied individuals. 
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The respiratory care of individuals with spinal cord injury (SCI) improved substantially over the 
last decades. Nevertheless, morbidity and mortality is still high in this population (15, 46) and 
there are various issues to be studied yet in order to further improve the respiratory care and the 
quality of life as well as to decrease respiratory complications, health care costs and mortality. In 
this thesis, three main aspects on respiration in SCI were assessed in seven specific studies. 
These three aspects were ‘respiratory function after SCI’, ‘respiratory muscle endurance training 
in SCI’ and ‘rib cage mobility’. In the present chapter, the resulting data from these studies are 
put within the context of other data in the literature and are discussed in a comprehensive way. 
Further, the implications of the studies for future research that is striving to improve respiratory 
function of individuals with SCI are presented at the end of this chapter. 
 
Respiratory function after SCI 
The regression equations for lesion specific lung function and respiratory muscle pressure 
generating capacity presented in chapters 2 and 3 provide interesting information on influences 
of additional factors in SCI as well as changes over time early after injury.  
In order to discuss the findings of former studies that tested respiratory function in SCI and to set 
them in relation to the results of the Dutch cohort study presented in this thesis, we created an 
overview of the largest studies published (2, 25, 26, 29, 37, 40) in combination with findings 
from our studies presented in chapters 2 and 3 (Table 1). This table shows relative lung function 
values and data representing respiratory muscle pressure generating capacity as percentage of 
able bodied predicted (4, 35) as well as group means of known determinants of respiratory 
function (i.e. time post injury and age). Since we found that completeness of the lesion 
significantly influences respiratory function (chapter 2), it is difficult to compare data of motor 
complete and incomplete individuals. Unfortunately not all of the larger studies distinguished 
between motor complete and incomplete subjects (26, 29, 40). Thus, where data of complete and 
incomplete subjects was reported separately, we only present the data of the motor complete 
subjects in Table 1. From this point of view, our own data can therefore mainly be compared to 
the studies of Almenoff et al., Roth et al. and Linn et al. (2, 25, 37). Only one study (37) tested 
subjects in the acute stage of SCI. These findings showed substantially lower lung function 
values than those we found one year after discharge from inpatient rehabilitation, confirming our 
findings of significantly increasing lung function during inpatient rehabilitation (chapter 3). 
Results of forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1) of the other 
two studies (2, 25) on individuals with motor complete SCI are lower than the values of our 
studies. These subjects were tested at longer time post injury and had a higher mean age, 
supporting our findings of negative regression coefficients for increasing age. 
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Table 1: Overview on findings of cohort studies that assessed respiratory function in subjects 
with SCI. Values are presented as group means and % of able bodied predicted. 
Abbreviations: n = number of subjects; TPI = time post injury; y = years; FVC = forced vital capacity; FEV1 = 
forced expiratory volume in 1 s; PEF = peak expiratory flow; Pimax = maximal inspiratory muscle pressure; Pemax = 
maximal expiratory muscle pressure; % = percent of able bodied predicted; C = cervical lesion; T = thoracic lesion; 
L = lumbar lesion; nonS = non smoker; S = smoker; TP = tetraplegics; PP = paraplegics. Concerning chapter 3: 
Note that only data from 1 year after discharge are presented in Table 1. 
 
The study of Mateus et al. (29) is to our knowledge, the only one in the literature that provides 
values for Pimax and Pemax  and the best one comparable to our studies concerning time post 
Author 
year 
Lesion 
level         [n] 
Complete- 
ness 
TPI 
[y] 
Age 
[y] 
FVC 
[%] 
FEV1 
[%] 
PEF 
[%] 
Pimax 
[%] 
Pemax 
[%] 
Almenoff 
et al. 
1995 
C4 ↑         [7] 
C5-C8      [5] 
T1-T7      [9] 
T8-L3    [18] 
motor 
complete 
15 
17 
33 
22 
49 
38 
60 
54 
34 
57 
84 
87 
35 
66 
95 
86 
34 
63 
85 
85 
  
Roth et 
al. 1997  
C4           [7] 
C5           [8] 
C6         [18] 
C7         [10] 
T1           [5] 
motor 
complete < 0.5 
16-
60 
35 
39 
39 
45 
39 
39 
43 
42 
48 
43 
   
Linn et 
al. 2000 
C2-C5   [26] 
C6-C8     [9] 
T1-T7    [28] 
T8-L5    [13] 
motor 
complete 14 40 
49 
62 
81 
95 
53 
69 
85 
97 
42 
54 
68 
84 
  
Linn  
et al. 
2001 
C2-C5  [115] 
C6-C8    [93] 
T1-T6    [78] 
T7-L5  [169] 
mixed 
15 
15 
18 
17 
44 
44 
46 
47 
53 
69 
79 
88 
    
Spungen 
et al. 
2002 
TP nonS [56] 
TP S       [23] 
PP nonS [78] 
PP S       [23] 
mixed 
17 
12 
22 
15 
49 
43 
54 
46 
57 
63 
84 
77 
60 
59 
86 
73 
47 
49 
78 
71 
  
Mateus et 
al. 2007 
C4-C5    [30] 
C6-C8    [22] 
T1-T6    [32] 
T7-L3    [47] 
mixed 
2 
2.5 
2 
2 
34 
28 
27 
32 
49 
61 
70 
84 
58 
72 
77 
92 
 
50 
68 
84 
86 
19 
31 
38 
51 
Chapter 2 TP         [30 ] PP          [61] 
motor 
complete 
2.4 
1.8 
29 
39 
74 
89 
76 
87 
54 
69 
56   [8] 
82  [16] 
14  [11] 
36  [17] 
Chapter 3 
C3-C5    [14] 
C6-C8    [16] 
T1-T6    [25] 
T7-T12  [36] 
motor 
complete 
2.5 
2.3 
1.9 
1.7 
36 
33 
43 
38 
63 
85 
84 
95 
64 
84 
82 
93 
46 
61 
66 
71 
53   [7] 
62   [4] 
71   [6] 
72  [10] 
16    [7] 
16    [4] 
28    [6] 
35  [11] 
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injury. They assessed subjects with similar lesion level groups as we did in our longitudinal 
survey (chapter 3), but unfortunately they did not separate between motor complete and 
incomplete injuries. Since we found significant influences of completeness on Pimax and Pemax, 
the values found by Mateus et al. (29) can’t be compared to the values of our study presented in 
chapter 2 of this thesis (Table 1). Nevertheless, even though our data and those of Mateus et al. 
(29) are based on a low number of subjects, both studies found that Pemax is much more affected 
than Pimax and that values increase with decreasing lesion level. Taking together all data on peak 
expiratory flow (PEF) shown in Table 1, which are based on a total of 477 subjects with SCI. 
Further support of our own findings is given by the groups of Almenoff, Linn and Spungen (2, 
25, 40), showing that PEF values are more affected than FVC and FEV1 (Table 1). Since 
expiratory muscle function, which can be measured by PEF and Pemax, is closely related to the 
ability to cough, a weak expiratory muscle function may influence the occurrence of respiratory 
tract infections substantially. Fugl-Meyer already reported in the mid-seventies that in patients 
with about 50% of the able bodied predicted Pemax, PEF is sufficient for a productive cough (14). 
Although a reduction of 50% is substantial, all of our tested groups and most of the subjects 
tested by Mateus et al. (29) were below these 50% Pemax (Table 1).  
Coughing capacity which is related to the improvement of secretion clearance may be enhanced 
by various different methods described in the literature. Such methods consist of wearing an 
abdominal binder (5, 16), consulting the manual assistance of a therapist during coughing 
maneuvers (23), using electrical stimulation of the abdominal muscles (23) or in the spinal cord 
(9, 12) or training of in- or expiratory muscles (41). Since respiratory muscle training showed 
some evidence to increase respiratory muscle function and since this is the only method that is 
not directly dependent on technical equipment or a therapist during coughing, i.e. promising the 
highest independence for patients, we concentrated on respiratory muscle training in this thesis.  
 
Respiratory muscle endurance training in SCI 
Until now, most studies that investigated respiratory muscle training in individuals with SCI 
used inspiratory muscle strength training (11, 19, 21, 24, 27, 38, 44, 45). As early as the late 
nineties, Silva et al. (39) found that physical endurance exercise (arm cranking) improves 
ventilatory muscle endurance in paraplegic men, showing that the endurance component should 
be investigated as well. Nevertheless, until now influences of isolated respiratory muscle 
endurance training (normocapnic hyperpnoea) on respiratory and physical exercise performance 
have only been investigated in one very recent study with SCI subjects (42). This study was 
performed with a mixed SCI group of motor complete and incomplete para- and tetraplegic 
subjects between two and six month post injury. Nevertheless, results show positive first 
evidence of improved respiratory muscle strength and endurance and less frequent respiratory 
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complications (42). These results have to be confirmed for more consistent lesion groups as well 
as for individuals with acute and chronic SCI. 
We showed that respiratory muscle endurance training can be performed by subjects with para- 
and tetraplegia, using normocapnic hyperpnoea training. The optimal training intensity is hereby 
lower for individuals with tetraplegia (40% maximal voluntary ventilation (MVV)) than for 
individuals with paraplegia (60% MVV) due to lower respiratory muscle endurance (chapter 4).  
 
User specific objectives of normocapnic hyperpnoea training 
While the main aim of normocapnic hyperpnoea training in healthy able bodied individuals 
constitutes an improvement of the physical exercise endurance performance, this may be similar 
in individuals with paraplegia, but it may be different in individuals with tetraplegia. Due to the 
very small amount of muscle mass that can be used for locomotion in individuals with tetraplegia 
(e.g. wheelchair propulsion or hand cycling), fatigue of arm and shoulder muscles may precede 
fatigue of respiratory muscles and thus normocapnic hyperpnoea training may not increase 
physical exercise performance to the same extent as it would in able bodied individuals (6, 7). 
Even if experiences from clinical practice support this hypothesis it should be tested in a 
controlled training study. The main aim of normocapnic hyperpnoea training in subjects with 
tetraplegia may be improvements in expiratory muscle pressure generating capacity and 
respiratory muscle endurance. Further goals may consist in improvements of respiratory muscle 
function in order to foster the coughing capacity and to reduce respiratory effort and probably 
also ventilator dependency during the night. Such effects may have substantial positive 
consequences on quality of life and hopefully also on reducing respiratory complications in 
individuals with tetraplegia. For individuals with C4 tetraplegia, normocapnic hyperpnoea 
training may be one of the only and most applicable endurance training methods that is expected 
to help boosting the confidence in a proper functioning of the own respiratory system. 
 
Potential effects of normocapnic hyperpnoea training in individuals with SCI 
Wheelchair racing athletes train their respiratory muscles during daily exercise practice. 
Nevertheless, results of the normocapnic hyperpnoea training study presented in chapter 5 
showed that respiratory muscle endurance can further be improved. Physical endurance exercise 
performance and Pemax showed a tendency to increase after normocapnic hyperpnoea training. 
The finding of an increased Pemax in wheelchair racing athletes after 6 weeks of normocapnic 
hyperpnoea training represents the result with a high relevance for clinical practice and akinesic 
subjects with SCI. Since Pemax is the most affected parameter in individuals with SCI (chapter 2 
and 3), normocapnic hyperpnoea training may be an interesting option to increase expiratory 
muscle strength and hopefully decrease respiratory tract infections due to an increased coughing 
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capacity. The results of van Houtte et al. (42) confirm our findings of improved respiratory 
muscle strength and endurance after normocapnic hyperpnoea training in individuals with an 
acute SCI and even showed reductions in respiratory tract infections. This finding would of 
course be most important for subjects with tetraplegia which unfortunately were not evaluated 
separately in the study of van Houtte et al. (42). Due to the lower amount of active expiratory 
muscle mass in these individuals, effects of normocapnic hyperpnoea training may differ from 
results found in athletes with paraplegia. 
 
Normocapnic hyperpnoea exercise as a mean to accelerate lactate removal? 
A further potential effect of normocapnic hyperpnoea exercise is based on the fact that 
respiratory muscles mainly consist of type I muscle fibers which are able to use lactate as energy 
source (1, 8). Our results of normocapnic hyperpnoea exercise at different intensities (chapter 4) 
clearly showed that in subjects with paraplegia, lactate is used by respiratory muscles breathing 
at 20 and 40% of the individual MVV and in subjects with tetraplegia at 20% MVV. This shows 
that the reduced respiratory muscle mass of individuals with SCI is still able to metabolize 
lactate during normocapnic hyperpnoea, but also reflects the consequences on lactate removal 
due to differences in innervated respiratory muscle mass between individuals with para- and 
tetraplegia. 
This effect may also be interesting for wheelchair racing athletes who often participate over 
various distances on the same competition day. Especially medium distance races over 400, 800 
and 1500 m reveal high lactate concentrations in the working muscles (34). In order to give the 
arm muscles a break which may accelerate refill time of intramuscular carbohydrate storages but 
still improve lactate removal, low intensity normocapnic hyperpnoea exercise may theoretically 
be an interesting alternative to rest or low intensity wheelchair propulsion. Unfortunately, our 
results of the study reported in chapter 6 did not show faster lactate removal after low intensity 
normocapnic hyperpnoea exercise compared to passive and low intensity active recovery. Since 
this study was done in able bodied individuals, effects of normocapnic hyperpnoea on lactate 
removal may even be worse in individuals with SCI due to the lower amount of respiratory 
muscle mass that can be used for breathing exercise. As reported in chapter 6, the magnitude of 
the affected muscle mass seems to be critical to effective active recovery. Therefore we suggest 
that normocapnic hyperpnoea exercise should be used primarily in order to increase respiratory 
muscle and physical exercise performance in individuals with SCI. 
 
Cardiovascular changes during normocapnic hyperpnoea training 
Due to the frequently encountered akinesic lifestyle of individuals with SCI and limited 
possibilities to be active, secondary risk factors due to the degeneration of the cardio-pulmonary 
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system may cause severe complications and substantially decrease quality of life (31, 32). 
Normocapnic hyperpnoea training may have positive effects on the cardio-pulmonary function of 
subjects with SCI as well. Even though in able bodied individuals no effects from normocapnic 
hyperpnoea training on cardio-vascular responses to exercise were found (28), results of the 
study presented in chapter 4 potentially provide first indices of a possible cardio-pulmonary 
training effect from normocapnic hyperpnoea training in subjects with SCI. Subjects with 
paraplegia showed a larger increase of the systolic blood pressure than of the diastolic blood 
pressure during single sessions of normocapnic hyperpnoea exercise at an intensity of 60% 
MVV. This finding indicates that stroke volume may increase during normocapnic hyperpnoea 
training in subjects with paraplegia, which in turn may lead to a cardio-pulmonary training effect 
after regular normocapnic hyperpnoea training at 60% MVV over a period of several weeks. 
However, in this thesis we did not assess cardio-pulmonary changes after a period of 
normocapnic hyperpnoea training and therefore this assumption has yet to be tested in detail. 
Should normocapnic hyperpnoea training prove to have positive effects not only on respiratory 
muscle endurance performance but also on the cardio-pulmonary system, normocapnic 
hyperpnoea training may become relevant for a much wider range of individuals with SCI. 
Haisma et al. (20) recently showed that physical fitness (i.e. peak power output and maximal 
oxygen uptake) was negatively associated with complications after discharge from inpatient 
rehabilitation in individuals with SCI. This study showed that bed rest time has to be kept as 
short as possible and high effort has to be put in improvements of physical fitness of individuals 
with SCI (20), in order to protect patients from getting into a downward spiral of low fitness and 
complications. Probably normocapnic hyperpnoea training can help to reach this goal at least in 
individuals with paraplegia. In subjects with tetraplegia, however, cardio-vascular effects of 
normocapnic hyperpnoea training may be lower or even absent due to the lack of activity of the 
sympathetic nervous system and a very low amount of respiratory muscle mass that can be 
activated during intensive breathing.  
Moreover, shoulder problems are frequent in wheelchair users and often impair possibilities to 
additionally train the cardio-pulmonary system (10, 33). If normocapnic hyperpnoea training 
reveals positive effects on the cardio-pulmonary system in subjects with paraplegia, 
normocapnic hyperpnoea training may be a good alternative training option for individuals with 
shoulder problems. Therefore, studies on the effects of normocapnic hyperpnoea training on the 
cardio-pulmonary system of subjects with paraplegia should be conducted in the near future.  
 
Rib cage mobility in able bodied and tetraplegic individuals 
Rib cage mobility is substantially decreased in subjects with tetraplegia due to either respiratory 
muscle paralysis that changes and impairs respiratory mechanics, but also due to progressive 
stiffening of tissues and ankylosis in joints with increasing lesion duration (17). Stiffening of the 
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rib cage additionally increases the work put into breathing and may thus accelerate respiratory 
failure in individuals with tetraplegia (36). Thus, respiratory muscle training should also aim at 
improvements or at least maintenance of rib cage mobility. We developed a new method to 
measure rib cage mobility which showed very good reproducibility of measurements at maximal 
in- and expiration (chapter 7). We further compared diaphragmatic movement, intra-thoracic 
areas as well as anterior-posterior (AP) distances and transverse diameters of rib cage excursions 
from maximal breathing maneuvers between tetraplegic and gender-, age- and height- matched 
able bodied individuals (chapter 8).  
 
Error vs. differences of rib cage mobility in tetraplegic and able bodied individuals 
The added measurement errors of data at maximal in- and expiration plus their standard 
deviations (reported in chapter 7) have to be set in relation to changes between maximal in- and 
expiration in both groups of subjects (reported in chapter 8). Figures 1a and 1b show these total 
measurement errors of maximal breathing maneuvers including measurement errors’ standard 
deviations in relation to absolute changes in areas and distances. 
Figures 1a and 1b clearly show that added errors including their standard deviations (= error bars 
in Figures 1a and 1b) are still much smaller than differences in rib cage mobility between able 
bodied and tetraplegic individuals. Interestingly, areas and AP distances of rib cage excursions in 
individuals with tetraplegia are consistently around 40% of the ones from able bodied 
individuals. This raises the question whether both measures (areas and AP distances) are really 
necessary in order to report changes in rib cage mobility. For research purposes, due to the better 
reproducibility of intra-thoracic areas, both measures may produce better evidence, since 
changes due to interventions may be small. Nevertheless, for clinical use of this method a 
restriction on AP distances and transverse diameters should be discussed since this may bring 
forth important time saving and thus cost reduction of analysis. Nevertheless, to really answer 
this question, knowledge of changes due to interventions in individuals with tetraplegia is 
necessary.  
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Figures 1a and 1b: Changes in intra-costal area (Figure 1a) as well as anterior-posterior (AP) distance and 
transversal diameters (Figure 1b) from maximal inspiration to maximal expiration with indication of total 
measurement errors in tetraplegic and able bodied individuals. T4 = fourth thoracic vertebra; T9 = ninth thoracic 
vertebra. Note that errors of transversal diameters are too small to be shown (0.0004 to 0.008 cm) 
 
Expected changes in rib cage mobility due to respiratory muscle training 
Several studies found improvements in vital capacity (VC) after respiratory muscle training in 
subjects with tetraplegia (18, 22, 24, 38, 43, 47). Increases in VC may have effects on either rib 
cage or diaphragmatic excursions. In chapter 8 we showed that diaphragmatic function of 
individuals with motor complete tetraplegia below C5 is intact and the range of movement is not 
significantly lower than the one of able bodied individuals. Therefore, we can’t expect any 
significant change in diaphragmatic volume displacement after respiratory muscle training. Thus, 
improvements in VC may primarily increase rib cage mobility. This would have effects on the 
intra-costal area and concomitantly also on AP distances and/or transverse diameters. In order to 
guess how much change in these parameters respiratory muscle training may induce, Table 2 
presents an overview on the above mentioned studies that found improvements in VC after 
respiratory muscle training.  
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Table 2: Overview of respiratory muscle training studies that found improvements in vital capacity (VC) 
Abbreviations: TPI = time post injury; C = cervical; EMT = expiratory muscle training; IMT = inspiratory muscle training; FVC = forced vital capacity
Autor / 
year 
 
Groups/ 
subjects 
[n] 
Lesion level 
complete-
ness 
Mean 
age 
(range) 
TPI 
[month] 
Training method and  duration Change in VC, if measured thoracic excursions 
Gounden et 
al.; 1990 
2 / 40 C5-C8 
complete-
ness 
unknown 
31  
(16-64) 
4-192 
(acute 
and 
chronic) 
EMT at 60% Pemax initially increasing 
intensity  
5 x 5-8 min/day, total at least 30 min/day 
6 d/week for 8 weeks 
Training Group: VC: 33% increase 1.47 to 1.97 l  
Control Group:  no significant increases 
Huldtgren 
et al.; 1980 
2 / 35 C4-C8 
complete 
23 
(16-69) 
3-39  EMT + IMT 
15 min/day for 6 weeks 
additionally: insuflating air to 100% TLC 
predicted with abdomen strapped  
Training group: Significant increases in VC,  
Control group: no significant differences  
no data of absolute values and changes (figures with individual 
values) 
Liaw et al.; 
2000 
2 / 20 C4 - C7  
 
34 
(16-52) 
1-4.5  IMT with individually increasing 
resistance 
15-20 min  twice daily, 7 days/week, for 
6 weeks 
 
Training group: VC increased 66.7% from 1.2 to 2.0 l; FVC 
increased 50% from 1.2 to 1.8 l 
Control group: VC and FVC increased 26.7% from 1.5 to 1.9 l;  
Chest circumference only increased sign. in training group (+ 
3.3cm at Xyphoid process; + 4.7cm at Umbilicus) 
Rutchick et 
al.; 1998 
 
1 / 10 C4-C7      
(5 complete; 
 6 incom-
plete) 
36 
(23-65) 
24-228 
(chronic) 
IMT for 15 min twice daily; for 8 weeks VC increased 8% from 2.9 to 3.1 l after training,  
FVC increased 11% from 2.81 to 3.07 l after training 
Walker et 
al.; 1989 
1 / 15 C4-C8 
incomplete 
? 
(17-33) 
? 
(chronic) 
3 to 5 x/week 15 min of incentive 
spirometry + 3x/week 30 min 
armcranking exercise; 7-12 week 
VC increased 23.6 % from 2.5 to 3.26 l after training  
 
Zupan et 
al.; 1997 
1 / 13 C4-C7 
(10 com-
plete; 3 
incomplete) 
27 
(17-46) 
3-12  4 weeks IMT, 4 weeks EMT, 4 weeks no 
respiratory training in random order 
7 different breathing exercises for 10 
reps. each; twice a day 20-30 min; 6 
days/week 
after IMT: FVC increased 17% in supine position and 19% in 
sitting position 
after EMT: FVC increased 17% in supine position but showed 
no change in sitting position 
150
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Changes in rib cage mobility after respiratory muscle training in individuals with tetraplegia 
may substantially be influenced by the time post injury. Due to progressive stiffening of the 
rib cage, respiratory muscle training may theoretically have more impact on rib cage mobility 
early after injury than in individuals with chronic tetraplegia. Nevertheless, since we found 
that lung volumes and respiratory muscle pressure generating capacity increased 
spontaneously during the first year post injury (chapter 3), improvements of the control group 
(Table 2) have to be subtracted from improvements of the training group for studies 
performed in individuals early after injury. In the study of Liaw et al. (24) for example, 
changes in VC that may be related to 6 weeks of inspiratory muscle training would then even 
be 40%, which is remarkable (see Table 2). Chest circumference measurements showed that 
in this study (24) individuals gained more volume in the lower part of the trunk, indicating 
that changes may predominantly come from improvements in diaphragmatic function. In our 
study all tested subjects were individuals with chronic tetraplegia (chapter 8) and we found no 
differences in diaphragmatic movements between able bodied individuals and subjects with 
tetraplegia. Therefore we can not make any conclusions about the potential to increase 
diaphragmatic function in individuals with acute tetraplegia at present.  
Estenne and de Troyer (13) also reported that in tetraplegic individuals the general breathing 
pattern showed a greater expansion of the lower rather than the upper rib cage. They further 
found a more elliptical shape of the lower thoracic cage during inspiration. We also found a 
greater expansion of the lower than of the upper thoracic cage. The two studies in our 
overview (38, 43) (Table 2) that were conducted on individuals with chronic tetraplegia 
investigated quite different respiratory muscle training protocols. Probably as a cause of the 
additional arm cranking training in the study of Walker et al. (43) VC increases were much 
higher than in the other study where only inspiratory muscle strength training was performed. 
Due to various differences in time post injury, training method and duration, completeness of 
injury and in some studies (24, 38, 43, 47) the lack of a control group makes it quite difficult 
to draw conclusions about the impact of respiratory muscle training on changes in chest wall 
mobility of tetraplegic individuals. Nevertheless, these six studies show evidence for potential 
increases in VC in individuals with acute and chronic tetraplegia after respiratory muscle 
training. Due to this positive first evidence, further studies should examine the effects of 
different respiratory muscle training methods in individuals with acute and chronic 
tetraplegia. Effects on thorax mobility, associated changes in respiratory function and, ideally, 
also possible influences on breathing capacity and concomitantly the rate and severance of 
respiratory complications should be addressed. To assess changes in thorax mobility our new 
method using CT (Chapter 7) should be used. 
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Some questions concerning this issue have to be answered by future studies; e.g. what type of 
training, how much change due to which respiratory muscle training can be expected and how 
much change would be advantageous for individuals with tetraplegia?  
 
Implications of the studies and future directions for respiratory research in SCI 
Lesion specific reference values for lung function and respiratory muscle pressure generating 
capacity 
In chapter 2 and 3 we showed that respiratory function is affected to different extents in 
subjects with SCI, depending on lesion level and completeness. Therefore, lesion specific 
reference values are needed for lung function parameters and respiratory muscle pressure 
generating capacity. Such reference values would be very helpful for clinical practice in order 
to easily detect individuals with an increased risk at an early stage and to improve guidance 
for prevention as well as respiratory interventions. A meta-analysis of published studies that 
included a high number of subjects (25, 26, 29, 40), supplemented by further datasets of 
ample and uniformly distributed SCI cohorts would be necessary in order to build stable and 
lesion specific reference values for respiratory function parameters of individuals with SCI.  
A further step would be to determine which respiratory function parameter correlates best 
with which pulmonary complication with respect to level and completeness of the lesion. 
Thresholds of increased risk for pulmonary complications should be defined for those 
respiratory function parameters with the highest correlations with pulmonary complications. 
The aim of such thresholds would be to get an objective measurement instrument for subjects 
with an increased risk. This could help to intensify respiratory care before complications 
occur and thus decrease respiratory complications and health care costs and increase quality 
of life and life expectancy, especially in subjects with tetraplegia. 
 
Longitudinal trajectories and further influencing factors on respiratory function 
The effects of aging on respiratory function in SCI may differ from those effects encountered 
in able bodied individuals. Therefore this aspect would be interesting to study in a long term 
follow-up study. Further, possible confounding factors such as age at injury, number, severity 
and frequency of respiratory tract infections, rehospitalisations, duration and intensity of 
physical and respiratory exercise training, artificial ventilation at night and various 
medications have not been identified yet and would be interesting factors to be studied in a 
long term follow-up as well. 
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Respiratory muscle training in individuals with tetraplegia 
Respiratory muscle endurance training using normocapnic hyperpnoea showed increases in 
respiratory muscle endurance and expiratory muscle pressure generating capacity in 
paraplegic wheelchair racing athletes (chapter 5). These results are promising for individuals 
with tetraplegia. Thus, the effects of normocapnic hyperpnoea training on respiratory muscle 
endurance, pressure generating capacity and fatigue but also on rib cage mobility, the rate of 
respiratory complications, health care costs and quality of life in individuals with tetraplegia 
should be tested in a randomized controlled trial. Comparisons of normocapnic hyperpnoea 
training with other respiratory muscle training methods, e.g. training of in- or expiratory 
muscle pressure generating capacity or incentive spirometry, could be another important area 
of research. Concerning changes in rib cage mobility, comparisons of different respiratory 
muscle training methods would furthermore be instructive. Assuming that different 
respiratory muscle training methods exert varying effects on different respiratory muscle 
groups, the effects on rib cage mobility may differ as well. Using our method described in 
chapter 7, subjects of different respiratory muscle training groups could be measured before 
and after a training period in order to draw conclusions on changes in respiratory mechanics. 
This will hopefully help to find the individual optimal respiratory muscle training method for 
individuals according to their lesion level and respiratory problems.  
Sleep disordered breathing is an additional further problem with a high incidence in 
individuals with tetraplegia. During the first year after acute tetraplegia, Berlowitz et al. (3) 
found an incidence of 60-83% of individuals with tetraplegia showing an apnea-hypopnea 
index of > 10 events/h. Wang et al. (44) provide first evidence that resistive inspiratory 
muscle endurance training may enhance sleep disordered breathing in individuals with 
tetraplegia. We hypothesize that normocapnic hyperpnoea training may have similar or even 
stronger effects on sleep disordered breathing than resistive inspiratory muscle endurance 
training, because sleep disordered breathing may depend more on endurance properties of 
respiratory muscles than on their maximal pressure generating capacity. Thus, effects of 
normocapnic hyperpnoea training on sleep disordered breathing in SCI patients with 
tetraplegia would be a further interesting issue for future research. 
In summary, the overall goals of future research in the field of respiration in spinal cord 
injury should focus on finding means to effectively reduce respiratory complications and thus 
also reduce health care costs. This would in turn increase quality of life and life expectancy in 
individuals with SCI. Possible studies to achieve this goal thus should focus on:  
i) Defining lesion specific reference values for lung function and respiratory 
muscle pressure generation including its most important influencing factors 
and thresholds for increased risk of respiratory complications.  
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ii) Controlled respiratory muscle training studies in both subject with acute and 
chronic spinal cord injury. These studies should evaluate short and longterm 
effects of various respiratory muscle training methods on respiratory function 
and mechanics, rate and duration of respiratory complications, quality of life 
and sleep disordered breathing in individuals with SCI. 
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A spinal cord injury (SCI) causes lesion dependent impairments of respiratory muscles and 
thus may affect the respiratory system substantially. Respiratory complications increase with 
a higher lesion level and accordingly morbidity and mortality of individuals with SCI is 
substantially increased compared to the able bodied population (1, 4). In order to decrease 
respiratory complications, detailed knowledge of time-courses and lesion specific baseline 
characteristics of the respiratory function in subjects with SCI is needed. Thus, this thesis 
focused on baseline lung function and respiratory muscle pressure as well as on their time-
courses during the first two years after injury, rib cage mobility, and respiratory muscle 
endurance training of different subgroups with SCI.  
In Chapter 1 a general overview of lesion specific impairments in SCI and its’ epidemiology 
is shown. Then, the current knowledge of respiratory mechanics and different methods of 
respiratory muscle training in able bodied individuals and subjects with SCI are discussed and 
summarized. At the end of the chapter, the purposes of the studies presented in this thesis and 
the methods applied are presented.   
The aim of the study presented in Chapter 2 was to assess the influences of lesion and 
personal characteristics on respiratory function in subjects with SCI, one year after discharge 
from inpatient rehabilitation. We found that higher lesion levels are associated with lower 
lung function and especially lower respiratory muscle pressure generating capacity. Subjects 
with motor complete tetraplegia showed the highest impairments and expiratory muscle 
pressure was the most affected parameter in all subjects with SCI. Further, we present 
regression equations to estimate lesion specific lung function and respiratory muscle pressure 
for individuals with SCI, around two years post injury. 
In Chapter 3 we present trajectories of lung function and respiratory muscle pressure during 
and one year after inpatient rehabilitation for four different lesion level groups of subjects 
with motor complete SCI. We found that respiratory function improved during inpatient 
rehabilitation, but only forced vital capacity, forced expiratory volume in 1 s and maximal 
inspiratory muscle strength further improved during the first year after discharge from 
inpatient rehabilitation. The fact that maximal expiratory muscle pressure
 
already decreased 
during the first year after inpatient rehabilitation shows that interventions to improve 
expiratory muscle function should be an important issue in respiratory care of subjects with 
SCI. 
The aim of the study presented in Chapter 4 was to adapt respiratory muscle endurance 
training using normocapnic hyperpnoea to the specific respiratory conditions of subjects with 
para- and tetraplegia, since this method was not used in subjects with SCI before. Thus, the 
aim was to find the level of ventilation that subjects with para-and tetraplegia can sustain for 
10 to 20 minutes. These intensities may then be used as guidelines to implement respiratory 
muscle endurance training in subjects with SCI. In contrast to able bodied individuals who 
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sustain about 70% of their individual maximal voluntary ventilation (MVV) during 10 to 20 
minutes, subjects with tetraplegia sustain only around 40% of their individual MVV during 
the target time and subjects with paraplegia are able to perform respiratory muscle endurance 
training at about 60% of their individual MVV for 10 to 20 minutes.  
In Chapter 5 we assessed the effects of respiratory muscle endurance training, using 
normocapnic hyperpnoea exercise, on exercise performance in wheelchair racing athletes with 
SCI. Effects of respiratory muscle endurance training on upper extremity exercise 
performance have not yet been investigated. They may differ from effects reported on leg 
endurance exercise performance in able bodied individuals, due to the concurrent use of upper 
extremity muscles for locomotion and respiration. We found significant increases in 
respiratory muscle endurance after six weeks of respiratory muscle endurance training 
performed five times a week during 30 min each. Due to high inter-individual differences and 
small group sizes, increases in expiratory muscle pressure and exercise performance (10 km 
time-trial) were only significant within the training group, but not between the training and 
the control group. Nevertheless, this study provides interesting preliminary results that show 
the potential effects of normopcapnic hyperpnoea training on respiratory muscle endurance, 
upper body exercise performance and expiratory muscle pressure in subjects with SCI. 
High blood lactate levels are produced during anaerobic exercise intensities and blood lactate 
is used as energy source during low intensity exercise by type I muscle fibres. Normocapnic 
hyperpnoea exercise is performed by respiratory muscles which mainly contain type I fibres. 
Normocapnic hyperpnoea at low intensities may be advantageous as a recovery strategy in 
order to preserve energy sources of the limb muscles. The aim of the study presented in 
Chapter 6 was to investigate the impact of low intensity normocapnic hyperpnoea on blood 
lactate disappearance after exhaustive arm exercise in comparison to passive and active 
recovery using the previously loaded muscle groups. The results showed that low intensity 
normocapnic hyperpnoea does not seem to enhance blood lactate disappearance after 
exhaustive arm exercise compared to passive or active recovery using the previously loaded 
muscle group. The magnitude of the involved muscle mass appears critical to effective active 
recovery. 
Stiffening of the thoracic cage decreases rib cage mobility and respiratory function, especially 
in subjects with chronic tetraplegia (2, 3). Thus, improvements in rib cage mobility should be 
a further aim of respiratory care in subjects with SCI. To determine which intervention should 
be used to achieve this goal, an easy to perform and highly reproducible measurement method 
of rib cage mobility should be available. In Chapter 7 we present a new method to assess rib 
cage mobility in humans, using computed tomography. We showed that this method is highly 
reproducible in able bodied individuals and subjects with tetraplegia and thus useful for 
clinical practice. 
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In Chapter 8 we assessed differences in rib cage mobility and diaphragmatic movements 
between able bodied individuals and subjects with chronic, motor complete tetraplegia, using 
the method described in chapter 7. Knowledge of such differences is important in order to 
quantify changes achieved in subjects with tetraplegia due to respiratory interventions, aiming 
at improvements in rib cage mobility. We found that rib cage mobility of individuals with 
chronic tetraplegia is reduced but not absent, whereas movement of the diaphragm is intact. 
Further, we present data of absolute differences in rib cage mobility and diaphragm 
movement between able bodied individuals and gender, age and height matched persons with 
chronic tetraplegia, including 95% confidence intervals. 
In Chapter 9 the current knowledge from former studies and data from this thesis on time-
courses of respiratory function after injury and lesion specific impairments in respiratory 
function in SCI were discussed in a comprehensive way. Further, the potential of respiratory 
muscle endurance training to improve respiratory function in SCI was reviewed and discussed 
from previous studies and available data from this thesis. In addition, the issue of rib cage 
mobility and it’s consequences on respiratory function were summarized and ideas to increase 
rib cage mobility were presented. Finally, we discussed some consequences and ideas for 
future research in order to improve respiratory function, decrease respiratory complications 
and health care costs and thus increase quality of life and life expectancy of subjects with 
spinal cord injury. 
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Een gevolg van een dwarslaesie is dat er, afhankelijk van de hoogte van de laesie, uitval van 
de ademhalingsspieren optreedt. Deze uitval van ademhalingsspieren heeft gevolgen voor het 
functioneren van het ademhalingssysteem als geheel. Hoe hoger het niveau van de 
dwarslaesie, hoe groter de kans op complicaties van het ademhalingssysteem met als gevolg 
een hogere morbiditeit en mortaliteit in vergelijking tot gezonde personen (1, 4). Om het 
risico op complicaties te verminderen, is gedetailleerde kennis nodig van onder andere 
specifieke laesieniveau afhankelijke kenmerken en het beloop over tijd van deze kenmerken. 
Dit proefschrift concentreert zich op de basale longfunctie, de kracht en het 
uithoudingsvermogen van de ademhalingsspieren, als ook de beweeglijkheid van de thorax in 
de verschillende subgroepen van personen met een dwarslaesie. Daarnaast wordt het effect 
van training van het uithoudingsvermogen van de ademhalingsspieren besproken.  
In Hoofdstuk 1 wordt de epidemiologie van een dwarslaesie getoond en een algemeen 
overzicht gegeven van de gevolgen van een dwarslaesie. Vervolgens wordt de huidige kennis 
omtrent de werking van de ademhalingsspieren en het effect van verschillende 
trainingsvormen in de gezonde populatie en in personen met een dwarslaesie samengevat en 
besproken. Dit hoofdstuk eindigt met het benoemen van de doelen van de verschillende 
studies die gedaan werden voor dit proefschrift en met presentatie van de gebruikte 
methodiek. 
Het doel van de studie, zoals in Hoofdstuk 2 besproken, was het vaststellen van de invloeden 
van laesiespecifieke en persoonsspecifieke kenmerken op de ademhalingsfunctie in personen 
met een dwarslaesie, één jaar na ontslag uit het revalidatiecentrum. Er is een verband 
gevonden tussen laesieniveau, longfunctie en kracht van de ademhalingsspieren. Een hoger 
laesieniveau is geassocieerd met een verminderde longfunctie en een verminderd vermogen 
van de ademhalingsspieren om kracht te genereren. Personen met een complete tetraplegie 
hebben de meest aangedane longfunctie en de minste kracht van ademhalingsspieren. 
Daarnaast worden in dit hoofdstuk regressievergelijkingen gepresenteerd voor het schatten 
van de longfunctie en de kracht van de ademhalingsspieren voor personen met een 
dwarslaesie, 2 jaar na het ontstaan van de laesie. 
In Hoofdstuk 3 wordt het beloop van longfunctie en kracht van de ademhalingsspieren 
tijdens en 1 jaar na de klinische revalidatie besproken. Vier, op laesieniveau ingedeelde, 
groepen met een motorisch complete dwarslaesie zijn geanalyseerd. Gegevens uit de 
longitudinale studie lieten zien dat de ademhalingsfunctie tijdens klinische revalidatie 
verbeterde, maar dat in het eerste jaar na klinische revalidatie alleen geforceerde vitale 
capaciteit, geforceerde expiratoire volume in 1 seconde en maximale in- of uitademingskracht 
nog verder verbeterden. De maximale in- en uitademingskracht zijn vermindert in het eerste 
jaar na klinische revalidatie. Dit gegeven leidt tot de conclusie dat interventies nodig zijn om 
de kracht van de uitademingsspieren functie te verbeteren. Dit is een belangrijk aandachtspunt 
in de zorg voor personen met een dwarslaesie. 
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Het doel van de studie, zoals gepresenteerd in Hoofdstuk 4, is het ontwikkelen van het 
uithoudingsvermogen van de ademhalingsspieren op basis van normaocapnic hyperpnoe, 
voor personen met een dwarslaesie. Aangezien dit soort training niet eerder is toegepast bij 
dwarslaesiepatiënten, is deze training aangepast aan de specifieke kenmerken van deze groep. 
De trainingsintensiteit is zo ontwikkeld dat personen met een dwarslaesie deze training 10 tot 
20 minuten konden volhouden. Deze intensiteit is als richtlijn gebruikt voor training van 
nieuwe dwarslaesiepatiënten. In vergelijking met de gezonde populatie, die ongeveer 70% van 
hun maximale vrijwillige ventilatie (MVV) gebruiken binnen de 10 tot 20 minuten durende 
trainingstijd, gebruiken personen met een paraplegie 60% en personen met een tetraplegie 
maar 40% van hun MVV. 
In Hoofdstuk 5 beschrijven we de uitkomsten van een onderzoek naar training van het 
uithoudingsvermogen van de ademhalingsspieren, door middel van normocapnic hyperpnoe 
oefeningen, op de fysieke prestatie van rolstoelatleten met een dwarslaesie. Er is nog geen 
eerder onderzoek gedaan naar het effect van training van de ademhalingsspieren op de 
prestatie geleverd door de bovenste extremiteit. Onze hypothese was dat bij gezonde 
proefpersonen, ademhalingsspiertraining een ander effect zou hebben op inspanning geleverd 
door de bovenste extremiteiten dan op inspanning geleverd door de onderste extermiteiten. 
Het idee hierachter is dat dezelfde spiergroepen gebruikt worden voor ademhalen en het 
gebruik van de bovenste extremiteiten. In deze studie vonden we na 6 weken training van de 
ademhalingsspieren (5 maal per week 30 min) een significante toename van het 
uithoudingsvermogen van deze ademhalingsspieren. Ook vonden we een significant verschil 
tussen de kracht van de uitademingsspieren en de prestatie op een 10 kilometer tijdrit in de 
trainingsgroep. Deze uitkomsten zijn niet significant verschillend tussen de controlegroep en 
de trainingsgroep, waarschijnlijk ten gevolge van de kleine groepsgrootte en de grote 
verschillen tussen de proefpersonen. De resultaten van deze studie tonen wel aan dat er een 
potentieel effect is van normocapnic hyperpnoe training op het uithoudingsvermogen van de 
ademhalingsspieren, de prestatie van de bovenste extremiteit en de kracht van de 
uitademingsspieren in personen met een dwarslaesie. 
Tijdens anaerobe inspanning wordt een verhoogd gehalte van bloedlactaat 
gevonden. Bloedlactaat wordt gebruikt als een bron van energie tijdens inspanning met lage 
intensiteit door type 1 spiervezels. Normaocapnic hyperpnoe traint voornamelijk de 
ademhalingsspieren die uit dit type 1 vezels bestaan en wordt op lage intensiteit verricht. 
Normaocapnic hyperpnoe heeft daardoor het voordeel dat er energie gespaard kan worden 
voor beenspieren. Het doel van de studie beschreven in Hoofdstuk 6, was het onderzoeken 
van de impact van normocapnic hyperpnoe op afname van bloedlactaat niveau na arm-
inspanning in vergelijking tot de afname bij passief en actief herstel van de eerder belaste 
spiergroepen. Onze resultaten tonen aan dat normocapnic hyperpnoe de afname van 
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bloedlactaat na arm-inspanning niet verhoogd. Wel werd een verband aangetoond tussen de 
hoeveelheid spiermassa en het effectief actief herstel. 
Stijfheid van de borstkas vermindert de beweeglijkheid van de borstkas en daardoor ook de 
ademhalingsfunctie, in het bijzonder in personen met een chronische tetraplegie (2, 3). 
Verbetering van de mobiliteit van de borstkas zou een aandachtspunt moeten zijn in de zorg 
van personen met een dwarslaesie. Om de beweeglijkheid van de borstkas in de klinische 
praktijk te kunnen meten en te bepalen welke interventie er plaats zou moeten vinden is een 
gemakkelijk uit te voeren en reproduceerbare meetmethode nodig. In Hoofdstuk 7 
presenteren we een nieuwe methode om de mobiliteit van de borstkas te bepalen door gebruik 
van computer tomografie (CT). We tonen aan dat deze methode reproduceerbaar is bij 
gezonde personen en bij personen met een tetraplegie en bruikbaar is in de praktijk. 
Hoofdstuk 8 richt zich op het beschrijven van de verschillen in beweeglijkheid van de 
borstkas in gezonde personen en personen met een complete tetraplegie. Hiertoe hebben we 
de methode zoals in hoofdstuk 7 beschreven gebruikt. Het is van belang de verschillen in de 
mobiliteit van de borstkas te weten tussen gezonde proefpersonen en personen met een 
tetraplegie om de veranderingen in de beweeglijkheid van de borstkas, die gemeten werd in 
personen met een tetraplegie door interventies te kunnen kwantificeren. We vonden dat in 
personen met een complete tetraplegie de mobiliteit van de borstkas verminderd is, maar niet 
geheel afwezig. De verklaring die we hiervoor geven is dat de werking van het diafragma 
intact is. In dit hoofdstuk presenteren we verder de data betreffende de verschillen in de 
beweeglijkheid van de borstkas tussen gezonde proefpersonen en op geslacht, leeftijd en 
lichaamslengte gematchte personen met een tetraplegie.  
In Hoofdstuk 9 bediscussiëren we de tot nu toe beschreven kennis betreffende beloop in 
ademhalingsfunctie, en laesie specifieke beperkingen in ademhalingsfunctie in personen met 
een dwarslaesie zoals beschreven in de literatuur en de door ons gevonden resultaten. Ook 
wordt het potentiële effect van ademhalingsspier-training door middel van normocapnic 
hyperpnoe training, zoals gevonden in onze studie, besproken aan de hand van eerder 
gevonden studieresultaten. Vervolgens bespreken we de resultaten van onze studie 
betreffende de beweeglijkheid van de borstkas en de gevolgen van een verminderde 
beweeglijkheid van de borstkas in personen met een dwarslaesie en doen we een voorstel om 
de beweeglijkheid van de borstkas te verbeteren. Ten slotte beschrijven we de gevolgen van 
een verminderde ademhalingsfunctie in personen met een dwarslaesie en doen voorstellen om 
deze te verbeteren. Deze voorstellen hebben een potentieel tot een vermindering van 
complicaties van de ademhalingswegen, zoals infecties. Het gevolg hiervan is een 
vermindering van kosten voor de gezondheidszorg en een verbeterde kwaliteit van leven in 
personen met een dwarslaesie. 
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Eine Querschnittlähmung führt oft zu Beeinträchtigungen der Atmungsmuskulatur und dies 
wirkt sich auf das gesamte respiratorische System aus. Dabei gilt: Je höher die Lähmung, 
desto grösser die Beeinträchtigungen der Atmungsmuskulatur und die Gefahr von 
Atemwegskomplikationen. Infolgedessen sind die Morbidität und Mortalität von 
querschnittgelähmten Personen im Vergleich zu Fussgängern substantiell erhöht (1, 4). Um 
das Auftreten von Atemwegskomplikationen in Zukunft zu vermindern, ist es notwendig den 
Verlauf sowie läsionsabhängige Einschränkungen der Lungenfunktion von Patienten mit 
Querschnittlähmung genau zu kennen. Daher sind die Hauptthemen dieser Dissertation dem 
Verlauf der Lungenfunktion und Atmungsmuskelkraft, den Einschränkungen der 
Thoraxmobilität sowie dem Atmungsausdauertraining mittels normokapnischer Hyperpnoe 
gewidmet.  
In Kapitel 1 wird ein genereller Überblick zum Thema Querschnittlähmung, deren 
Epidemiologie und läsionsabhängiger Funktionseinschränkungen vermittelt. Anschliessend 
wird das heutige Wissen der Bereiche Atemmechanik sowie verschiedene 
Atmungstrainingsmethoden bei Fussgängern und querschnittgelähmten Personen diskutiert 
und zusammengefasst. Am Schluss dieses Kapitels werden die Fragestellungen der einzelnen 
Kapitel dieser Dissertation vorgestellt sowie die verwendeten Methoden erklärt.  
In Kapitel 2 wird eine Studie präsentiert, deren Ziel es war den Einfluss der Lähmungshöhe 
sowie persönlicher Faktoren auf die Atmungsfunktion bei Personen ein Jahr nach Ende der 
Erstrehabilitation zu bestimmen. Dabei haben wir herausgefunden dass eine höhere 
Lähmungshöhe eine schlechtere Lungenfunktion und vor allem eine tiefere 
Atmungsmuskelkraft zur Folge hat. Patienten mit motorisch kompletter Tetraplegie waren die 
am stärksten betroffene Patientengruppe und die maximale Kraft der Ausatmungsmuskulatur 
war der am meisten beeinträchtigte Parameter. Zudem präsentieren wir in diesem Kapitel 
Regressionsgleichungen um läsionsspezifische Lungenfunktions- und Atmungs-
muskelkraftwerte für querschnittgelähmte Personen ein Jahr nach Ende der Erstrehabilitation 
zu berechnen.  
In Kapitel 3 werden die Verläufe der Lungenfunktion und Atmungsmuskelkraft während der 
Erstrehabilitation sowie 1 Jahr danach bei verschiedenen ‚Läsionshöhen-Gruppen’ motorisch 
komplett gelähmter Patienten untersucht. Dabei fanden wir heraus, dass sich die 
Lungenfunktion während der Erstrehabilitation signifikant verbessert, danach jedoch nur die 
forcierte Vitalkapazität, die Erstsekundenkapazität sowie die maximale inspiratorische Kraft 
nach Ende der Erstrehabilitation noch weiter ansteigen. Die Tatsache, dass die maximal Kraft 
der Ausatmungsmuskulatur bereits während der Erstrehabilitation wieder abnimmt, zeigt, 
dass Interventionen zur Funktionsverbesserung der Ausatmungsmuskulatur ein wichtiger 
Faktor des Atemwegsmanagements bei Querschnittlähmung sein sollten.  
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Das Ziel der Studie, die in Kapitel 4 präsentiert wird, war das Atmungsausdauertraining 
mittels normokapnischer Hyperpnoe auf die speziellen Voraussetzungen von Personen mit 
Para- und Tetraplegie zu adaptieren. Bis dato wurde diese Methode noch in keiner 
wissenschaftlichen Publikation mit querschnittgelähmten Patienten beschrieben. Daher war 
das Ziel unserer Studie eine Trainingsintensität zu finden, bei der Para- und Tetraplegiker im 
Stande sind zwischen 10 und 20 Minuten zu trainieren. Diese Intensitäten sollen dann 
gebraucht werden um Atmungsausdauertraining auch bei Patienten mit Para- und Tetraplegie 
in der Praxis anzuwenden. Im Vergleich zu Fussgängern, die eine Intensität von 70% des 
Atemgrenzwertes ca. 10-20 Minuten ausüben können, fanden wir tiefere Intensitäten für 
querschnittgelähmte Personen. Tetraplegiker können bei nur etwa 40% des individuellen 
Atemgrenzwertes 10-20 Minuten atmen, während Paraplegiker dies bei ca. 60% des 
individuellen Atemgrenzwertes gelingt.  
In Kapitel 5 haben wir die Effekte eines Atmungsausdauertrainings mittels normokapnischer 
Hyperpnoe auf die Ausdauerleistungsfähigkeit von Rennrollstuhlathleten untersucht. Die 
Effekte eines Atmungsausdauertrainings auf die körperliche Leistungsfähigkeit der oberen 
Extremitäten wurden bis dato nicht untersucht; diese könnten sich von Effekten auf die 
unteren Extremitäten unterscheiden, da die oberen Extremitäten gleichzeitig zum atmen und 
zur Fortbewegung gebraucht werden. Wir fanden signifikante Verbesserungen der 
Atmungsausdauer nach sechs Wochen Atmungsausdauertraining, das fünf Mal wöchentlich 
während je 30 Minuten absolviert wurde. Wegen grosser inter-individueller Unterschiede und 
kleinen Gruppengrössen waren die Verbesserungen der Maximalkraft der 
Ausatmungsmuskulatur sowie die Verbesserungen im 10 km Zeitfahren nur innerhalb der 
Trainingsgruppe, jedoch nicht zwischen Trainings- und Kontrollgruppe signifikant. 
Nichtsdestotrotz zeigt diese Studie interessante erste Resultate, nämlich die potentiell 
positiven Effekte eines Atmungsausdauertrainings bei Patienten mit Querschnittlähmung auf 
die Atmungsmuskelausdauer, die Ausatmungskraft und die Ausdauerleistungsfähigkeit der 
oberen Extremitäten.  
Während hochintensiven körperlichen Anstrengungen entstehen hohe 
Blutlaktatkonzentrationen. Laktat kann aber bei sportlichen Aktivitäten tiefer Intensität von 
den Typ I Muskelfasern wieder als Energiequelle genutzt werden. Die Atmungsmuskulatur 
besteht mehrheitlich aus Typ I Fasern. Normokapnische Hyperpnoe kann auch bei tiefen 
Intensitäten durchgeführt werden und dadurch hohe Blutlaktatkonzentrationen 
möglicherweise wesentlich senken. Daher könnte normokapnische Hyperpnoe eine 
vorteilhafte Erholungsmethode sein, da die intramuskulären Glykogenspeicher der 
Arbeitsmuskulatur (Arme oder Beine) geschont oder sogar schneller wieder aufgefüllt werden 
könnten. Das Ziel der Studie, die in Kapitel 6 präsentiert wird, war daher, den Einfluss von 
normokapnischer Hyperpnoe auf den Abbau der Blutlaktatkonzentration nach intensiver 
Armarbeit im Vergleich zu passiver und aktiver Erholung der zuvor belasteten Muskulatur zu 
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untersuchen. Die Resultate haben gezeigt, dass normokapnische Hyperpnoe tiefer Intensität 
die Abbaurate der Blutlaktatkonzentration nach intensiver Armarbeit im Vergleich zu passiver 
und aktiver Erholung der belasteten Muskulatur nicht zu erhöhen vermag. Die zur Erholung 
eingesetzte Muskelmasse scheint entscheidend zu sein für eine effektive aktive Erholung.  
Das progressive Versteifen des Thorax, welches vor allem bei Tetraplegikern häufig ist, 
vermindert dessen Mobilität und in der Folge auch die Funktion der Atmungsmuskulatur (2, 
3). Deshalb sollten Verbesserungen der Thoraxmobilität ein weiteres Ziel der Atemtherapie 
bei Querschnittlähmung sein. Um überhaupt bestimmen zu können, welche Intervention zu 
den grössten Verbesserungen der Thoraxmobilität führt, ist eine einfache und genaue 
Messmethode der Thoraxmobilität nötig. Daher präsentieren wir in Kapitel 7 eine neue 
Methode um die Thoraxmobilität mittels Computertomographie zu messen. Wir konnten 
zeigen, dass diese Methode sowohl bei Fussgängern als auch bei Patienten mit chronischer 
Tetraplegie sehr gut reproduzierbare Resultate erzeugt und daher in der Praxis einsetzbar ist.  
In Kapitel 8 haben wir die Unterschiede der Thoraxmobilität von Fussgängern und motorisch 
kompletten, chronischen Tetraplegikern mittels der in Kapitel 6 beschriebenen Methode 
untersucht. Die genaue Kenntnis solcher Unterschiede ist wichtig, um Veränderungen der 
Thoraxmobilität über die Zeit hinweg oder nach bestimmten Interventionen zu quantifizieren. 
Wir fanden heraus, dass die Thoraxmobilität bei chronischen Tetraplegikern zwar reduziert, 
aber doch vorhanden ist und dass die Diaphragmamobilität noch vollständig intakt ist. Weiter 
präsentieren wir Daten, inklusive deren 95% Konfidenz Intervalle, der absoluten Unterschiede 
der Thoraxmobilität von Fussgängern und Tetraplegikern.  
In Kapitel 9 werden das derzeitige Wissen aus der Literatur und die Daten dieser Dissertation 
in den Bereichen ‘Verläufe der Lungenfunktion nach Querschnittlähmung’ und 
‚Läsionsspezifische Einschränkungen der Lungenfunktion’ übergreifend diskutiert. Weiter 
wird das Potential von Atmungsausdauertraining im Bereich der Querschnittlähmung in 
Verbindung mit Resultaten anderer Atmungstrainingsstudien diskutiert. Zum Thema der 
Thoraxmobilität und deren Konsequenzen auf die Atmung zusammengefasst und Ideen zur 
Verbesserung der Thoraxmobilität werden diskutiert. Schliesslich werden einige 
Konsequenzen, die aus den in dieser Dissertation präsentierten Studien hervorgehen, 
diskutiert und Vorschläge für weiterführende Studien präsentiert. Ziele dieser 
weiterführenden Studien sollten die Verminderung von Atemwegskomplikationen sein und 
damit verbundene tiefere Gesundheitskosten sowie eine verbesserte Lebensqualität 
querschnittgelähmter Personen.  
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"Life is a fragile, fleeting thing,  
under any circumstances,  
and living it can be comic or tragic,  
weird or wonderful -  
regardless of one's motor 
limitations." (Maddox)
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